<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5983702</article-id><article-id pub-id-type="doi">10.3390/ijms19051511</article-id><article-id pub-id-type="publisher-id">ijms-19-01511</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title><italic>Copaifera</italic> of the Neotropics: A Review of the Phytochemistry and Pharmacology</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>da Trindade</surname><given-names>Rafaela</given-names></name><xref ref-type="aff" rid="af1-ijms-19-01511">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9351-876X</contrib-id><name><surname>da Silva</surname><given-names>Joyce Kelly</given-names></name><xref ref-type="aff" rid="af1-ijms-19-01511">1</xref><xref ref-type="aff" rid="af2-ijms-19-01511">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3639-0528</contrib-id><name><surname>Setzer</surname><given-names>William N.</given-names></name><xref ref-type="aff" rid="af3-ijms-19-01511">3</xref><xref ref-type="aff" rid="af4-ijms-19-01511">4</xref><xref rid="c1-ijms-19-01511" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-19-01511"><label>1</label>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Biotecnologia, Universidade Federal do Par&#x000e1;, 66075-900 Bel&#x000e9;m, Brazil; <email>rcabral@ufpa.br</email> (R.d.T.); <email>joycekellys@ufpa.br</email> (J.K.d.S.)</aff><aff id="af2-ijms-19-01511"><label>2</label>Programa de P&#x000f3;s-Gradua&#x000e7;&#x000e3;o em Qu&#x000ed;mica, Universidade Federal do Par&#x000e1;, 66075-900 Bel&#x000e9;m, Brazil</aff><aff id="af3-ijms-19-01511"><label>3</label>Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA</aff><aff id="af4-ijms-19-01511"><label>4</label>Aromatic Plant Research Center, 615 St. George Square Court, Suite 300, Winston-Salem, NC 27103, USA</aff><author-notes><corresp id="c1-ijms-19-01511"><label>*</label>Correspondence: <email>wsetzer@chemistry.uah.edu</email> or <email>wsetzer@aromaticplant.org</email>; Tel.: +1-256-824-6519</corresp></author-notes><pub-date pub-type="epub"><day>18</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2018</year></pub-date><volume>19</volume><issue>5</issue><elocation-id>1511</elocation-id><history><date date-type="received"><day>25</day><month>4</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>5</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; 2018 by the authors.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The oleoresin of <italic>Copaifera</italic> trees has been widely used as a traditional medicine in Neotropical regions for thousands of years and remains a popular treatment for a variety of ailments. The copaiba resins are generally composed of a volatile oil made up largely of sesquiterpene hydrocarbons, such as &#x003b2;-caryophyllene, &#x003b1;-copaene, &#x003b2;-elemene, &#x003b1;-humulene, and germacrene D. In addition, the oleoresin is also made up of several biologically active diterpene acids, including copalic acid, kaurenoic acid, alepterolic acid, and polyalthic acid. This review presents a summary of the ecology and distribution of <italic>Copaifera</italic> species, the traditional uses, the biological activities, and the phytochemistry of copaiba oleoresins. In addition, several biomolecular targets relevant to the bioactivities have been implicated by molecular docking methods.</p></abstract><kwd-group><kwd>copaiba</kwd><kwd>oleoresin</kwd><kwd>essential oil</kwd><kwd>sesquiterpenoids</kwd><kwd>diterpenoids</kwd><kwd>biological activity</kwd><kwd>molecular targets</kwd></kwd-group></article-meta></front><body><sec id="sec1-ijms-19-01511"><title>1. Introduction to the Genus <italic>Copaifera</italic></title><p>The copaiba trees belong to the genus <italic>Copaifera</italic>, family Fabaceae, and subfamily Caesalpinoideae. The genus was described the first time by Marcgraf and Piso in 1638, who employed the name &#x0201c;Copaiba&#x0201d; without designating the species [<xref rid="B1-ijms-19-01511" ref-type="bibr">1</xref>]. In 1760, Nicolaus Joseph Von Jacquin described the species <italic>Copaiva officinalis</italic> in the work <italic>Enumeratio Systematica Plantarum</italic> [<xref rid="B2-ijms-19-01511" ref-type="bibr">2</xref>]. Afterwards, in the year 1764, Carl von Linnaeus did a more detailed study of the genus in the work <italic>Species Plantarum</italic>, in which he described the type species <italic>Copaifera officinalis</italic> (Jacq.) L. [<xref rid="B3-ijms-19-01511" ref-type="bibr">3</xref>]. There are more than 70 <italic>Copaifera</italic> species distributed throughout the world, with widespread occurrence in Central and South America; there are also four species found in Africa and one species found on the island of Borneo, situated in the Pacific Ocean [<xref rid="B4-ijms-19-01511" ref-type="bibr">4</xref>]. Brazil is the country with the greatest biodiversity of <italic>Copaifera</italic> with 26 species and 8 varieties [<xref rid="B5-ijms-19-01511" ref-type="bibr">5</xref>].</p><p>The vernacular name copa&#x000ed;ba probably originated from the Tupi-Guarani and alludes to the names used by indigenous peoples, copa&#x000ed;va and copahu (kupa&#x02019;iwa and kupa&#x02019;u, respectively), which refers to the tree exudate, in reference to the oil stored in its interior [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>]. Sixteenth-century records produced by chroniclers during the Brazilian colonization report the widespread use of copaiba oil among the natives as anti-inflammatory and healing agents, and also for esoteric purposes, such as aphrodisiac and contraceptive [<xref rid="B4-ijms-19-01511" ref-type="bibr">4</xref>,<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>,<xref rid="B7-ijms-19-01511" ref-type="bibr">7</xref>]. This natural product is known and valued to the present day, mainly in the Amazon region, where the rural population has little access to industrialized pharmaceutical products and public health care [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>,<xref rid="B8-ijms-19-01511" ref-type="bibr">8</xref>].</p><p>The copaiba trees have shrub or arboreal habits, can reach up to 40 m height and 4 m diameter at breast height (dbh), have slow growth, and can live up to 400 years [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>]. Their cylindrical trunks contain intercellular secretory channels arranged in bands of marginal axial parenchyma, the lumen from secretory cells is formed schizogenously, and the oleoresin is synthesized in parenchyma cells of the canal. The species have alternate leaves, which are pinnate with 2&#x02013;12 pairs of leaflets (opposite, alternate, or subopposite), usually glabrous, and may have translucent points and glands at the base of the marginal vein; they have small and interpetiolar stipules and are generally deciduous. The inflorescences are alternate panicles and the flower buds are protected by small bracts; they have small flowers, numerous and sessile, which are monoclamids with a tetramer chalice that forms short tubes and contains internally hirsute sepals. The androecium holds 10 free stamens, glabrous fillets, and oblong and rimose anther; and the gynoecium presents a sessile ovary with two elongate ovules, filiform style, and globular and papillary stigma. The fruits are bivalved, dehiscent, laterally compressed, and monospermic. The seed is a pendulum, oblong-globose, covered by abundant white or yellow aril, and lacking endosperm [<xref rid="B1-ijms-19-01511" ref-type="bibr">1</xref>,<xref rid="B9-ijms-19-01511" ref-type="bibr">9</xref>,<xref rid="B10-ijms-19-01511" ref-type="bibr">10</xref>,<xref rid="B11-ijms-19-01511" ref-type="bibr">11</xref>].</p><p>Although the <italic>Copaifera</italic> genus has been extensively studied taxonomically, there are still difficulties in identifying some species, mainly due to their intricate floral morphology and absence of reproductive structures in the samples studied. With regard to the Amazonian species, the scarcity of field information and illustrations of specimens comprise the main limitations for botanical descriptions of the group. These taxonomic problems have restricted the advance of chemical and pharmacological research, limited the industrial and rational uses of resin oils and wood, and have also hampered the development of projects, plans for sustainable management, and conservation of commercially targeted species [<xref rid="B9-ijms-19-01511" ref-type="bibr">9</xref>,<xref rid="B12-ijms-19-01511" ref-type="bibr">12</xref>].</p><p>The main economic contributions of <italic>Copaifera</italic> species have been wood and oleoresins. Among <italic>Copaifera</italic> species that are used in the production of oleoresins, <italic>C. reticulata</italic> is the most frequent, representing 70% of the production [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>]. Copaiba oleoresin is one of the most important renewable natural remedies for the indigenous people from the Amazon region and its use is widely diffused due its various pharmacological properties [<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]. The oleoresin is a transparent, colored liquid with variable viscosity, and is constituted by a nonvolatile fraction composed of diterpenes and a volatile fraction composed of sesquiterpenes [<xref rid="B14-ijms-19-01511" ref-type="bibr">14</xref>,<xref rid="B15-ijms-19-01511" ref-type="bibr">15</xref>]. Its chemical profile may vary according to species, seasonal and climatic characteristics of the environment, soil type and composition, and rainfall index. Biotic pressures, such as insect predation and pathogen infection, also cause differences in oleoresin composition [<xref rid="B16-ijms-19-01511" ref-type="bibr">16</xref>,<xref rid="B17-ijms-19-01511" ref-type="bibr">17</xref>]. The extraction of copaiba oil is done through the perforation of the trunk with a punch, and the resin is collected with the help of a polyvinyl chloride (PVC) pipe, through which the oil flows and is then stored. This practice is mainly done by plant extraction; therefore, the product of several trees is often mixed, resulting in an additional obstacle to the botanical identity of the copaiba trees. In addition, the lack of parameters to characterize the oil and to perform quality control of the botanical drug also constitutes an obstacle for the registration and exportation of herbal products containing copaiba [<xref rid="B18-ijms-19-01511" ref-type="bibr">18</xref>,<xref rid="B19-ijms-19-01511" ref-type="bibr">19</xref>].</p></sec><sec id="sec2-ijms-19-01511"><title>2. Ecology and Distribution of <italic>Copaifera</italic></title><p>The genus <italic>Copaifera</italic> is native to tropical regions of Latin America, an area of great species diversity [<xref rid="B1-ijms-19-01511" ref-type="bibr">1</xref>]. Distributed widely in the Americas, stretching from Mexico to northern Argentina, the genus also occurs in West Africa and Asia [<xref rid="B20-ijms-19-01511" ref-type="bibr">20</xref>]. The greatest richness of species occurs in Brazil, where they are distributed from the north to the south of the country. The most common species are <italic>C. multijuga</italic> Hayne, which is found in the Amazonas, Par&#x000e1; and Rond&#x000f4;nia states; <italic>C. reticulata</italic> Ducke that occurs in Amap&#x000e1;, Par&#x000e1; and Roraima;, and <italic>C. langsdorffii</italic> Desf., which can occur from the northern to southern regions of Brazil [<xref rid="B5-ijms-19-01511" ref-type="bibr">5</xref>]. Other species have more restricted distribution, such as <italic>C. guyanensis</italic> Desf. (Amazonas), <italic>C. majorina</italic> Dwyer (Bahia), <italic>C. cearensis</italic> Huber ex Ducke (Cear&#x000e1;, Bahia, Piau&#x000ed; and Rio de Janeiro), <italic>C. elliptica</italic> Mart. (Goias and Mato Grosso), <italic>C. paupera</italic> (Herzog) Dwyer (Acre), and <italic>C. lucens</italic> Dwyer (Bahia, Esp&#x000ed;rito Santo, Minas Gerais, Rio de Janeiro, S&#x000e3;o Paulo) [<xref rid="B5-ijms-19-01511" ref-type="bibr">5</xref>]. Although many species of <italic>Copaifera</italic> have wide occurrence within the Brazilian territory, and may occur in different phytogeographic domains (e.g., <italic>C. langsdorffii</italic>), some feature endemism, such as <italic>C. trapezifolia</italic> Hayne, which occurs in an extremely disturbed region of the Atlantic rainforest, of which only 11.6% of the natural vegetation cover remains [<xref rid="B21-ijms-19-01511" ref-type="bibr">21</xref>]. Thus, morphological, physiological, and ecological studies are highly relevant for the preservation of species and their natural environment [<xref rid="B11-ijms-19-01511" ref-type="bibr">11</xref>]. A study conducted in the Minas Gerais state on the geographical distribution and environmental characteristics of arboreal species showed that <italic>C. langsdorffii</italic> has wide occurrence throughout the whole state, where latosol type soil predominates, but additionally has a preference for ustic soils (62%) [<xref rid="B22-ijms-19-01511" ref-type="bibr">22</xref>].</p><p>In relation to the ecological group, copa&#x000ed;ba are classified as long-living, late secondary, and climax tree species, demanding of light but tolerant to shade [<xref rid="B23-ijms-19-01511" ref-type="bibr">23</xref>]. They are considered generalists because they are adapted to a wide variety of environments. They can occur in floodplains, riparian forest, and streams of the Amazon basin and the forests of the Cerrado in the center of Brazil [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>]. <italic>C. langsdorffii</italic>, for example, has great ecological plasticity, occurring in several biomes, such as Cerrado, Atlantic Forest, Caatinga, and Amazon rainforest [<xref rid="B23-ijms-19-01511" ref-type="bibr">23</xref>]. <italic>Copaifera</italic> species have great plasticity in relation to edaphic conditions; they occur in areas with fertile soil and well-drained soil and in areas with very poor acidic soils, such as Cerrado fields. They grow well on sandy and clayey soils and generally occupy the forest canopy [<xref rid="B25-ijms-19-01511" ref-type="bibr">25</xref>,<xref rid="B26-ijms-19-01511" ref-type="bibr">26</xref>].</p><p>Phenological studies on <italic>Copaifera</italic> are important for the rational use of the species and for the preparation of management plans [<xref rid="B27-ijms-19-01511" ref-type="bibr">27</xref>]. The reproduction of copaibas occurs from the fifth year of growth after planting in a climax forest ecosystem [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>]. <italic>C. multijuga</italic>, commonly found in the Amazon, blooms in the rainy season&#x02014;between the months of December&#x02013;April&#x02014;and fructifies between April and July [<xref rid="B27-ijms-19-01511" ref-type="bibr">27</xref>]. Blooming of <italic>C. reticulata</italic> occurs from January to March, with fruiting from March to August, lasting into October [<xref rid="B26-ijms-19-01511" ref-type="bibr">26</xref>,<xref rid="B28-ijms-19-01511" ref-type="bibr">28</xref>]. <italic>C. langsdorffii</italic>, observed in the Tijuca Forest, Rio de Janeiro, blooms between March and April and fructifies between August and September. Another survey carried out near Campinas, S&#x000e3;o Paulo state, showed that flowering of <italic>C. langsdorffii</italic> occurs in the middle of the rainy season (December&#x02013;February), with development of fruit during the dry season (April&#x02013;September) [<xref rid="B29-ijms-19-01511" ref-type="bibr">29</xref>,<xref rid="B30-ijms-19-01511" ref-type="bibr">30</xref>]. The phenophases of <italic>C. officinalis</italic> were monitored in the municipality of Boa Vista (Roraima state, Brazil), and showed that the flowering of the species occurs between the months of September and November and the fruiting from November to March. Depending on the stage of fruit ripening, the dehiscence can begin in January, in which the seeds enveloped by the aril are exposed, allowing for their dispersal [<xref rid="B28-ijms-19-01511" ref-type="bibr">28</xref>]. </p><p><italic>Copaifera</italic> is a hermaphrodite plant of mixed reproduction with a predominance of allogamy. The trees are generally bee pollinated (melittophily), and <italic>Apis mellifera</italic> and <italic>Trigona</italic> spp. are its main pollinating agents [<xref rid="B25-ijms-19-01511" ref-type="bibr">25</xref>]. <italic>C. langsdorffii</italic> has high fecundity, producing large quantity of fruits in a short period of time. Its seeds have low nutritional value, mainly composed of carbohydrates, but can attract a wide variety of animals with a general diet [<xref rid="B30-ijms-19-01511" ref-type="bibr">30</xref>]. The dispersion of the copaiba seeds occurs mainly in zoocoric and barocoric forms [<xref rid="B27-ijms-19-01511" ref-type="bibr">27</xref>,<xref rid="B28-ijms-19-01511" ref-type="bibr">28</xref>]. Some vertebrates, such as birds and mammals, have been observed visiting the fruits of <italic>Copaifera</italic> [<xref rid="B31-ijms-19-01511" ref-type="bibr">31</xref>]. Its seeds have morphological characteristics that fit the ornithocoria syndrome, mainly because they are black with colored, fleshy arils, which, after being swallowed, can be regurgitated intact and remain viable for germination [<xref rid="B32-ijms-19-01511" ref-type="bibr">32</xref>]. A study revealed that 10 species of Passeriformes, such as <italic>Ramphastos toco</italic>, <italic>Cyanocorax cristatellus</italic>, and <italic>Turdus rufiventris</italic>, visited the fruits of <italic>C. langsdorffii</italic>. Likewise, monkeys of the species <italic>Eriodes arachnoides</italic> and <italic>Cebus paella</italic> also eat the fruits of <italic>C. langsdorffii</italic> [<xref rid="B31-ijms-19-01511" ref-type="bibr">31</xref>]. Copaiba seeds may also present hydrocoric dispersion due to their frequent occurrence near waterways [<xref rid="B25-ijms-19-01511" ref-type="bibr">25</xref>]. Copaiba seeds are of conventional behavior and may be conserved in the long term ex situ, with dormancy due to the deposition of coumarin in the tegument, and its germination is of the epigene type [<xref rid="B25-ijms-19-01511" ref-type="bibr">25</xref>]. A tree can produce from 2 to 3 kg of seeds [<xref rid="B33-ijms-19-01511" ref-type="bibr">33</xref>].</p><p>The population density of copaiba trees in an area is usually very low. It is possible to find only one tree every 5 ha, but they may occur in densities of one to two trees per hectare. The production of oleoresin by species is fairly variable and can be influenced by genetic differences among species, habitat, soil, and intensity of exploitation [<xref rid="B34-ijms-19-01511" ref-type="bibr">34</xref>]. The production of oleoresin per tree ranges from 100 mL to 60 L per year. In addition, not all trees produce oil [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>]. Therefore, detailed investigations regarding extraction methods and equipment that do not harm the plant, correlation of genetic data to botanical identification of species, floristic inventory of copaiba populations, and ecological studies on its ecosystems are indispensable for the sustainable and rational use of this resource [<xref rid="B35-ijms-19-01511" ref-type="bibr">35</xref>,<xref rid="B36-ijms-19-01511" ref-type="bibr">36</xref>].</p></sec><sec id="sec3-ijms-19-01511"><title>3. Traditional Uses of <italic>Copaifera</italic></title><sec id="sec3dot1-ijms-19-01511"><title>3.1. Medicinal Uses</title><p>In Par&#x000e1; state (Amazon region, Brazil), people of all ages and social classes consider copaiba one of the most important natural remedies from the Amazon region. Several parts and preparations of the plant are used in folk medicine [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>]. The oleoresin or bark decoction is used as an anti-inflammatory and contraceptive by native people from the Brazilian Amazon. The topical application of oil on the skin serves to heal wounds. It is used in massages on the head to cure paralysis, pains, and convulsions. In Amap&#x000e1; state, it is recommended to soak a cotton ball in oil and place on tumors, ulcers, or hives. The daily intake of two drops of oil mixed with one tablespoon of honey is indicated for inflammation, syphilis, bronchitis, and cough [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>,<xref rid="B37-ijms-19-01511" ref-type="bibr">37</xref>,<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>]. In Venezuela, the oil is used to prepare a patch that is applied to heal ulcers and wounds, and the decoction of the bark in the form of a bath is used to combat rheumatism, to wash infected wounds such as dog bites, and to use as an anti-tetanus [<xref rid="B37-ijms-19-01511" ref-type="bibr">37</xref>,<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>]. A tea from the seeds is also used as a purgative and for treatment of asthma. In northern Brazil, the practice of &#x0201c;embrocation&#x0201d; (applying oil directly to the throat) is common to treat throat infections [<xref rid="B39-ijms-19-01511" ref-type="bibr">39</xref>]. In Bel&#x000e9;m, the &#x0201c;garrafada&#x0201d;&#x02014;an infusion of the bark sold in bottles&#x02014;is currently used as a substitute for the oleoresin due to the difficulty in obtaining the oil in the city [<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>]. </p><p>Copaiba has a wide range of ethnopharmacological indications, including for the treatment of: cystitis, urinary incontinence, gonorrhea, and syphilis; respiratory ailments, including bronchitis, strep throat, hemoptysis, pneumonia, and sinusitis; infections in the skin and mucosa, such as dermatitis, eczema, psoriasis, and wounds; ulcers and lesions of the uterus; leishmaniasis and leucorrhea; anemia; headaches; and snake bites. It is also used for its aphrodisiac, stimulant, anti-inflammatory, antiseptic, anti-tetanus, antirheumatic, antiherpetic, anthelminthic, anticancer, antitumor (prostate tumors), and antiparalytic properties [<xref rid="B4-ijms-19-01511" ref-type="bibr">4</xref>,<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>,<xref rid="B26-ijms-19-01511" ref-type="bibr">26</xref>,<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>,<xref rid="B40-ijms-19-01511" ref-type="bibr">40</xref>]. <italic>Copaifera</italic> species are used by people of Igarap&#x000e9; Miri (Par&#x000e1; state) for healing wounds [<xref rid="B41-ijms-19-01511" ref-type="bibr">41</xref>].</p><p>Studies have shown that the ingestion of high doses of copaiba oil can cause adverse side effects, such as gastrointestinal irritation, sialorrhea, and central nervous system depression. A dose of 10 g may cause symptoms of intolerance, nausea, vomiting, colic and diarrhea, and exanthema. Prolonged use may cause kidney damage and topical reactions in susceptible individuals [<xref rid="B39-ijms-19-01511" ref-type="bibr">39</xref>,<xref rid="B42-ijms-19-01511" ref-type="bibr">42</xref>]. Thus, the advance in pharmacological and quality control studies of copaiba formulations sold at herbal markets is indispensable for the safe use of this plant drug. </p></sec><sec id="sec3dot2-ijms-19-01511"><title>3.2. Human Nutrition</title><p>Copaiba oil was approved in the United States as a food additive and is used in small amounts as a flavoring agent in foods and beverages [<xref rid="B43-ijms-19-01511" ref-type="bibr">43</xref>].</p></sec><sec id="sec3dot3-ijms-19-01511"><title>3.3. Cosmetic Uses</title><p>The species of <italic>Copaifera</italic> are intensively pursued for inclusion in the cosmetics market due to their therapeutic properties and fragrant value of their oils [<xref rid="B44-ijms-19-01511" ref-type="bibr">44</xref>]. Copaiba oil is currently used in the cosmetic industry as a fixative for perfumes and perfuming soaps [<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>]. As an emollient, bactericidal, and anti-inflammatory agent, copaiba oil is used in the production of soaps, lotions, creams and moisturizers, bath foams, shampoos, and hair conditioners [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>,<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>]. In addition, it aids in the treatment of dandruff and acne [<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>,<xref rid="B45-ijms-19-01511" ref-type="bibr">45</xref>]. Despite its fragrant value, little information regarding its odorant potential is available in the literature [<xref rid="B44-ijms-19-01511" ref-type="bibr">44</xref>].</p></sec><sec id="sec3dot4-ijms-19-01511"><title>3.4. Fuel</title><p>As a renewable source of hydrocarbons, the use of copaiba oil as an ecologically clean fuel has been evaluated. Experimental plantations were started in the early 1980s near Manaus, Brazil to test its viability as an alternative energy source to fossil fuels [<xref rid="B7-ijms-19-01511" ref-type="bibr">7</xref>]. For potential use as fuel, a combination with diesel oil in a ratio of 9:1 (diesel oil to copaiba) has been recommended [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>]. Various reports indicate that the liquid can be poured directly into the fuel tank of a diesel-powered car and the vehicle will run normally, with a bluish exhaust smoke being the only noticeable difference [<xref rid="B46-ijms-19-01511" ref-type="bibr">46</xref>]. Traditionally, the oil is used in lamps as fuel for lighting [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>].</p></sec><sec id="sec3dot5-ijms-19-01511"><title>3.5. Wood</title><p>The copaiba trees are considered hardwoods with high demand due to their properties of strength, as well as insect and xylophagous fungi repellency. The wood is saturated with oil and resin and has been used in both shipbuilding and civil construction, especially in the manufacture of steam caves, pool cues, and decorative and furniture coverings. It is also used in the preparation of lumbers, rafters, door and window frames, and boards in general, including for agricultural implements, general carpentry, flooring furniture, coatings, lamination, plywood sheets. The wood has a high content of lignin and is very good for the production of alcohol and charcoal. <italic>C. langsdorffii</italic> has traditionally been exploited extensively for charcoal in the Cariri Region, south of Cear&#x000e1; [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>,<xref rid="B47-ijms-19-01511" ref-type="bibr">47</xref>]. </p></sec><sec id="sec3dot6-ijms-19-01511"><title>3.6. Veterinary Uses</title><p>In southern Par&#x000e1; state, farmers have used copaiba oil to prevent foot-and-mouth infection in cattle. The oil is poured on the floor next to the salt lick so that when cattle approach to eat salt, they step in oil soaking their feet [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>]. When wounded, some animals lick and rub their bodies in the oil that flows from the trees [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>].</p></sec><sec id="sec3dot7-ijms-19-01511"><title>3.7. Other Uses</title><p>Hunters often hunt under the copaiba tree during fruiting because the seeds and oil attract animals [<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>]. The oleoresin is used in the photographic industry to improve image clarity in areas of low contrast and resolution. The resin has also been used in paper making, as an additive for butadiene in the production of synthetic rubber, as a source of a chiral substrate in the synthesis of biomarkers of sediment and oil residues, and as fixative in the manufacture of varnish, perfume, and paints used in the painting of porcelain, fabrics, and for dying cotton yarn [<xref rid="B6-ijms-19-01511" ref-type="bibr">6</xref>,<xref rid="B24-ijms-19-01511" ref-type="bibr">24</xref>,<xref rid="B38-ijms-19-01511" ref-type="bibr">38</xref>].</p></sec></sec><sec id="sec4-ijms-19-01511"><title>4. Essential Oil Chemistry of <italic>Copaifera</italic></title><p>The major components of the essential oils from <italic>Copaifera</italic> species are summarized in <xref ref-type="table" rid="ijms-19-01511-t001">Table 1</xref>. In general, copaiba oils derived from <italic>Copaifera</italic> oleoresins are rich in sesquiterpene hydrocarbons and often dominated by &#x003b2;-caryophyllene [<xref rid="B15-ijms-19-01511" ref-type="bibr">15</xref>]. Some copaiba oils, however, also show significant concentrations of diterpene acids, which are generally analyzed as their methyl esters [<xref rid="B15-ijms-19-01511" ref-type="bibr">15</xref>]. A perusal of internet sources of copaiba oil suggests that the most important commercial sources of copaiba oil are <italic>C. langsdorffii</italic>, <italic>C. officinalis</italic>, and <italic>C. reticulata</italic>, and the most prized copaiba oils are rich in &#x003b2;-caryophyllene. The oleoresin essential oils from these three <italic>Copaifera</italic> species can have as much as 33% (<italic>C. langsdorffii</italic>), 87% (<italic>C. officinalis</italic>), and 68% (<italic>C. reticulata</italic>) &#x003b2;-caryophyllene (see <xref ref-type="table" rid="ijms-19-01511-t001">Table 1</xref>).</p></sec><sec id="sec5-ijms-19-01511"><title>5. Nonvolatile Chemistry of <italic>Copaifera</italic></title><p>The oleoresins of several <italic>Copaifera</italic> species have been shown to be rich sources of clerodane, kaurane, and labdane triterpenoids (<xref ref-type="fig" rid="ijms-19-01511-f001">Figure 1</xref>, <xref ref-type="fig" rid="ijms-19-01511-f002">Figure 2</xref> and <xref ref-type="fig" rid="ijms-19-01511-f003">Figure 3</xref>, <xref ref-type="table" rid="ijms-19-01511-t002">Table 2</xref>). In particular, <italic>C. langsdorffii</italic> resin is composed of biologically active copalic acid [<xref rid="B70-ijms-19-01511" ref-type="bibr">70</xref>,<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>] and kaurenoic acid [<xref rid="B72-ijms-19-01511" ref-type="bibr">72</xref>,<xref rid="B73-ijms-19-01511" ref-type="bibr">73</xref>,<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]. <italic>C. multijuga</italic> [<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>] and <italic>C. paupera</italic> [<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>] resins are also good sources of copalic acid.</p></sec><sec id="sec6-ijms-19-01511"><title>6. Biological Activities of <italic>Copaifera</italic></title><p><italic>Copaifera</italic> oleoresins have shown remarkable biological activities, many of which have been attributed to diterpenoid acids (see <xref ref-type="table" rid="ijms-19-01511-t003">Table 3</xref>). Generally, <italic>Copaifera</italic> oleoresins and their diterpenoid constituents have shown antibacterial, anti-inflammatory, antileishmanial, antiproliferative, antitrypanosomal, and wound-healing activities.</p><sec id="sec6dot1-ijms-19-01511"><title>6.1. Antiparasitic Activity of Copaiba</title><p>Several <italic>Copaifera</italic> oleoresin oils have shown in vitro antiparasitic activity against <italic>Leishmania amazonensis</italic> promastigotes, including <italic>C. cearensis</italic>, <italic>C. langsdorffii</italic>, <italic>C. lucens</italic>, <italic>C. martii</italic>, <italic>C. multijuga</italic>, <italic>C. officinalis</italic>, <italic>C. paupera</italic>, and <italic>C. reticulata</italic> [<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]. The resin oil of <italic>C. martii</italic> showed in vivo antileishmanial activity in a mouse model [<xref rid="B97-ijms-19-01511" ref-type="bibr">97</xref>] and <italic>C. reticulata</italic> resin oil showed activity against <italic>L. amazonensis</italic> axenic amastigotes (IC<sub>50</sub> = 15.0 &#x003bc;g/mL) and intracellular amastigotes (IC<sub>50</sub> = 20 &#x003bc;g/mL) [<xref rid="B109-ijms-19-01511" ref-type="bibr">109</xref>]. Diterpenoids isolated from <italic>C. officinalis</italic>&#x02014;agathic acid, alepterolic acid, kaurenoic acid, methyl copalate, pinifolic acid, and <italic>ent</italic>-polyalthic acid&#x02014;showed antileishmanial activity against <italic>L. amazonensis</italic> promastigotes [<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>].</p><p><italic>Copaifera</italic> oleoresins and diterpene acids have also shown antitrypanosomal activities. <italic>C. duckei</italic> and <italic>C. reticulata</italic> resins showed in vitro activity against <italic>T. evansi</italic> trypomastigotes [<xref rid="B86-ijms-19-01511" ref-type="bibr">86</xref>]. The diterpene acids&#x02014;agathic acid, copalic acid, alepterolic acid, kaurenoic acid, methyl copalate, pinifolic acid, and <italic>ent</italic>-polyalthic acid&#x02014;all showed antitrypanosomal activity against <italic>T. cruzi</italic>, including in the epimastigote, trypomastigote, and amastigote forms of the protozoan [<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>].</p><p>A number of parasitic protozoal proteins have been identified as potential targets for antiparasitic chemotherapy [<xref rid="B113-ijms-19-01511" ref-type="bibr">113</xref>]. In conjunction with this review, we have examined the potential parasitic targets of <italic>Copaifera</italic> diterpenoids using molecular docking. It is currently not known what biomolecular targets from <italic>Leishmania</italic> or <italic>Trypanosoma</italic> may be responsible for the antiprotozoal activities of copaiba. The <italic>Copaifera</italic> diterpenoids (<xref ref-type="fig" rid="ijms-19-01511-f001">Figure 1</xref>, <xref ref-type="fig" rid="ijms-19-01511-f002">Figure 2</xref> and <xref ref-type="fig" rid="ijms-19-01511-f003">Figure 3</xref>) were screened, in silico, against <italic>Leishmania</italic> drug targets [<xref rid="B114-ijms-19-01511" ref-type="bibr">114</xref>,<xref rid="B115-ijms-19-01511" ref-type="bibr">115</xref>,<xref rid="B116-ijms-19-01511" ref-type="bibr">116</xref>] and <italic>Trypanosoma cruzi</italic> protein targets [<xref rid="B117-ijms-19-01511" ref-type="bibr">117</xref>] using Molegro Virtual Docker v. 6.0.1 as previously described [<xref rid="B114-ijms-19-01511" ref-type="bibr">114</xref>,<xref rid="B115-ijms-19-01511" ref-type="bibr">115</xref>,<xref rid="B116-ijms-19-01511" ref-type="bibr">116</xref>,<xref rid="B117-ijms-19-01511" ref-type="bibr">117</xref>]. The docking energies are summarized in <xref ref-type="table" rid="ijms-19-01511-t004">Table 4</xref> and <xref ref-type="table" rid="ijms-19-01511-t005">Table 5</xref>.</p><p>The <italic>Leishmania</italic> protein target with the best overall docking properties with <italic>Copaifera</italic> diterpenoids was <italic>L. major</italic> dihydroorotate dehydrogenase (average <italic>E</italic><sub>dock</sub> = &#x02212;109.2 kJ/mol). These docking energies were better than the docking energy for the normal substrate, dihydroorotate (<italic>E</italic><sub>dock</sub> = &#x02212;72.1 kJ/mol) and comparable to the co-crystallized ligand for this protein, nitroorotate (<italic>E</italic><sub>dock</sub> = &#x02212;104.2 kJ/mol). Docking energies for <italic>Copaifera</italic> diterpenoids with TcDHODH (average &#x02212;92.5 kJ/mol) were also better than the normal substrate (dihydroorotate, <italic>E</italic><sub>dock</sub> = &#x02212;64.2 kJ/mol), but worse than the synthetic TcDHODH inhibitor, 5-[2-(5-carboxynaphthalen-2-yl)ethyl]-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidine-4-carboxylic acid (TT2-2-199, <italic>E</italic><sub>dock</sub> = &#x02212;140.7 kJ/mol). Similarly, <italic>Copaifera</italic> diterpenoids docked with <italic>L. donovani</italic> DHODH (average <italic>E</italic><sub>dock</sub> = &#x02212;89.9 kJ/mol) better than dihydroorotate (<italic>E</italic><sub>dock</sub> = &#x02212;60.9 kJ/mol). Based on these docking energies, protozoal dihydroorotate dehydrogenases are likely targets for <italic>Copaifera</italic> diterpenoids.</p><p><italic>Leishmania major</italic> methionyl-tRNA synthetase was another <italic>Leishmania</italic> protein target with good docking energies. Although the docking energies with this protein were excellent (average <italic>E</italic><sub>dock</sub> = &#x02212;106.9 kJ/mol), they are much poorer than the docking energy of the normal substrate, methionyl adenylate (<italic>E</italic><sub>dock</sub> = &#x02212;168.1 kJ/mol). Similarly, the <italic>T. cruzi</italic> target protein with the best docking was UDP-galactose mutase (average <italic>E</italic><sub>dock</sub> = &#x02212;104.5 kJ/mol), but the normal substrate and co-crystallized ligand, uridine diphosphate (UDP), had a much superior docking energy (<italic>E</italic><sub>dock</sub> = &#x02212;232.8 kJ/mol). Likewise, <italic>L. major</italic> UDP-glucose pyrophosphorylase showed an average docking energy of &#x02212;99.9 kJ/mol, which was much worse than UDP itself (<italic>E</italic><sub>dock</sub> = &#x02212;145.9 kJ/mol). The diterpenoids showed good docking to <italic>T. cruzi</italic> spermidine synthase, with an average docking energy of &#x02212;96.8 kJ/mol; however, these are much worse than the docking energy of the co-crystallized ligand, <italic>S</italic>-adenosyl methionine, with a docking energy of &#x02212;133.0 kJ/mol. Thus, although they exhibited good docking properties, it is unlikely that <italic>Copaifera</italic> diterpenoids can compete with the normal substrate ligands for these proteins.</p><p><italic>Copaifera</italic> diterpenoids showed excellent docking to <italic>L. mexicana</italic> pyruvate kinase (average <italic>E</italic><sub>dock</sub> = &#x02212;103.4 kJ/mol), much better than the normal substrate, phosphoenolpyruvate (<italic>E</italic><sub>dock</sub> = &#x02212;59.8 kJ/mol). Docking energies with <italic>T. cruzi</italic> pyruvate kinase were not as impressive (average &#x02212;80.3 kJ/mol), but still better than phosphoenolpyruvate (<italic>E</italic><sub>dock</sub> = &#x02212;48.6 kJ/mol) and comparable to the TcPYK inhibitor, ponceau S (<italic>E</italic><sub>dock</sub> = &#x02212;83.6 kJ/mol). Parasite pyruvate kinases can be expected to be target proteins for <italic>Copaifera</italic> diterpenoids.</p><p>Protozoal triosephosphate isomerases (LmexTIM and TcTIM) are expected to be targeted by <italic>Copaifera</italic> diterpenoids. The average docking energy with LmexTIM (&#x02212;90.7 kJ/mol) was much better than either the normal substrate (dihydroxyacetone phosphate, <italic>E</italic><sub>dock</sub> = &#x02212;52.4 kJ/mol) or the co-crystallized ligand, phosphoglycolohydroxamic acid (<italic>E</italic><sub>dock</sub> = &#x02212;61.1 kJ/mol). Likewise, docking energies with TcTIM (average &#x02212;88.2 kJ/mol) were better than the dihydroxyacetone phosphate (<italic>E</italic><sub>dock</sub> = &#x02212;59.7 kJ/mol) and comparable to the TcTIM inhibitor, 3-(2-benzothiazolylthio)-1-propanesulfonic acid (<italic>E</italic><sub>dock</sub> = &#x02212;85.5 kJ/mol).</p><p>Both <italic>L. major</italic> pteridine reductase and <italic>T. cruzi</italic> pteridine reductase had docking properties with <italic>Copaifera</italic> diterpenoids with comparable energies (average <italic>E</italic><sub>dock</sub> = &#x02212;93.8 and &#x02212;96.8 kJ/mol, respectively) with the normal substrate dihydrobiopterin (<italic>E</italic><sub>dock</sub> = &#x02212;96.9 and &#x02212;100.1 kJ/mol, respectively). Thus, <italic>Copaifera</italic> diterpenoids may compete with dihydrobiopterin for pteridine reductase.</p><p>Sterols are the normal substrates for sterol 14&#x003b1;-demethylase (CYP51), and triterpenoids are expected to also target this protein as inhibitors [<xref rid="B118-ijms-19-01511" ref-type="bibr">118</xref>]. Nevertheless, <italic>Copaifera</italic> diterpenoids showed docking energies that may compete with normal sterols for these protein targets. <italic>L. infantum</italic> CYP51 had an average docking energy with the diterpenoids of &#x02212;90.2 kJ/mol, which was generally not as good as a normal sterol substrate (obtusifoliol, <italic>E</italic><sub>dock</sub> = &#x02212;104.4 kJ/mol), but comparable to the known LinfCYP51 inhibitor fluconazole (<italic>E</italic><sub>dock</sub> = &#x02212;87.5 kJ/mol). Likewise, <italic>T. cruzi</italic> CYP51 had an average diterpenoid docking energy of &#x02212;89.5 kJ/mol, but substrate (obtusifoliol) docking of &#x02212;105.6 kJ/mol, and fluconazole docking energy of &#x02212;90.9 kJ/mol.</p><p><italic>Copaifera</italic> diterpenoids generally showed weak docking energies against the parasite cysteine proteases, <italic>L. donovani</italic> cathepsin B, <italic>L. major</italic> cathepsin B, or cruzain. This docking behavior of diterpenoids with <italic>Leishmania</italic> cathepsin B [<xref rid="B114-ijms-19-01511" ref-type="bibr">114</xref>] and cruzain [<xref rid="B117-ijms-19-01511" ref-type="bibr">117</xref>] was previously observed. <italic>Leishmania donovani</italic> and <italic>T. cruzi</italic> cyclophilins also showed weak docking energies.</p><p>Although <italic>Copaifera</italic> diterpenoids showed only weak docking to parasite glyceraldehyde-3-phosphate dehydrogenases, they may still target these proteins. LmexGAPDH had an average <italic>E</italic><sub>dock</sub> of &#x02212;73.0 kJ/mol and TcGAPDH had an average <italic>E</italic><sub>dock</sub> of &#x02212;70.3 kJ/mol, but these docking energies are better than the docking energies of the normal substrate, glyceraldehyde-3-phosphate (<italic>E</italic><sub>dock</sub> = &#x02212;58.9 and &#x02212;52.6 kJ/mol, respectively).</p><p>Additional <italic>Leishmania</italic> proteins expected to be targeted by <italic>Copaifera</italic> diterpenoids include glycerol-3-phosphate dehydrogenase, which showed excellent docking energies (average &#x02212;100.4 kJ/mol) to LmexGPDH, better than the normal substrate, glycerol-3-phosphate (<italic>E</italic><sub>dock</sub> = &#x02212;62.5 kJ/mol). Also targeted with a weak docking energy are: glucose-6-phosphate isomerase (Lmex GPI <italic>E</italic><sub>dock</sub> average = &#x02212;73.0 kJ/mol), though better than the docking energy of the normal substrate (glucose-6-phosphate, <italic>E</italic><sub>dock</sub> = &#x02212;62.0 kJ/mol); and phosphomannomutase (LmexPMM <italic>E</italic><sub>dock</sub> average = &#x02212;94.2 kJ/mol), which is better compared to the normal substrate (mannose-6-phosphate, <italic>E</italic><sub>dock</sub> = &#x02212;72.5 kJ/mol).</p><p>Additional <italic>T. cruzi</italic> protein targets may be dihydrofolate reductase&#x02014;thymidylate synthase (TcDHFR&#x02013;TS), which showed an average docking energy with <italic>Copaifera</italic> diterpenoids of &#x02212;93.2 kJ/mol, comparable to the docking energy of the normal substrate (dihydrofolate, &#x02212;99.3 kJ/mol), as well as the TcDHFR&#x02013;TS inhibitor cycloguanil (<italic>E</italic><sub>dock</sub> = &#x02212;83.1 kJ/mol); farnesyl diphosphate synthase (TcFPPS), with docking energies that averaged &#x02212;96.2 kJ/mol, which is comparable to the docking energy of the normal substrate, isopentenyl diphosphate (<italic>E</italic><sub>dock</sub> = &#x02212;98.9 kJ/mol); and hypoxanthine phosphoribosyltransferase (TcHPRT), having an average <italic>E</italic><sub>dock</sub> = &#x02212;82.1 kJ/mol, compared to the normal substrate, hypoxanthine, with <italic>E</italic><sub>dock</sub> of &#x02212;65.9 kJ/mol.</p></sec><sec id="sec6dot2-ijms-19-01511"><title>6.2. Antibacterial Activity of Copaiba</title><p>Copaiba oleoresin has shown antibacterial activity against several strains, in particular, Gram-positive <italic>Bacillus subtilis</italic> and <italic>Staphylococcus aureus</italic> with minimum inhibitory concentration (MIC) values of 5 &#x003bc;g/mL for both organisms [<xref rid="B110-ijms-19-01511" ref-type="bibr">110</xref>]. Copalic acid, isolated from <italic>C. langsdorffii</italic>, showed excellent antibacterial activity against <italic>Bacillus cereus</italic> (MIC 8.0 &#x003bc;g/mL), <italic>B. subtilis</italic> (MIC 5.0 &#x003bc;g/mL), <italic>Kocuria rhizophila</italic> (MIC 5.0 &#x003bc;g/mL), <italic>Streptococcus pyogenes</italic> (MIC 3.0 &#x003bc;g/mL), <italic>S. pneumoniae</italic> (MIC 3.0 &#x003bc;g/mL), <italic>S. agalactiae</italic> (MIC 2.0 &#x003bc;g/mL), <italic>S. dysgalactiae</italic> (MIC 1.0 &#x003bc;g/mL), <italic>S. epidermidis</italic> (MIC 0.5 &#x003bc;g/mL) [<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>], <italic>S. salivarius</italic> (MIC 2.0 &#x003bc;g/mL), <italic>S. mutans</italic> (MIC 3.0 &#x003bc;g/mL), <italic>S. mitis</italic> (MIC 5.0 &#x003bc;g/mL), <italic>S. sobrinus</italic> (MIC 3.0 &#x003bc;g/mL), and <italic>S. sanguinis</italic> (MIC 6.0 &#x003bc;g/mL) [<xref rid="B70-ijms-19-01511" ref-type="bibr">70</xref>]. Likewise, kaurenoic acid showed remarkable activity against <italic>S. pyogenes</italic> (MIC 5.0 &#x003bc;g/mL), <italic>S. pneumoniae</italic> (MIC 5.0 &#x003bc;g/mL), <italic>S. dysgalactiae</italic> (MIC 8.0 &#x003bc;g/mL) [<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>], <italic>S. epidermidis</italic> (MIC 4&#x02013;5 &#x003bc;g/mL), <italic>B. subtilis</italic> (MIC 3.1&#x02013;6.3 &#x003bc;g/mL), and <italic>S. aureus</italic> (MIC 8&#x02013;10 &#x003bc;g/mL) [<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>]. 3&#x003b1;-Alepterolic acid acetate (acetoxycopalic acid) showed moderate antibacterial activity against cariogenic <italic>Streptococcus</italic> bacteria, with MIC values ranging from 12.0 to 60.0 &#x003bc;g/mL [<xref rid="B70-ijms-19-01511" ref-type="bibr">70</xref>]. <italic>ent</italic>-Polyalthic acid also showed moderate antibacterial activity against <italic>B. subtilis</italic> (MIC 20&#x02013;30 &#x003bc;g/mL), <italic>S. aureus</italic> (MIC 40&#x02013;50 &#x003bc;g/mL), and <italic>S. epidermidis</italic> (MIC 40 &#x003bc;g/mL) [<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>].</p><p>In order to provide some insight into the mechanisms of activity, a virtual screening of copaiba diterpenoids has been carried out against several bacterial protein targets, including peptide deformylase, DNA gyrase, topoisomerase IV, UDP-galactopyranose mutase, protein tyrosine phosphatase, cytochrome P450 CYP 121, and nicotinamide adenine dinucleotide (NAD<sup>+</sup>)-dependent DNA ligase [<xref rid="B119-ijms-19-01511" ref-type="bibr">119</xref>] (see <xref ref-type="table" rid="ijms-19-01511-t006">Table 6</xref>). The best bacterial target for copalic acid was <italic>Mycobacterium tuberculosis</italic> DNA gyrase B (PDB 3ZKD) with a docking energy (<italic>E</italic><sub>dock</sub>) of &#x02212;105.7 kJ/mol. The protein with the best docking energy with kaurenoic acid was <italic>S. pneumoniae</italic> peptide deformylase (PDB 2AIE, <italic>E</italic><sub>dock</sub> = &#x02212;89.7 kJ/mol). 3&#x003b1;-Alepterolic acid acetate was the best docking ligand to <italic>Escherichia coli</italic> topoisomerase IV (PDB 1S16) and <italic>M. tuberculosis</italic> DNAGyrB (PDB 3ZKD) with docking energies of &#x02212;118.8 and &#x02212;118.3 kJ/mol, respectively. 3&#x003b2;-Alepterolic acid acetate also showed excellent docking to these two proteins with docking energies of &#x02212;117.1 and &#x02212;117.3 kJ/mol, respectively. The best bacterial target for <italic>ent</italic>-polyalthic acid was <italic>M. tuberculosis</italic> protein tyrosine phosphatase (PDB 2OZ5, <italic>E</italic><sub>dock</sub> = &#x02212;107.2 kJ/mol). The copaiba diterpenoid ligand with the best docking properties was 7&#x003b1;-acetoxyhardwickiic acid with <italic>S. aureus</italic> peptide deformylase (PDB 3U7M, <italic>E</italic><sub>dock</sub> = &#x02212;120.6 kJ/mol).</p></sec><sec id="sec6dot3-ijms-19-01511"><title>6.3. Antiproliferative Activity of Copaiba</title><p>Copaiba oleoresins have exhibited both in vitro and in vivo antiproliferative activities (<xref ref-type="table" rid="ijms-19-01511-t003">Table 3</xref>). <italic>Copaifera reticulata</italic> oleoresin, for example, has shown in vitro cytotoxic activity against GM07492-A human lung fibroblast cells with an IC<sub>50</sub> of 51.85 &#x003bc;g/mL [<xref rid="B68-ijms-19-01511" ref-type="bibr">68</xref>]. The oleoresin of <italic>C. multijuga</italic> has shown in vitro cytotoxic activity against B16F10 murine melanoma cells with an IC<sub>50</sub> of 457 &#x003bc;g/mL [<xref rid="B57-ijms-19-01511" ref-type="bibr">57</xref>]. Furthermore, in a mouse model of lung metastasis and tumor growth, oral administration of <italic>C. multijuga</italic> oleoresin reduced tumor growth, tumor mass, and number of lung nodules after inoculation of B16F10 tumor cells [<xref rid="B57-ijms-19-01511" ref-type="bibr">57</xref>]. Likewise, <italic>C. multijuga</italic> oleoresin, in doses varying between 100 and 200 mg/kg, showed antineoplastic properties against Ehrlich ascetic tumors and solid tumors in an in vivo mouse model [<xref rid="B98-ijms-19-01511" ref-type="bibr">98</xref>]. On the other hand, <italic>C. officinalis</italic> oleoresin actually stimulated growth of Walker 256 carcinoma by 70% in an in vivo rat model [<xref rid="B101-ijms-19-01511" ref-type="bibr">101</xref>].</p><p>Diterpenoids isolated from <italic>Copaifera</italic> species have shown cytotoxic activities (<xref ref-type="table" rid="ijms-19-01511-t003">Table 3</xref>). Copalic acid, isolated from <italic>C. langsdorffii</italic>, showed in vitro cytotoxicity on MO59J human glioblastoma cells and HeLa human cervical adenocarcinoma cells with IC<sub>50</sub> of 68.3 and 44.0 &#x003bc;g/mL, respectively [<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>]. Kaurenoic acid has demonstrated cytotoxicity against several human tumor cell lines, including CEM leukemia, MCF-7 breast tumor, HCT-8 colon tumor [<xref rid="B73-ijms-19-01511" ref-type="bibr">73</xref>], AGP01 gastric tumor, and SF-295 glioblastoma [<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]. Growth inhibition of AGP01 and SF-295 cells was also demonstrated by 3&#x003b2;-alepterolic acid and 3&#x003b2;-alepterolic acid acetate [<xref rid="B73-ijms-19-01511" ref-type="bibr">73</xref>]. Methyl copalate showed remarkable cytotoxic activity on P-388 murine lymphoma (IC<sub>50</sub> = 2.5 &#x003bc;g/mL), A-549 human lung carcinoma (IC<sub>50</sub> = 5 &#x003bc;g/mL), HT-29 human colon carcinoma (IC<sub>50</sub> = 5 &#x003bc;g/mL), and MEL-28 human melanoma (IC<sub>50</sub> = 10 &#x003bc;g/mL) cells [<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>].</p><p>Molecular docking (Molegro Virtual Docker, Aarhus, Denmark) has been carried out with <italic>Copaifera</italic> diterpenoids on cancer molecular targets, including androgen receptor, aromatase, caseine kinase II, cyclin-dependent kinases 2, 4, and 6, cyclooxygenase 2, DNA (cytosine-5)-methyltransferase-1 and -3A, epidermal growth factor receptor, estrogen receptor &#x003b1;, estrogen receptor &#x003b2;, heat shock protein 90, insulin-like growth factor 1 receptor, 5-lipoxygenase, mitogen-activated protein kinase 1, NF-&#x003ba;B, p90 ribosomal protein S6 kinase, P-glycoprotein, phosphatidylinositol-4,5-bisphosphate 3-kinase, topoisomerase I, topoisomerase II&#x003b1;, topoisomerase II&#x003b2;, tubulin, and vascular endothelial growth factor receptor (<xref ref-type="table" rid="ijms-19-01511-t007">Table 7</xref>). The best overall cancer targets for the copaiba diterpenoids were human DNA (cytosine-5)-methyltransferase-1 (HsDNMT1), human estrogen receptor &#x003b2; (HsER&#x003b2;), and human mitogen-activated protein kinase 1 (HsMEK1), with average MolDock docking energies of &#x02212;102.7, &#x02212;99.2, and &#x02212;101.5 kJ/mol, respectively. DNA (cytosine-5)-methyltransferase-1 (DNMT1) is the enzyme responsible for DNA methylation of carbon-5 of cytosine within CpG dinucleotides [<xref rid="B120-ijms-19-01511" ref-type="bibr">120</xref>]. The enzyme is required for embryonic development [<xref rid="B121-ijms-19-01511" ref-type="bibr">121</xref>], but is overexpressed in lung, liver, colorectal, gastric, breast, and lung tumors [<xref rid="B122-ijms-19-01511" ref-type="bibr">122</xref>]. Thus, DNMT1 has emerged as an attractive target for cancer chemotherapy [<xref rid="B123-ijms-19-01511" ref-type="bibr">123</xref>,<xref rid="B124-ijms-19-01511" ref-type="bibr">124</xref>]. The mitogen-activated protein kinase (MAPK) signaling cascade is one of the most important pathways involved in cellular proliferation and differentiation [<xref rid="B125-ijms-19-01511" ref-type="bibr">125</xref>] and, therefore, inhibition of components of this pathway, such as MEK1, can potentially target tumors that depend on MAPK signaling [<xref rid="B126-ijms-19-01511" ref-type="bibr">126</xref>]. Agonism of estrogen receptor &#x003b1; (ER&#x003b1;) stimulates proliferation of breast, uterus, and prostate tissues, whereas ER&#x003b2; agonism inhibits proliferation of these tissues [<xref rid="B127-ijms-19-01511" ref-type="bibr">127</xref>]. Thus, compounds that can selectively bind and activate ER&#x003b2;, but not ER&#x003b1;, could represent effective antitumor agents for treatment of prostate and breast cancer [<xref rid="B128-ijms-19-01511" ref-type="bibr">128</xref>]. Copalic acid and methyl copalate both targeted HsMEK1, with docking energies of &#x02212;108.2 and &#x02212;111.0 kJ/mol, respectively, while 3&#x003b2;-alepterolic acid and 3&#x003b2;-alepterolic acid acetate showed excellent docking with HsDNMT1 (<italic>E</italic><sub>dock</sub> = &#x02212;107.2 and &#x02212;121.7 kJ/mol, respectively). Kaurenoic acid was a relatively weakly docking ligand but did show selective docking to aromatase (<italic>E</italic><sub>dock</sub> = &#x02212;93.7 kJ/mol). The best-docking ligand was patagonic acid, which had a docking energy of &#x02212;121.8 kJ/mol with HsDNMT1.</p></sec><sec id="sec6dot4-ijms-19-01511"><title>6.4. Anti-Inflammatory Activity of Copaiba</title><p>Inflammation is the biological response of body tissues to detrimental stimuli, such as pathogenic microorganisms, chemical or physical irritants, or injury. Inflammation is manifested by redness, swelling, heat, and sometimes pain. While acute inflammation is a normal part of the healing process, chronic inflammation often plays a role in chronic diseases such as osteoarthritis, lupus, and inflammatory bowel disease, and can be problematic. Several copaiba oleoresins have shown anti-inflammatory activity, including <italic>C. cearensis</italic> [<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>], <italic>C. duckei</italic> [<xref rid="B84-ijms-19-01511" ref-type="bibr">84</xref>], <italic>C. langsdorffii</italic> [<xref rid="B50-ijms-19-01511" ref-type="bibr">50</xref>,<xref rid="B91-ijms-19-01511" ref-type="bibr">91</xref>], <italic>C. multijuga</italic> [<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>,<xref rid="B58-ijms-19-01511" ref-type="bibr">58</xref>,<xref rid="B61-ijms-19-01511" ref-type="bibr">61</xref>,<xref rid="B100-ijms-19-01511" ref-type="bibr">100</xref>], <italic>C. officinalis</italic> [<xref rid="B62-ijms-19-01511" ref-type="bibr">62</xref>], and <italic>C. reticulata</italic> [<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>] (<xref ref-type="table" rid="ijms-19-01511-t003">Table 3</xref>).</p><p>The immune response is a complex cascade of interacting cytokines and reactions, and there are several biomolecular targets important in treating chronic inflammation. We have carried out virtual screening of copaiba diterpenoids against soluble epoxide hydrolase (EPHX2), fibroblast collagenase, phospholipase A2 (PLA2), 5-lipoxygenase, inducible nitric oxide synthase, phosphoinositide 3-kinase, interleukin-1 receptor-associated kinase 4, glutathione <italic>S</italic>-transferase &#x003c9;-1, cyclooxygenase-1, cyclooxygenase-2, c-Jun <italic>N</italic>-terminal kinase, nuclear factor &#x003ba;-light-chain-enhancer of activated B cells (NF-&#x003ba;B), inhibitor of &#x003ba;B kinase &#x003b2;, NF-&#x003ba;B essential modulator, lipid binding protein MD-2, myeloperoxidase, p38 mitogen-activated protein kinase, peroxisome proliferator-activated receptor &#x003b3;, and cAMP-specific 3&#x02032;,5&#x02032;-cyclic phosphodiesterase 4D (<xref ref-type="table" rid="ijms-19-01511-t008">Table 8</xref>). The overall best target proteins were murine soluble epoxide hydrolase and murine phospholipase A2, with average docking energies of &#x02212;108.3 and &#x02212;100.0 kJ/mol. Secretory phospholipase A2 and cytosolic phospholipase A2 are both targets for anti-inflammatory drug development [<xref rid="B129-ijms-19-01511" ref-type="bibr">129</xref>]. Soluble epoxide hydrolase has been identified as a molecular target not only for inflammatory diseases, but also as a target for neurodegenerative diseases and for treatment of pain [<xref rid="B130-ijms-19-01511" ref-type="bibr">130</xref>]. Thus, targeting EPHX2 and/or PLA2 by copaiba diterpenoids may explain the anti-inflammatory activities of copaiba oleoresins.</p></sec></sec><sec id="sec7-ijms-19-01511"><title>7. Computational Methods&#x02014;Molecular Docking</title><p>Molecular docking analyses were carried out using Molegro Virtual Docker (v. 6.0.1, Molegro ApS, Aarhus, Denmark) against known bacterial [<xref rid="B119-ijms-19-01511" ref-type="bibr">119</xref>], <italic>Leishmania</italic> [<xref rid="B114-ijms-19-01511" ref-type="bibr">114</xref>,<xref rid="B115-ijms-19-01511" ref-type="bibr">115</xref>,<xref rid="B116-ijms-19-01511" ref-type="bibr">116</xref>], <italic>Trypanosoma cruzi</italic> [<xref rid="B117-ijms-19-01511" ref-type="bibr">117</xref>], and cancer-relevant and inflammation-relevant protein targets [<xref rid="B131-ijms-19-01511" ref-type="bibr">131</xref>], as previously described [<xref rid="B114-ijms-19-01511" ref-type="bibr">114</xref>,<xref rid="B115-ijms-19-01511" ref-type="bibr">115</xref>,<xref rid="B116-ijms-19-01511" ref-type="bibr">116</xref>,<xref rid="B117-ijms-19-01511" ref-type="bibr">117</xref>,<xref rid="B119-ijms-19-01511" ref-type="bibr">119</xref>,<xref rid="B132-ijms-19-01511" ref-type="bibr">132</xref>].</p></sec><sec id="sec8-ijms-19-01511"><title>8. Conclusions</title><p>The oleoresins from <italic>Copaifera</italic> species (copaiba) have been used by native peoples of the Amazon region for thousands of years. These materials have shown remarkable biological activities, including antibacterial, antiparasitic, antineoplastic, and anti-inflammatory activities. Copaiba resins have been distilled to give essential oils that are largely composed of sesquiterpenoids, particularly &#x003b2;-caryophyllene. The resins are also composed of diterpene acids, which are responsible for many of the observed biological activities. Molecular docking of copaiba diterpene acids with documented protein targets has revealed potential mechanisms of activity for these bioactive constituents. Future research to validate the molecular mechanisms of copaiba diterpenoids is encouraged.</p></sec></body><back><notes><title>Author Contributions</title><p>R.d.T., J.K.d.S. and W.N.S. authors contributed equally to literature searching and manuscript writing, review and editing; W.N.S. carried out the molecular docking.</p></notes><notes><title>Funding</title><p>W.N.S. is grateful to d&#x0014d;TERRA International (Available online: <uri xlink:href="https://www.doterra.com/US/en">https://www.doterra.com/US/en</uri>) for financial support of the Aromatic Plant Research Centers (APRC, Available online: <uri xlink:href="https://aromaticplant.org/">https://aromaticplant.org/</uri>).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-ijms-19-01511"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwyer</surname><given-names>J.D.</given-names></name></person-group><article-title>The Central American, West Indian, and South American species of <italic>Copaifera</italic> (Caesalpiniaceae)</article-title><source>Brittonia</source><year>1951</year><volume>7</volume><fpage>143</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.2307/2804703</pub-id></element-citation></ref><ref id="B2-ijms-19-01511"><label>2.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Jacquin</surname><given-names>N.J.</given-names></name></person-group><source>Enumeratio Systematica Plantarum</source><publisher-name>Apud Theodorum Haak</publisher-name><publisher-loc>Leiden, The Netherlands</publisher-loc><year>1760</year></element-citation></ref><ref id="B3-ijms-19-01511"><label>3.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Linn&#x000e9;</surname><given-names>C.</given-names></name></person-group><source>Species Plantarum</source><publisher-name>Joannis Thomae de Trattner</publisher-name><publisher-loc>Vienna, Austria</publisher-loc><year>1764</year></element-citation></ref><ref id="B4-ijms-19-01511"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>B.L.</given-names></name><name><surname>Al-Ahmad</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Stewart</surname><given-names>C.N.</given-names></name></person-group><article-title>Diesel Trees</article-title><source>Handbook of Bioenergy Crop Plants</source><person-group person-group-type="editor"><name><surname>Kole</surname><given-names>C.</given-names></name><name><surname>Joshi</surname><given-names>C.P.</given-names></name><name><surname>Shonnard</surname><given-names>D.R.</given-names></name></person-group><publisher-name>CRC Press</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2012</year><fpage>619</fpage><lpage>629</lpage></element-citation></ref><ref id="B5-ijms-19-01511"><label>5.</label><element-citation publication-type="gov"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>J.A.S.</given-names></name><collab>Copaifera</collab></person-group><article-title>In Flora do Brasil 2020, em Constru&#x000e7;&#x000e3;o</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://floradobrasil.jbrj.gov.br/reflora/floradobrasil/FB22895">http://floradobrasil.jbrj.gov.br/reflora/floradobrasil/FB22895</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2018-03-06">(accessed on 6 March 2018)</date-in-citation></element-citation></ref><ref id="B6-ijms-19-01511"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name></person-group><article-title>O g&#x000ea;nero <italic>Copaifera</italic> L.</article-title><source>Quim. Nova</source><year>2002</year><volume>25</volume><fpage>273</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422002000200016</pub-id></element-citation></ref><ref id="B7-ijms-19-01511"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plowden</surname><given-names>C.</given-names></name></person-group><article-title>The ethnobotany of copaiba (<italic>Copaifera</italic>) oleoresin in the Amazon</article-title><source>Econ. Bot.</source><year>2004</year><volume>58</volume><fpage>729</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1663/0013-0001(2004)058[0729:TEOCCO]2.0.CO;2</pub-id></element-citation></ref><ref id="B8-ijms-19-01511"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cascon</surname><given-names>V.</given-names></name><name><surname>Gilbert</surname><given-names>B.</given-names></name></person-group><article-title>Characterization of the chemical composition of oleoresins of <italic>Copaifera guianensis</italic> Desf., <italic>Copaifera duckei</italic> Dwyer and <italic>Copaifera multijuga</italic> Hayne</article-title><source>Phytochemistry</source><year>2000</year><volume>55</volume><fpage>773</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)00284-3</pub-id><pub-id pub-id-type="pmid">11190394</pub-id></element-citation></ref><ref id="B9-ijms-19-01511"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins-da-Silva</surname><given-names>R.C.V.</given-names></name><name><surname>Pereira</surname><given-names>J.F.</given-names></name><name><surname>de Lima</surname><given-names>H.C.</given-names></name></person-group><article-title>O g&#x000ea;nero <italic>Copaifera</italic> (Leguminosae&#x02014;Caesalpinioideae) na Amaz&#x000f4;nia Brasileira</article-title><source>Rodrigu&#x000e9;sia</source><year>2008</year><volume>59</volume><fpage>455</fpage><lpage>476</lpage></element-citation></ref><ref id="B10-ijms-19-01511"><label>10.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>V.C.</given-names></name><name><surname>Lorenzi</surname><given-names>H.</given-names></name></person-group><source>Bot&#x000e2;nica Sistem&#x000e1;tica: Guia Ilustrado para Identifica&#x000e7;&#x000e3;o das Fam&#x000ed;lias de Angiospermas da Flora Brasileira, Baseado na APG III</source><edition>3rd ed.</edition><publisher-name>Instituto Plantarum</publisher-name><publisher-loc>Nova Odessa, Brazil</publisher-loc><year>2012</year></element-citation></ref><ref id="B11-ijms-19-01511"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milani</surname><given-names>J.F.</given-names></name><name><surname>Rocha</surname><given-names>J.F.</given-names></name><name><surname>de P&#x000e1;dua Teixeira</surname><given-names>S.</given-names></name></person-group><article-title>Oleoresin glands in copa&#x000ed;ba (<italic>Copaifera trapezifolia</italic> Hayne: Leguminosae), a Brazilian rainforest tree</article-title><source>Trees</source><year>2012</year><volume>26</volume><fpage>769</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1007/s00468-011-0642-y</pub-id></element-citation></ref><ref id="B12-ijms-19-01511"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>N.S.</given-names></name><name><surname>Goncalves</surname><given-names>C.A.</given-names></name><name><surname>Araujo</surname><given-names>G.M.</given-names></name><name><surname>Lomonaco</surname><given-names>C.</given-names></name></person-group><article-title>Floristic composition and abundance in forest fragments: A case study from southern Goias, Brazil</article-title><source>Biosci. J.</source><year>2015</year><volume>31</volume><fpage>1238</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.14393/BJ-v31n4a2015-26303</pub-id></element-citation></ref><ref id="B13-ijms-19-01511"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Rosas</surname><given-names>E.C.</given-names></name><name><surname>Carvalho</surname><given-names>M.V.</given-names></name><name><surname>Henriques</surname><given-names>M.G.M.O.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name></person-group><article-title>Chemical composition and anti-inflammatory activity of copaiba oils from <italic>Copaifera cearensis</italic> Huber ex Ducke, <italic>Copaifera reticulata</italic> Ducke and <italic>Copaifera multijuga</italic> Hayne&#x02014;A comparative study</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>112</volume><fpage>248</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2007.03.005</pub-id><?supplied-pmid 17446019?><pub-id pub-id-type="pmid">17446019</pub-id></element-citation></ref><ref id="B14-ijms-19-01511"><label>14.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Langenheim</surname><given-names>J.H.</given-names></name></person-group><source>Plant Resins: Chemistry, Evolution, Ecology, and Ethnobotany</source><publisher-name>Timber Press, Inc.</publisher-name><publisher-loc>Portland, OR, USA</publisher-loc><year>2003</year></element-citation></ref><ref id="B15-ijms-19-01511"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leandro</surname><given-names>L.M.</given-names></name><name><surname>de Sousa Vargas</surname><given-names>F.</given-names></name><name><surname>Barbosa</surname><given-names>P.C.S.</given-names></name><name><surname>Neves</surname><given-names>J.K.O.</given-names></name><name><surname>da Silva</surname><given-names>J.A.</given-names></name><name><surname>da Veiga-Junior</surname><given-names>V.F.</given-names></name></person-group><article-title>Chemistry and biological activities of terpenoids from copaiba (<italic>Copaifera</italic> spp.) oleoresins</article-title><source>Molecules</source><year>2012</year><volume>17</volume><fpage>3866</fpage><lpage>3889</lpage><pub-id pub-id-type="doi">10.3390/molecules17043866</pub-id><?supplied-pmid 22466849?><pub-id pub-id-type="pmid">22466849</pub-id></element-citation></ref><ref id="B16-ijms-19-01511"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenheim</surname><given-names>J.H.</given-names></name></person-group><article-title>Higher plant terpenoids: A phytcentric overview of their ecological roles</article-title><source>J. Chem. Ecol.</source><year>1994</year><volume>20</volume><fpage>1223</fpage><lpage>1280</lpage><pub-id pub-id-type="doi">10.1007/BF02059809</pub-id><?supplied-pmid 24242340?><pub-id pub-id-type="pmid">24242340</pub-id></element-citation></ref><ref id="B17-ijms-19-01511"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>P.C.S.</given-names></name><name><surname>Medeiros</surname><given-names>R.S.</given-names></name><name><surname>Sampaio</surname><given-names>P.T.B.</given-names></name><name><surname>Vieira</surname><given-names>G.</given-names></name><name><surname>Wiedemann</surname><given-names>L.S.M.</given-names></name><name><surname>Veiga-Junior</surname><given-names>V.F.</given-names></name></person-group><article-title>Influence of abiotic factors on the chemical composition of copaiba oil (<italic>Copaifera multijuga</italic> Hayne): Soil composition, seasonality and diameter at breast height</article-title><source>J. Braz. Chem. Soc.</source><year>2012</year><volume>23</volume><fpage>1823</fpage><lpage>1833</lpage><pub-id pub-id-type="doi">10.1590/S0103-50532012005000049</pub-id></element-citation></ref><ref id="B18-ijms-19-01511"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biavatti</surname><given-names>M.W.</given-names></name><name><surname>Dossin</surname><given-names>D.</given-names></name><name><surname>Deschamps</surname><given-names>F.C.</given-names></name><name><surname>Lima</surname><given-names>M.D.P.</given-names></name></person-group><article-title>An&#x000e1;lise de &#x000f3;leos-resinas de copa&#x000ed;ba: Contribui&#x000e7;&#x000e3;o para o seu controle de qualidade</article-title><source>Rev. Bras. Farmacogn.</source><year>2006</year><volume>16</volume><fpage>230</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1590/S0102-695X2006000200017</pub-id></element-citation></ref><ref id="B19-ijms-19-01511"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieri</surname><given-names>F.A.</given-names></name><name><surname>Mussi</surname><given-names>M.C.</given-names></name><name><surname>Moreira</surname><given-names>M.A.S.</given-names></name></person-group><article-title>&#x000d3;leo de copa&#x000ed;ba (<italic>Copaifera</italic> sp.): Hist&#x000f3;rico, extra&#x000e7;&#x000e3;o, aplica&#x000e7;&#x000f5;es industriais e propriedades medicinais</article-title><source>Rev. Bras. Plantas Med.</source><year>2009</year><volume>11</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1590/S1516-05722009000400016</pub-id></element-citation></ref><ref id="B20-ijms-19-01511"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosa</surname><given-names>J.C.</given-names></name><name><surname>da Silva Gomes</surname><given-names>A.M.</given-names></name></person-group><article-title>Os aspectos etnobot&#x000e2;nicos da copa&#x000ed;ba</article-title><source>Rev. Geogr.</source><year>2009</year><volume>4</volume><fpage>59</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.5380/geografar.v4i1.14428</pub-id></element-citation></ref><ref id="B21-ijms-19-01511"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>R.D.</given-names></name><name><surname>de Lima</surname><given-names>H.C.</given-names></name></person-group><article-title>Riqueza e distribui&#x000e7;&#x000e3;o geogr&#x000e1;fica de esp&#x000e9;cies arb&#x000f3;reas da fam&#x000ed;lia Leguminosae e implica&#x000e7;&#x000f5;es para conserva&#x000e7;&#x000e3;o no Centro de Diversidade Vegetal de Cabo Frio, Rio de Janeiro, Brasil</article-title><source>Rodrigu&#x000e9;sia</source><year>2009</year><volume>60</volume><fpage>111</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1590/2175-7860200960106</pub-id></element-citation></ref><ref id="B22-ijms-19-01511"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>M.C.</given-names></name><name><surname>Gomide</surname><given-names>L.R.</given-names></name><name><surname>Santos</surname><given-names>R.M.D.</given-names></name><name><surname>Scolforo</surname><given-names>J.R.S.</given-names></name><name><surname>Carvalho</surname><given-names>L.M.T.D.</given-names></name><name><surname>Mello</surname><given-names>J.M.D.</given-names></name></person-group><article-title>Modeling ecological niche of tree species in Brazilian tropical area</article-title><source>Cerne</source><year>2017</year><volume>23</volume><fpage>229</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1590/01047760201723022308</pub-id></element-citation></ref><ref id="B23-ijms-19-01511"><label>23.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>P.E.R.</given-names></name></person-group><source>Esp&#x000e9;cies Arb&#x000f3;reas Brasileiras, Vol. 1</source><publisher-name>EMBRAPA Informa&#x000e7;&#x000e3;o Tecnol&#x000f3;gica</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2003</year></element-citation></ref><ref id="B24-ijms-19-01511"><label>24.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shanley</surname><given-names>P.</given-names></name><name><surname>Leite</surname><given-names>A.</given-names></name><name><surname>Alechandre</surname><given-names>A.</given-names></name><name><surname>Azevedo</surname><given-names>C.</given-names></name></person-group><article-title>Copa&#x000ed;ba: <italic>Copaifera</italic> spp.</article-title><source>Frut&#x000ed;feras e Plantas &#x000da;teis na Vida Amaz&#x000f4;nica</source><person-group person-group-type="editor"><name><surname>Shanley</surname><given-names>P.</given-names></name><name><surname>Medina</surname><given-names>G.</given-names></name></person-group><publisher-name>CIFOR and IMAZON</publisher-name><publisher-loc>Bel&#x000e9;m, Brazil</publisher-loc><year>2005</year><fpage>85</fpage><lpage>94</lpage></element-citation></ref><ref id="B25-ijms-19-01511"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>P.E.R.</given-names></name></person-group><source>Esp&#x000e9;cies Florestais Brasileiras: Recomenda&#x000e7;&#x000f5;es Silviculturais, Potencialidades e Uso da Madeira</source><publisher-name>EMBRAPA-CNPF</publisher-name><publisher-loc>Colombo, Brazil</publisher-loc><year>1994</year></element-citation></ref><ref id="B26-ijms-19-01511"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rigamonte-Azevedo</surname><given-names>O.C.</given-names></name><name><surname>Wadt</surname><given-names>P.G.S.</given-names></name><name><surname>Wadt</surname><given-names>L.D.O.</given-names></name></person-group><source>Copa&#x000ed;ba: Ecologia e Produ&#x000e7;&#x000e3;o de &#x000d3;leo-Resina</source><publisher-name>Embrapa Acre</publisher-name><publisher-loc>Rio Branco, Brazil</publisher-loc><year>2004</year></element-citation></ref><ref id="B27-ijms-19-01511"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alencar</surname><given-names>J.D.C.</given-names></name></person-group><article-title>Estudos silviculturais de uma popula&#x000e7;&#x000e3;o natural de <italic>Copaifera multijuga</italic> Hayne&#x02014;Leguminosae, na Amaz&#x000f4;nia central. IV. Interpreta&#x000e7;&#x000e3;o de dados fenol&#x000f3;gicos em rela&#x000e7;&#x000e3;o a elementos clim&#x000e1;ticos</article-title><source>Acta Amaz.</source><year>1988</year><volume>18</volume><fpage>199</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1590/1809-43921988183209</pub-id></element-citation></ref><ref id="B28-ijms-19-01511"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muniz</surname><given-names>F.H.</given-names></name></person-group><article-title>Padr&#x000f5;es de flora&#x000e7;&#x000e3;o e frutifica&#x000e7;&#x000e3;o de &#x000e1;rvores da Amaz&#x000f4;nia Maranhense</article-title><source>Acta Amaz.</source><year>2008</year><volume>38</volume><fpage>617</fpage><lpage>626</lpage><pub-id pub-id-type="doi">10.1590/S0044-59672008000400004</pub-id></element-citation></ref><ref id="B29-ijms-19-01511"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>N.</given-names></name></person-group><article-title>Fenologia</article-title><source>Rodrigu&#x000e9;sia</source><year>1979</year><volume>31</volume><fpage>223</fpage><lpage>226</lpage></element-citation></ref><ref id="B30-ijms-19-01511"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedroni</surname><given-names>F.</given-names></name><name><surname>Sanchez</surname><given-names>M.</given-names></name><name><surname>Santos</surname><given-names>F.A.M.</given-names></name></person-group><article-title>Fenologia da copa&#x000ed;ba (<italic>Copaifera langsdorffii</italic> Desf.&#x02014;Leguminosae, Caesalpinioideae) em uma floresta semidec&#x000ed;dua no sudeste do Brasil</article-title><source>Rev. Bras. Bot&#x000e2;nica</source><year>2002</year><volume>25</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1590/S0100-84042002000200007</pub-id></element-citation></ref><ref id="B31-ijms-19-01511"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pedroni</surname><given-names>F.</given-names></name></person-group><source>Ecologia da Copa&#x000ed;ba (Copaifera langsdorffii Desf. Caelsapiniaceae) na Reserva Municipal de Santa Genebra, Campinas, SP</source><publisher-name>Universidade Estadual de Campinas</publisher-name><publisher-loc>Bar&#x000e3;o Geraldo, Brazil</publisher-loc><year>1993</year></element-citation></ref><ref id="B32-ijms-19-01511"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motta Junior</surname><given-names>C.J.</given-names></name><name><surname>Lombardi</surname><given-names>J.A.</given-names></name></person-group><article-title>Aves como agentes dispersores da copaiba (<italic>Copaifera langsdorffii</italic>, Caesalpiniaceae) em S&#x000e3;o Carlos, estado de S&#x000e3;o Paulo</article-title><source>Rev. Bras. Ornitol.</source><year>1990</year><volume>1</volume><fpage>105</fpage><lpage>106</lpage></element-citation></ref><ref id="B33-ijms-19-01511"><label>33.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Brum</surname><given-names>H.D.</given-names></name><name><surname>Camargo</surname><given-names>J.L.C.</given-names></name><name><surname>Ferraz</surname><given-names>I.D.K.</given-names></name></person-group><article-title>Copa&#x000ed;ba-roxa, <italic>Copaifera mutlijuga</italic> Hayne</article-title><source>Manual de Sementes da Amaz&#x000f4;nia</source><person-group person-group-type="editor"><name><surname>Ferraz</surname><given-names>I.D.K.</given-names></name><name><surname>Camargo</surname><given-names>J.L.C.</given-names></name></person-group><publisher-name>INPA</publisher-name><publisher-loc>Manaus, Brazil</publisher-loc><year>2009</year><fpage>12</fpage></element-citation></ref><ref id="B34-ijms-19-01511"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>A.</given-names></name><name><surname>Amaral</surname><given-names>P.</given-names></name><name><surname>Gaia</surname><given-names>C.</given-names></name><name><surname>de Oliveira</surname><given-names>W.</given-names></name></person-group><source>Boas Pr&#x000e1;ticas para Manejo Florestal e Agroindustrial de Produtos Florestais N&#x000e3;o Madeireiros: A&#x000e7;a&#x000ed;, Andiroba, Baba&#x000e7;u, Castanha-do-Brasil, Copa&#x000ed;ba e Unha-de-Gato</source><publisher-name>Sebrae-AM</publisher-name><publisher-loc>Bel&#x000e9;m, Brazil</publisher-loc><year>2010</year></element-citation></ref><ref id="B35-ijms-19-01511"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>J.C.</given-names></name><name><surname>Leite</surname><given-names>A.C.P.</given-names></name><name><surname>Wadt</surname><given-names>L.H.O.</given-names></name><name><surname>Borges</surname><given-names>K.H.</given-names></name><name><surname>Andrade</surname><given-names>F.G.</given-names></name><name><surname>Menezes</surname><given-names>R.S.</given-names></name><name><surname>Muniz</surname><given-names>P.S.B.</given-names></name></person-group><source>Demandas Tecnologicas para o Sistema Produtivo de &#x000d3;leo de Copa&#x000ed;ba (Copaifera spp.) no Estado do Acre</source><publisher-name>Embrapa Acre</publisher-name><publisher-loc>Rio Branco, Brazil</publisher-loc><year>2001</year></element-citation></ref><ref id="B36-ijms-19-01511"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>P.</given-names></name><name><surname>Watkinson</surname><given-names>A.R.</given-names></name><name><surname>Peres</surname><given-names>C.A.</given-names></name></person-group><article-title>Determinants of yield in a non-timber forest product: <italic>Copaifera</italic> oleoresin in Amazonian extractive reserves</article-title><source>For. Ecol. Manag.</source><year>2011</year><volume>261</volume><fpage>255</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.foreco.2010.10.014</pub-id></element-citation></ref><ref id="B37-ijms-19-01511"><label>37.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Estrella</surname><given-names>E.</given-names></name></person-group><source>Plantas Medicinales Amaz&#x000f3;nicas: Realidad y Perspectivas</source><publisher-name>Tratado de Cooperaci&#x000f3;n Amaz&#x000f3;nica</publisher-name><publisher-loc>Lima, Peru</publisher-loc><year>1995</year></element-citation></ref><ref id="B38-ijms-19-01511"><label>38.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rios</surname><given-names>M.N.D.S.</given-names></name><name><surname>Pastore Junior</surname><given-names>F.</given-names></name></person-group><source>Plantas da Amaz&#x000f4;nia: 450 Esp&#x000e9;cies de Uso Geral</source><publisher-name>Universidade de Bras&#x000ed;lia</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2011</year></element-citation></ref><ref id="B39-ijms-19-01511"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciel</surname><given-names>M.A.M.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name></person-group><article-title>Plantas medicinais: A necessidade de estudos multidisciplinares</article-title><source>Quim. Nova</source><year>2002</year><volume>25</volume><fpage>429</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422002000300016</pub-id></element-citation></ref><ref id="B40-ijms-19-01511"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luz</surname><given-names>F.J.F.</given-names></name></person-group><article-title>Plantas medicinais de uso popular em Boa Vista, Roraima, Brasil</article-title><source>Hortic. Bras.</source><year>2001</year><volume>19</volume><fpage>88</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1590/S0102-05362001000100019</pub-id></element-citation></ref><ref id="B41-ijms-19-01511"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Albuquerque</surname><given-names>K.C.O.</given-names></name><name><surname>da Veiga</surname><given-names>A.D.S.S.</given-names></name><name><surname>da Silva e Silva</surname><given-names>J.V.</given-names></name><name><surname>Brigido</surname><given-names>H.P.C.</given-names></name><name><surname>Ferreira</surname><given-names>E.P.D.R.</given-names></name><name><surname>Costa</surname><given-names>E.V.S.</given-names></name><name><surname>Marinho</surname><given-names>A.M.D.R.</given-names></name><name><surname>Perc&#x000e1;rio</surname><given-names>S.</given-names></name><name><surname>Dolabela</surname><given-names>M.F.</given-names></name></person-group><article-title>Brazilian Amazon traditional medicine and the treatment of difficult to heal leishmaniasis wounds with <italic>Copaifera</italic></article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2017</year><volume>2017</volume><pub-id pub-id-type="doi">10.1155/2017/8350320</pub-id><?supplied-pmid 28194218?><pub-id pub-id-type="pmid">28194218</pub-id></element-citation></ref><ref id="B42-ijms-19-01511"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basile</surname><given-names>A.C.</given-names></name><name><surname>Serti&#x000e9;</surname><given-names>J.A.</given-names></name><name><surname>Freitas</surname><given-names>P.C.</given-names></name><name><surname>Zanini</surname><given-names>A.C.</given-names></name></person-group><article-title>Anti-inflammatory activity of oleoresin from Brazilian <italic>Copaifera</italic></article-title><source>J. Ethnopharmacol.</source><year>1988</year><volume>22</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(88)90235-8</pub-id><pub-id pub-id-type="pmid">3352280</pub-id></element-citation></ref><ref id="B43-ijms-19-01511"><label>43.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>L.</given-names></name></person-group><source>The Healing Power of Rainforest Herbs: A Guide to Understanding and Using Herbal Medicinals</source><publisher-name>Square One Publishers</publisher-name><publisher-loc>Garden City Park, NY, USA</publisher-loc><year>2005</year></element-citation></ref><ref id="B44-ijms-19-01511"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sant&#x02019;Anna</surname><given-names>B.M.P.</given-names></name><name><surname>Fontes</surname><given-names>S.P.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Rezende</surname><given-names>C.M.</given-names></name></person-group><article-title>Characterization of woody odorant contributors in copaiba oil (<italic>Copaifera multijuga</italic> Hayne)</article-title><source>J. Braz. Chem. Soc.</source><year>2007</year><volume>18</volume><fpage>984</fpage><lpage>989</lpage><pub-id pub-id-type="doi">10.1590/S0103-50532007000500016</pub-id></element-citation></ref><ref id="B45-ijms-19-01511"><label>45.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Revilla</surname><given-names>J.</given-names></name></person-group><source>Apontamentos para a Cosm&#x000e9;tica Amaz&#x000f4;nica</source><publisher-name>SEBRAE-INPA</publisher-name><publisher-loc>Manaus, Brazil</publisher-loc><year>2002</year></element-citation></ref><ref id="B46-ijms-19-01511"><label>46.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Shanley</surname><given-names>P.</given-names></name><name><surname>Pierce</surname><given-names>A.R.</given-names></name><name><surname>Laird</surname><given-names>S.A.</given-names></name><name><surname>Guill&#x000e9;n</surname><given-names>A.</given-names></name></person-group><source>Tapping the Green Market: Certification &#x00026; Management of Non-Timber Forest Products</source><publisher-name>Earthscan</publisher-name><publisher-loc>London, UK</publisher-loc><year>2002</year></element-citation></ref><ref id="B47-ijms-19-01511"><label>47.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gonzaga</surname><given-names>A.L.</given-names></name></person-group><source>Madeira: Uso e Conserva&#x000e7;&#x000e3;o</source><publisher-name>IPHAN/MONUMENTA</publisher-name><publisher-loc>Brasilia, Brazil</publisher-loc><year>2006</year></element-citation></ref><ref id="B48-ijms-19-01511"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>A.O.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Dias Filho</surname><given-names>B.P.</given-names></name><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name></person-group><article-title>Effect of Brazilian copaiba oils on <italic>Leishmania amazonensis</italic></article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>120</volume><fpage>204</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.08.007</pub-id><?supplied-pmid 18775772?><pub-id pub-id-type="pmid">18775772</pub-id></element-citation></ref><ref id="B49-ijms-19-01511"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lameira</surname><given-names>O.A.</given-names></name><name><surname>Martins-da-Silva</surname><given-names>R.C.V.</given-names></name><name><surname>Zoghbi</surname><given-names>M.D.G.B.</given-names></name><name><surname>Oliveira</surname><given-names>E.C.P.</given-names></name></person-group><article-title>Seasonal variation in the volatiles of <italic>Copaifera duckei</italic> Dwyer growing wild in the state of Par&#x000e1;&#x02014;Brazil</article-title><source>J. Essent. Oil Res.</source><year>2009</year><volume>21</volume><fpage>105</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1080/10412905.2009.9700124</pub-id></element-citation></ref><ref id="B50-ijms-19-01511"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelmini</surname><given-names>F.</given-names></name><name><surname>Beretta</surname><given-names>G.</given-names></name><name><surname>Anselmi</surname><given-names>C.</given-names></name><name><surname>Centini</surname><given-names>M.</given-names></name><name><surname>Magni</surname><given-names>P.</given-names></name><name><surname>Ruscica</surname><given-names>M.</given-names></name><name><surname>Cavalchini</surname><given-names>A.</given-names></name><name><surname>Maffei Facino</surname><given-names>R.</given-names></name></person-group><article-title>GC-MS profiling of the phytochemical constituents of the oleoresin from <italic>Copaifera langsdorffii</italic> Desf. and a preliminary in vivo evaluation of its antipsoriatic effect</article-title><source>Int. J. Pharm.</source><year>2013</year><volume>440</volume><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.ijpharm.2012.08.021</pub-id><?supplied-pmid 22939967?><pub-id pub-id-type="pmid">22939967</pub-id></element-citation></ref><ref id="B51-ijms-19-01511"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estev&#x000e3;o</surname><given-names>L.R.M.</given-names></name><name><surname>de Medeiros</surname><given-names>J.P.</given-names></name><name><surname>Baratella-Ev&#x000ea;ncio</surname><given-names>L.</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>R.S.</given-names></name><name><surname>Mendon&#x000e7;a</surname><given-names>F.D.S.</given-names></name><name><surname>Ev&#x000ea;ncio-Neto</surname><given-names>J.</given-names></name></person-group><article-title>Effects of the topical administration of copaiba oil ointment (<italic>Copaifera langsdorffii</italic>) in skin flaps viability of rats</article-title><source>Acta Cir&#x000fa;rgica Bras.</source><year>2013</year><volume>28</volume><fpage>863</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1590/S0102-86502013001200009</pub-id></element-citation></ref><ref id="B52-ijms-19-01511"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermam-Franco</surname><given-names>D.C.</given-names></name><name><surname>Bolutari</surname><given-names>E.B.</given-names></name><name><surname>Polonini</surname><given-names>H.C.</given-names></name><name><surname>do Carmo</surname><given-names>A.M.R.</given-names></name><name><surname>Chaves</surname><given-names>M.D.G.A.M.</given-names></name><name><surname>Raposo</surname><given-names>N.R.B.</given-names></name></person-group><article-title>Antifungal activity of <italic>Copaifera langsdorffii</italic> Desf oleoresin against dermatophytes</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>12561</fpage><lpage>12570</lpage><pub-id pub-id-type="doi">10.3390/molecules181012561</pub-id><?supplied-pmid 24126374?><pub-id pub-id-type="pmid">24126374</pub-id></element-citation></ref><ref id="B53-ijms-19-01511"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Almeida</surname><given-names>L.F.R.</given-names></name><name><surname>Portella</surname><given-names>R.D.O.</given-names></name><name><surname>Bufalo</surname><given-names>J.</given-names></name><name><surname>Marques</surname><given-names>M.O.M.</given-names></name><name><surname>Facanali</surname><given-names>R.</given-names></name><name><surname>Frei</surname><given-names>F.</given-names></name></person-group><article-title>Non-oxygenated sesquiterpenes in the essential oil of <italic>Copaifera langsdorffii</italic> Desf. increase during the day in the dry season</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0149332</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0149332</pub-id><?supplied-pmid 26886431?><pub-id pub-id-type="pmid">26886431</pub-id></element-citation></ref><ref id="B54-ijms-19-01511"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do Nascimento</surname><given-names>M.E.</given-names></name><name><surname>Zoghbi</surname><given-names>M.D.G.B.</given-names></name><name><surname>Pinto</surname><given-names>J.E.B.P.</given-names></name><name><surname>Bertolucci</surname><given-names>S.K.V.</given-names></name></person-group><article-title>Chemical variability of the volatiles of <italic>Copaifera langsdorffii</italic> growing wild in the southeastern part of Brazil</article-title><source>Biochem. Syst. Ecol.</source><year>2012</year><volume>43</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.bse.2012.02.003</pub-id></element-citation></ref><ref id="B55-ijms-19-01511"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Almeida</surname><given-names>L.F.R.</given-names></name><name><surname>Portella</surname><given-names>R.D.O.</given-names></name><name><surname>Facanali</surname><given-names>R.</given-names></name><name><surname>Marques</surname><given-names>M.O.M.</given-names></name><name><surname>Frei</surname><given-names>F.</given-names></name></person-group><article-title>Dry and wet seasons set the phytochemical profile of the <italic>Copaifera langsdorffii</italic> Desf. essential oils</article-title><source>J. Essent. Oil Res.</source><year>2014</year><volume>26</volume><fpage>292</fpage><lpage>300</lpage><pub-id pub-id-type="doi">10.1080/10412905.2014.889050</pub-id></element-citation></ref><ref id="B56-ijms-19-01511"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>M.D.G.B.</given-names></name><name><surname>Lameira</surname><given-names>O.A.</given-names></name><name><surname>Oliveira</surname><given-names>E.C.P.</given-names></name></person-group><article-title>Seasonal variation of oleoresin and volatiles from <italic>Copaifera martii</italic> Hayne growing wild in the State of Par&#x000e1;, Brazil</article-title><source>J. Essent. Oil Res.</source><year>2007</year><volume>19</volume><fpage>504</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1080/10412905.2007.9699316</pub-id></element-citation></ref><ref id="B57-ijms-19-01511"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>S.R.M.</given-names></name><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Christo</surname><given-names>H.B.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Fernandes</surname><given-names>P.D.</given-names></name></person-group><article-title>In vivo and in vitro studies on the anticancer activity of <italic>Copaifera multijuga</italic> Hayne and its fractions</article-title><source>Phyther. Res.</source><year>2003</year><volume>17</volume><fpage>1048</fpage><lpage>1053</lpage><pub-id pub-id-type="doi">10.1002/ptr.1295</pub-id><?supplied-pmid 14595585?><pub-id pub-id-type="pmid">14595585</pub-id></element-citation></ref><ref id="B58-ijms-19-01511"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>C.</given-names></name><name><surname>Fontanive</surname><given-names>T.O.</given-names></name><name><surname>Enzweiler</surname><given-names>B.G.</given-names></name><name><surname>de Bona</surname><given-names>L.R.</given-names></name><name><surname>Massoni</surname><given-names>T.</given-names></name><name><surname>Apel</surname><given-names>M.A.</given-names></name><name><surname>Henriques</surname><given-names>A.T.</given-names></name><name><surname>Richter</surname><given-names>M.F.</given-names></name><name><surname>Ardenghi</surname><given-names>P.</given-names></name><name><surname>Suyenaga</surname><given-names>E.S.</given-names></name></person-group><article-title>Pharmacological evaluation of <italic>Copaifera multijuga</italic> oil in rats</article-title><source>Pharm. Biol.</source><year>2011</year><volume>49</volume><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.3109/13880209.2010.515595</pub-id><?supplied-pmid 21323483?><pub-id pub-id-type="pmid">21323483</pub-id></element-citation></ref><ref id="B59-ijms-19-01511"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trindade</surname><given-names>F.T.T.</given-names></name><name><surname>Stabeli</surname><given-names>R.G.</given-names></name><name><surname>Pereira</surname><given-names>A.A.</given-names></name><name><surname>Facundo</surname><given-names>V.A.</given-names></name><name><surname>Silva</surname><given-names>A.D.A.</given-names></name></person-group><article-title><italic>Copaifera multijuga</italic> ethanolic extracts, oil-resin, and its derivatives display larvicidal activity against <italic>Anopheles darlingi</italic> and <italic>Aedes aegypti</italic> (Diptera: Culicidae)</article-title><source>Braz. J. Pharmacogn.</source><year>2013</year><volume>23</volume><fpage>464</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1590/S0102-695X2013005000038</pub-id></element-citation></ref><ref id="B60-ijms-19-01511"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza Barbosa</surname><given-names>P.C.</given-names></name><name><surname>Moreira Wiedemann</surname><given-names>L.S.</given-names></name><name><surname>da Silva Medeiros</surname><given-names>R.</given-names></name><name><surname>Barbosa Sampaio</surname><given-names>P.D.T.</given-names></name><name><surname>Vieira</surname><given-names>G.</given-names></name><name><surname>da Veiga-Junior</surname><given-names>V.F.</given-names></name></person-group><article-title>Phytochemical fingerprints of copaiba oils (<italic>Copaifera multijuga</italic> Hayne) determined by multivariate analysis</article-title><source>Chem. Biodivers.</source><year>2013</year><volume>10</volume><fpage>1350</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201200356</pub-id><?supplied-pmid 23847080?><pub-id pub-id-type="pmid">23847080</pub-id></element-citation></ref><ref id="B61-ijms-19-01511"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Luciano</surname><given-names>Z.</given-names></name><name><surname>Patitucci</surname><given-names>M.L.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Calixto</surname><given-names>J.B.</given-names></name></person-group><article-title>The inhibition of paw oedema formation caused by the oil of <italic>Copaifera multijuga</italic> Hayne and its fractions</article-title><source>J. Pharm. Pharmacol.</source><year>2006</year><volume>58</volume><fpage>1405</fpage><lpage>1410</lpage><pub-id pub-id-type="doi">10.1111/j.2042-7158.2006.tb01659.x</pub-id><?supplied-pmid 17034665?><pub-id pub-id-type="pmid">17034665</pub-id></element-citation></ref><ref id="B62-ijms-19-01511"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>D.S.</given-names></name><name><surname>Fontes</surname><given-names>L.B.A.</given-names></name><name><surname>Crotti</surname><given-names>A.E.M.</given-names></name><name><surname>Aarestrup</surname><given-names>B.J.V.</given-names></name><name><surname>Aarestrup</surname><given-names>F.M.</given-names></name><name><surname>da Silva Filho</surname><given-names>A.A.</given-names></name><name><surname>Corr&#x000ea;a</surname><given-names>J.O.A.</given-names></name></person-group><article-title>Copaiba oil suppresses inflammatory cytokines in splenocytes of C57Bl/6 mice induced with experimental autoimmune encephalomyelitis (EAE)</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>12814</fpage><lpage>12826</lpage><pub-id pub-id-type="doi">10.3390/molecules190812814</pub-id><?supplied-pmid 25153880?><pub-id pub-id-type="pmid">25153880</pub-id></element-citation></ref><ref id="B63-ijms-19-01511"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>M.D.G.B.</given-names></name><name><surname>Martins-da-Silva</surname><given-names>R.C.V.</given-names></name><name><surname>Trigo</surname><given-names>J.R.</given-names></name></person-group><article-title>Volatiles of oleoresins of <italic>Copaifera paupera</italic> (Herzog) Dwyer, <italic>C. piresii</italic> Dwyer and <italic>C. pubiflora</italic> Benth. (Leguminosae)</article-title><source>J. Essent. Oil Res.</source><year>2009</year><volume>21</volume><fpage>403</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1080/10412905.2009.9700203</pub-id></element-citation></ref><ref id="B64-ijms-19-01511"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoghbi</surname><given-names>M.D.G.B.</given-names></name><name><surname>Andrade</surname><given-names>E.H.A.</given-names></name><name><surname>Martins-Da-Silva</surname><given-names>R.C.V.</given-names></name><name><surname>Trigo</surname><given-names>J.R.</given-names></name></person-group><article-title>Chemical variation in the volatiles of <italic>Copaifera reticulata</italic> Ducke (Leguminosae) growing wild in the states of Par&#x000e1; and Amap&#x000e1;, Brazil</article-title><source>J. Essent. Oil Res.</source><year>2009</year><volume>21</volume><fpage>501</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1080/10412905.2009.9700228</pub-id></element-citation></ref><ref id="B65-ijms-19-01511"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrero-J&#x000e1;uregui</surname><given-names>C.</given-names></name><name><surname>Casado</surname><given-names>M.A.</given-names></name><name><surname>Zoghbi</surname><given-names>M.D.G.B.</given-names></name><name><surname>Martins-Da-Silva</surname><given-names>R.C.</given-names></name></person-group><article-title>Chemical variability of <italic>Copaifera reticulata</italic> Ducke oleoresin</article-title><source>Chem. Biodivers.</source><year>2011</year><volume>8</volume><fpage>674</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1002/cbdv.201000258</pub-id><?supplied-pmid 21480513?><pub-id pub-id-type="pmid">21480513</pub-id></element-citation></ref><ref id="B66-ijms-19-01511"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachetti</surname><given-names>C.G.</given-names></name><name><surname>de Carvalho</surname><given-names>R.R.</given-names></name><name><surname>Paumgartten</surname><given-names>F.J.R.</given-names></name><name><surname>Lameira</surname><given-names>O.A.</given-names></name><name><surname>Caldas</surname><given-names>E.D.</given-names></name></person-group><article-title>Developmental toxicity of copaiba tree (<italic>Copaifera reticulata</italic> Ducke, Fabaceae) oleoresin in rat</article-title><source>Food Chem. Toxicol.</source><year>2011</year><volume>49</volume><fpage>1080</fpage><lpage>1085</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2011.01.015</pub-id><?supplied-pmid 21266184?><pub-id pub-id-type="pmid">21266184</pub-id></element-citation></ref><ref id="B67-ijms-19-01511"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es-Santos</surname><given-names>A.</given-names></name><name><surname>Santos</surname><given-names>D.S.</given-names></name><name><surname>Santos</surname><given-names>I.R.</given-names></name><name><surname>Lima</surname><given-names>R.R.</given-names></name><name><surname>Pereira</surname><given-names>A.</given-names></name><name><surname>de Moura</surname><given-names>L.S.</given-names></name><name><surname>Carvalho</surname><given-names>R.N.</given-names></name><name><surname>Lameira</surname><given-names>O.</given-names></name><name><surname>Gomes-Leal</surname><given-names>W.</given-names></name></person-group><article-title>Copaiba oil-resin treatment is neuroprotective and reduces neutrophil recruitment and microglia activation after motor cortex excitotoxic injury</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2012</year><volume>2012</volume><pub-id pub-id-type="doi">10.1155/2012/918174</pub-id><?supplied-pmid 22461843?><pub-id pub-id-type="pmid">22461843</pub-id></element-citation></ref><ref id="B68-ijms-19-01511"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardaj&#x000ed;</surname><given-names>D.K.R.</given-names></name><name><surname>da Silva</surname><given-names>J.J.M.</given-names></name><name><surname>Bianchi</surname><given-names>T.C.</given-names></name><name><surname>de Souza Eug&#x000ea;nio</surname><given-names>D.</given-names></name><name><surname>de Oliveira</surname><given-names>P.F.</given-names></name><name><surname>Leandro</surname><given-names>L.F.</given-names></name><name><surname>Rogez</surname><given-names>H.L.G.</given-names></name><name><surname>Venezianni</surname><given-names>R.C.S.</given-names></name><name><surname>Ambrosio</surname><given-names>S.R.</given-names></name><name><surname>Tavares</surname><given-names>D.C.</given-names></name><etal/></person-group><article-title><italic>Copaifera reticulata</italic> oleoresin: Chemical characterization and antibacterial properties against oral pathogens</article-title><source>Anaerobe</source><year>2016</year><volume>40</volume><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.anaerobe.2016.04.017</pub-id><?supplied-pmid 27118478?><pub-id pub-id-type="pmid">27118478</pub-id></element-citation></ref><ref id="B69-ijms-19-01511"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veiga</surname><given-names>V.F.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>de Lima</surname><given-names>H.C.</given-names></name></person-group><article-title>The essential oil composition of <italic>Copaifera trapezifolia</italic> Hayne leaves</article-title><source>J. Essent. Oil Res.</source><year>2006</year><volume>18</volume><fpage>430</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1080/10412905.2006.9699132</pub-id></element-citation></ref><ref id="B70-ijms-19-01511"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>A.B.</given-names></name><name><surname>Martins</surname><given-names>C.H.G.</given-names></name><name><surname>Souza</surname><given-names>M.G.M.</given-names></name><name><surname>Furtado</surname><given-names>N.A.J.C.</given-names></name><name><surname>Heleno</surname><given-names>V.C.G.</given-names></name><name><surname>de Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Rocha</surname><given-names>E.M.P.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Cunha</surname><given-names>W.R.</given-names></name><name><surname>Veneziani</surname><given-names>R.C.S.</given-names></name><etal/></person-group><article-title>Antimicrobial activity of terpenoids from <italic>Copaifera langsdorffii</italic> Desf. against cariogenic bacteria</article-title><source>Phyther. Res.</source><year>2011</year><volume>25</volume><fpage>215</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1002/ptr.3244</pub-id><?supplied-pmid 20632306?><pub-id pub-id-type="pmid">20632306</pub-id></element-citation></ref><ref id="B71-ijms-19-01511"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abr&#x000e3;o</surname><given-names>F.</given-names></name><name><surname>de Ara&#x000fa;jo Costa</surname><given-names>L.D.</given-names></name><name><surname>Alves</surname><given-names>J.M.</given-names></name><name><surname>Senedese</surname><given-names>J.M.</given-names></name><name><surname>de Castro</surname><given-names>P.T.</given-names></name><name><surname>Ambr&#x000f3;sio</surname><given-names>S.R.</given-names></name><name><surname>Veneziani</surname><given-names>R.C.S.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>Tavares</surname><given-names>D.C.</given-names></name><name><surname>Martins</surname><given-names>C.H.G.</given-names></name></person-group><article-title><italic>Copaifera langsdorffii</italic> oleoresin and its isolated compounds: Antibacterial effect and antiproliferative activity in cancer cell lines</article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1186/s12906-015-0961-4</pub-id><?supplied-pmid 26691920?><pub-id pub-id-type="pmid">25617057</pub-id></element-citation></ref><ref id="B72-ijms-19-01511"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>L.A.F.</given-names></name><name><surname>Gurgel</surname><given-names>L.A.</given-names></name><name><surname>Silva</surname><given-names>R.M.</given-names></name><name><surname>Tom&#x000e9;</surname><given-names>A.R.</given-names></name><name><surname>Gramosa</surname><given-names>N.V.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Santos</surname><given-names>F.A.</given-names></name><name><surname>Rao</surname><given-names>V.S.N.</given-names></name></person-group><article-title>Anti-inflammatory effect of kaurenoic acid, a diterpene from <italic>Copaifera langsdorffii</italic> on acetic acid-induced colitis in rats</article-title><source>Vascul. Pharmacol.</source><year>2003</year><volume>39</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1016/S1537-1891(03)00028-4</pub-id></element-citation></ref><ref id="B73-ijms-19-01511"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Lotufo</surname><given-names>L.V.</given-names></name><name><surname>Cunha</surname><given-names>G.M.A.</given-names></name><name><surname>Farias</surname><given-names>P.A.M.</given-names></name><name><surname>Viana</surname><given-names>G.S.B.</given-names></name><name><surname>Cunha</surname><given-names>K.M.A.</given-names></name><name><surname>Pessoa</surname><given-names>C.</given-names></name><name><surname>Moraes</surname><given-names>M.O.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Gramosa</surname><given-names>N.V.</given-names></name><name><surname>Rao</surname><given-names>V.S.N.</given-names></name></person-group><article-title>The cytotoxic and embryotoxic effects of kaurenoic acid, a diterpene isolated from <italic>Copaifera langsdorffii</italic> oleo-resin</article-title><source>Toxicon</source><year>2002</year><volume>40</volume><fpage>1231</fpage><lpage>1234</lpage><pub-id pub-id-type="doi">10.1016/S0041-0101(02)00128-9</pub-id><pub-id pub-id-type="pmid">12165328</pub-id></element-citation></ref><ref id="B74-ijms-19-01511"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>F.D.S.</given-names></name><name><surname>de Almeida</surname><given-names>P.D.O.</given-names></name><name><surname>Aranha</surname><given-names>E.S.P.</given-names></name><name><surname>Boleti</surname><given-names>A.P.D.A.</given-names></name><name><surname>Newton</surname><given-names>P.</given-names></name><name><surname>de Vasconcellos</surname><given-names>M.C.</given-names></name><name><surname>Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Lima</surname><given-names>E.S.</given-names></name></person-group><article-title>Biological activities and cytotoxicity of diterpenes from <italic>Copaifera</italic> spp. oleoresins</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>6194</fpage><lpage>6210</lpage><pub-id pub-id-type="doi">10.3390/molecules20046194</pub-id><?supplied-pmid 25859778?><pub-id pub-id-type="pmid">25859778</pub-id></element-citation></ref><ref id="B75-ijms-19-01511"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tincusi</surname><given-names>B.M.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>I.A.</given-names></name><name><surname>Bazzocchi</surname><given-names>I.L.</given-names></name><name><surname>Moujir</surname><given-names>L.M.</given-names></name><name><surname>Mamani</surname><given-names>Z.A.</given-names></name><name><surname>Barroso</surname><given-names>J.P.</given-names></name><name><surname>Ravelo</surname><given-names>A.G.</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>B.V.</given-names></name></person-group><article-title>Antimicrobial terpenoids from the oleoresin of the Peruvian medicinal plant <italic>Copaifera paupera</italic></article-title><source>Planta Med.</source><year>2002</year><volume>68</volume><fpage>808</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1055/s-2002-34399</pub-id><?supplied-pmid 12357392?><pub-id pub-id-type="pmid">12357392</pub-id></element-citation></ref><ref id="B76-ijms-19-01511"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Braga</surname><given-names>W.F.</given-names></name><name><surname>Rezende</surname><given-names>C.M.</given-names></name><name><surname>Garrido</surname><given-names>F.M.S.</given-names></name><name><surname>Veiga</surname><given-names>V.F.</given-names></name><name><surname>Bergter</surname><given-names>L.</given-names></name><name><surname>Patitucci</surname><given-names>M.L.</given-names></name><name><surname>Antunes</surname><given-names>O.A.C.</given-names></name></person-group><article-title>Separation of acid diterpenes of <italic>Copaifera cearensis</italic> Huber ex Ducke by flash chromatography using potassium hydroxide impregnated silica gel</article-title><source>J. Braz. Chem. Soc.</source><year>2000</year><volume>11</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1590/S0103-50532000000400005</pub-id></element-citation></ref><ref id="B77-ijms-19-01511"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Souza</surname><given-names>A.B.</given-names></name><name><surname>de Souza</surname><given-names>M.G.M.</given-names></name><name><surname>Moreira</surname><given-names>M.A.</given-names></name><name><surname>Moreira</surname><given-names>M.R.</given-names></name><name><surname>Furtado</surname><given-names>N.A.J.C.</given-names></name><name><surname>Martins</surname><given-names>C.H.G.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>dos Santos</surname><given-names>R.A.</given-names></name><name><surname>Heleno</surname><given-names>V.C.G.</given-names></name><name><surname>Ambrosio</surname><given-names>S.R.</given-names></name><etal/></person-group><article-title>Antimicrobial evaluation of diterpenes from <italic>Copaifera langsdorffii</italic> oleoresin against periodontal anaerobic bacteria</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>9611</fpage><lpage>9619</lpage><pub-id pub-id-type="doi">10.3390/molecules16119611</pub-id><?supplied-pmid 22101836?><pub-id pub-id-type="pmid">22101836</pub-id></element-citation></ref><ref id="B78-ijms-19-01511"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemos</surname><given-names>M.</given-names></name><name><surname>Santin</surname><given-names>J.R.</given-names></name><name><surname>Mizuno</surname><given-names>C.S.</given-names></name><name><surname>Boeing</surname><given-names>T.</given-names></name><name><surname>de Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Nanayakkara</surname><given-names>D.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name><name><surname>de Andrade</surname><given-names>S.F.</given-names></name></person-group><article-title><italic>Copaifera langsdorffii</italic>: Evaluation of potential gastroprotective of extract and isolated compounds obtained from leaves</article-title><source>Braz. J. Pharmacogn.</source><year>2015</year><volume>25</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="doi">10.1016/j.bjp.2015.05.005</pub-id></element-citation></ref><ref id="B79-ijms-19-01511"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Sousa</surname><given-names>J.P.B.</given-names></name><name><surname>Brancalion</surname><given-names>A.P.S.</given-names></name><name><surname>Junior</surname><given-names>M.G.</given-names></name><name><surname>Bastos</surname><given-names>J.K.</given-names></name></person-group><article-title>A validated chromatographic method for the determination of flavonoids in <italic>Copaifera langsdorffii</italic> by HPLC</article-title><source>Nat. Prod. Commun.</source><year>2012</year><volume>7</volume><fpage>25</fpage><lpage>28</lpage><?supplied-pmid 22428235?><pub-id pub-id-type="pmid">22428235</pub-id></element-citation></ref><ref id="B80-ijms-19-01511"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>&#x000c2;.G.</given-names></name><name><surname>Ferrari</surname><given-names>A.S.</given-names></name><name><surname>da Cunha</surname><given-names>D.C.</given-names></name><name><surname>da Silva</surname><given-names>J.K.</given-names></name><name><surname>Cazarin</surname><given-names>C.B.B.</given-names></name><name><surname>Correa</surname><given-names>L.C.</given-names></name><name><surname>Prado</surname><given-names>M.A.</given-names></name><name><surname>de Carvalho-Silva</surname><given-names>L.B.</given-names></name><name><surname>Esteves</surname><given-names>E.A.</given-names></name><name><surname>Mar&#x000f3;stica J&#x000fa;nior</surname><given-names>M.R.</given-names></name></person-group><article-title>Polyphenols, antioxidants, and antimutagenic effects of <italic>Copaifera langsdorffii</italic> fruit</article-title><source>Food Chem.</source><year>2016</year><volume>197</volume><fpage>1153</fpage><lpage>1159</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2015.11.093</pub-id><?supplied-pmid 26675852?><pub-id pub-id-type="pmid">26675852</pub-id></element-citation></ref><ref id="B81-ijms-19-01511"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>A.R.M.</given-names></name><name><surname>Freitas</surname><given-names>L.A.P.</given-names></name><name><surname>Mendiola</surname><given-names>J.</given-names></name><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>E.</given-names></name></person-group><article-title><italic>Copaifera langsdorffii</italic> supercritical fluid extraction: Chemical and functional characterization by LC/MS and in vitro assays</article-title><source>J. Supercrit. Fluids</source><year>2015</year><volume>100</volume><fpage>86</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1016/j.supflu.2015.02.028</pub-id></element-citation></ref><ref id="B82-ijms-19-01511"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geris</surname><given-names>R.</given-names></name><name><surname>da Silva</surname><given-names>I.G.</given-names></name><name><surname>da Silva</surname><given-names>H.H.G.</given-names></name><name><surname>Barison</surname><given-names>A.</given-names></name><name><surname>Rodrigues-Filho</surname><given-names>E.</given-names></name><name><surname>Ferreira</surname><given-names>A.G.</given-names></name></person-group><article-title>Diterpenoids from <italic>Copaifera reticulata</italic> Ducke with larvicidal activity against <italic>Aedes aegypti</italic> (L.) (Diptera, Culicidae)</article-title><source>Rev. Inst. Med. Trop. Sao Paulo</source><year>2008</year><volume>50</volume><fpage>25</fpage><lpage>28</lpage><?supplied-pmid 18383630?><pub-id pub-id-type="pmid">18383630</pub-id></element-citation></ref><ref id="B83-ijms-19-01511"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>A.O.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Prado Dias Filho</surname><given-names>B.</given-names></name><name><surname>da Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name></person-group><article-title>Antimicrobial activity of Brazilian copaiba oils obtained from different species of <italic>Copaifera</italic></article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2008</year><volume>103</volume><fpage>277</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762008005000015</pub-id><pub-id pub-id-type="pmid">18545856</pub-id></element-citation></ref><ref id="B84-ijms-19-01511"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>J.C.T.</given-names></name><name><surname>Cascon</surname><given-names>V.</given-names></name><name><surname>Possebon</surname><given-names>L.S.</given-names></name><name><surname>Morimoto</surname><given-names>M.S.S.</given-names></name><name><surname>Cardoso</surname><given-names>L.G.V.</given-names></name><name><surname>Kaplan</surname><given-names>M.A.C.</given-names></name><name><surname>Gilbert</surname><given-names>B.</given-names></name></person-group><article-title>Topical antiinflammatory and analgesic activities of <italic>Copaifera duckei</italic> Dwyer</article-title><source>Phyther. Res.</source><year>2005</year><volume>19</volume><fpage>946</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1002/ptr.1762</pub-id><?supplied-pmid 16317651?><pub-id pub-id-type="pmid">16317651</pub-id></element-citation></ref><ref id="B85-ijms-19-01511"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro-e-Silva</surname><given-names>O.</given-names><suffix>Jr.</suffix></name><name><surname>Zucoloto</surname><given-names>S.</given-names></name><name><surname>Ramalho</surname><given-names>F.S.</given-names></name><name><surname>Ramalho</surname><given-names>L.N.Z.</given-names></name><name><surname>Reis</surname><given-names>J.M.C.</given-names></name><name><surname>Bastos</surname><given-names>A.A.C.</given-names></name><name><surname>Brito</surname><given-names>M.V.H.</given-names></name></person-group><article-title>Anti-proliferative activity of oleoresin from Brazilian <italic>Copaifera duckei</italic> oleoresin on liver regeneration in rats</article-title><source>Phyther. Res.</source><year>2004</year><volume>18</volume><fpage>92</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1002/ptr.1351</pub-id><?supplied-pmid 14750209?><pub-id pub-id-type="pmid">14750209</pub-id></element-citation></ref><ref id="B86-ijms-19-01511"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorneles</surname><given-names>F.D.S.</given-names></name><name><surname>Da Silva</surname><given-names>A.S.</given-names></name><name><surname>Oliveira</surname><given-names>C.B.</given-names></name><name><surname>Zimmermann</surname><given-names>C.E.P.</given-names></name><name><surname>Rosa</surname><given-names>L.D.</given-names></name><name><surname>Tonin</surname><given-names>A.A.</given-names></name><name><surname>de Oliveira</surname><given-names>E.C.P.</given-names></name><name><surname>Santurio</surname><given-names>J.M.</given-names></name><name><surname>Monteiro</surname><given-names>S.G.</given-names></name></person-group><article-title>Susceptibility of <italic>Trypanosoma evansi</italic> in the Copaiba oil: In vitro test and in mice experimentally infected with the parasite</article-title><source>Acta Sci. Vet.</source><year>2013</year><volume>41</volume><fpage>1136</fpage></element-citation></ref><ref id="B87-ijms-19-01511"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>L.A.F.</given-names></name><name><surname>Rao</surname><given-names>V.S.N.</given-names></name><name><surname>Gramosa</surname><given-names>N.V.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name></person-group><article-title>Gastroprotective effect of <italic>Copaifera langsdorffii</italic> oleo-resin on experimental gastric ulcer models in rats</article-title><source>J. Ethnopharmacol.</source><year>1998</year><volume>62</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/S0378-8741(98)00058-0</pub-id><pub-id pub-id-type="pmid">9720615</pub-id></element-citation></ref><ref id="B88-ijms-19-01511"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>L.A.F.</given-names></name><name><surname>Gurgel</surname><given-names>L.A.</given-names></name><name><surname>Campos</surname><given-names>A.R.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Rao</surname><given-names>V.S.N.</given-names></name></person-group><article-title>Attenuation of ischemia/reperfusion-induced intestinal injury by oleo-resin from <italic>Copaifera langsdorffii</italic> in rats</article-title><source>Life Sci.</source><year>2004</year><volume>75</volume><fpage>1979</fpage><lpage>1987</lpage><pub-id pub-id-type="doi">10.1016/j.lfs.2004.05.011</pub-id><?supplied-pmid 15306165?><pub-id pub-id-type="pmid">15306165</pub-id></element-citation></ref><ref id="B89-ijms-19-01511"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paiva</surname><given-names>L.A.F.</given-names></name><name><surname>de Alencar Cunha</surname><given-names>K.M.</given-names></name><name><surname>Santos</surname><given-names>F.A.</given-names></name><name><surname>Gramosa</surname><given-names>N.V.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Rao</surname><given-names>V.S.N.</given-names></name></person-group><article-title>Investigation on the wound healing activity of oleo-resin from <italic>Copaifera langsdorffii</italic> in rats</article-title><source>Phyther. Res.</source><year>2002</year><volume>16</volume><fpage>737</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1002/ptr.1049</pub-id><?supplied-pmid 12458476?><pub-id pub-id-type="pmid">12458476</pub-id></element-citation></ref><ref id="B90-ijms-19-01511"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Lima Silva</surname><given-names>J.J.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>S.B.</given-names></name><name><surname>da Silveira</surname><given-names>E.R.</given-names></name><name><surname>de Vasconcelos</surname><given-names>P.R.L.</given-names></name><name><surname>Lima</surname><given-names>G.G.</given-names></name><name><surname>Torres</surname><given-names>S.M.</given-names></name><name><surname>de Vasconcelos</surname><given-names>R.C.</given-names></name></person-group><article-title>Effects of <italic>Copaifera langsdorffii</italic> Desf. on ischemia-reperfusion of randomized skin flaps in rats</article-title><source>Aesthet. Plast. Surg.</source><year>2009</year><volume>33</volume><fpage>104</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1007/s00266-008-9263-2</pub-id><?supplied-pmid 18982383?><pub-id pub-id-type="pmid">18982383</pub-id></element-citation></ref><ref id="B91-ijms-19-01511"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neto</surname><given-names>J.N.</given-names></name><name><surname>Lindoso</surname><given-names>M.J.D.S.</given-names></name><name><surname>Coelho</surname><given-names>L.F.</given-names></name><name><surname>Antonio</surname><given-names>R.</given-names></name><name><surname>Carvalho</surname><given-names>R.A.F.</given-names></name><name><surname>Rodrigues</surname><given-names>T.G.P.D.M.</given-names></name><name><surname>de Ara&#x000fa;jo</surname><given-names>A.G.P.</given-names></name><name><surname>Gir&#x000e3;o</surname><given-names>M.J.B.C.</given-names></name><name><surname>Schor</surname><given-names>E.</given-names></name></person-group><article-title>Changes in the volume and histology of endometriosis foci in rats treated with copaiba oil (<italic>Copaifera langsdorffii</italic>)</article-title><source>Acta Cir&#x000fa;rgica Bras.</source><year>2011</year><volume>26</volume><fpage>20</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1590/S0102-86502011000800005</pub-id></element-citation></ref><ref id="B92-ijms-19-01511"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masson-Meyers</surname><given-names>D.S.</given-names></name><name><surname>Enwemeka</surname><given-names>C.S.</given-names></name><name><surname>Bumah</surname><given-names>V.</given-names></name><name><surname>Andrade</surname><given-names>T.A.M.</given-names></name><name><surname>Cashin</surname><given-names>S.E.</given-names></name><name><surname>Frade</surname><given-names>M.A.C.</given-names></name></person-group><article-title>Antimicrobial effects of <italic>Copaifera langsdorffii</italic> oleoresin in infected rat wounds</article-title><source>Int. J. Appl. Microbiol. Sci.</source><year>2013</year><volume>2</volume><fpage>9</fpage><lpage>20</lpage></element-citation></ref><ref id="B93-ijms-19-01511"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masson-Meyers</surname><given-names>D.S.</given-names></name><name><surname>Andrade</surname><given-names>T.A.M.</given-names></name><name><surname>Leite</surname><given-names>S.N.</given-names></name><name><surname>Frade</surname><given-names>M.A.C.</given-names></name></person-group><article-title>Cytotoxicity and wound healing properties of <italic>Copaifera langsdorffii</italic> oleoresin in rabbits</article-title><source>Int. J. Nat. Prod. Sci.</source><year>2013</year><volume>3</volume><fpage>10</fpage><lpage>20</lpage></element-citation></ref><ref id="B94-ijms-19-01511"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masson-Meyers</surname><given-names>D.</given-names></name><name><surname>Enweme</surname><given-names>C.S.</given-names></name><name><surname>Bumah</surname><given-names>V.</given-names></name><name><surname>Andrade</surname><given-names>T.</given-names></name><name><surname>Frade</surname><given-names>M.A.</given-names></name></person-group><article-title>Topical treatment with <italic>Copaifera langsdorffii</italic> oleoresin improves wound healing in rats</article-title><source>Int. J. Phytomed.</source><year>2013</year><volume>5</volume><fpage>378</fpage><lpage>386</lpage></element-citation></ref><ref id="B95-ijms-19-01511"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbosa</surname><given-names>F.S.</given-names></name><name><surname>Leite</surname><given-names>G.L.D.</given-names></name><name><surname>Alves</surname><given-names>S.M.</given-names></name><name><surname>Nascimento</surname><given-names>A.F.</given-names></name><name><surname>D&#x02019;&#x000c1;vila</surname><given-names>V.D.A.</given-names></name><name><surname>da Costa</surname><given-names>C.A.</given-names></name></person-group><article-title>Insecticide effects of <italic>Ruta graveolens</italic>, <italic>Copaifera langsdorffii</italic> and <italic>Chenopodium ambrosioides</italic> against pests and natural enemies in commercial tomato plantation</article-title><source>Acta Sci. Agron.</source><year>2011</year><volume>33</volume><fpage>37</fpage><lpage>43</lpage></element-citation></ref><ref id="B96-ijms-19-01511"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Alencar Cunha</surname><given-names>K.M.</given-names></name><name><surname>Paiva</surname><given-names>L.A.</given-names></name><name><surname>Santos</surname><given-names>F.A.</given-names></name><name><surname>Gramosa</surname><given-names>N.V.</given-names></name><name><surname>Silveira</surname><given-names>E.R.</given-names></name><name><surname>Rao</surname><given-names>V.S.</given-names></name></person-group><article-title>Smooth muscle relaxant effect of kaurenoic acid, a diterpene from <italic>Copaifera langsdorffii</italic> on rat uterus in vitro</article-title><source>Phyther. Res.</source><year>2003</year><volume>17</volume><fpage>320</fpage><lpage>324</lpage><pub-id pub-id-type="doi">10.1002/ptr.1133</pub-id><?supplied-pmid 12722132?><pub-id pub-id-type="pmid">12722132</pub-id></element-citation></ref><ref id="B97-ijms-19-01511"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>A.O.</given-names></name><name><surname>Costa</surname><given-names>M.A.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Dias-Filho</surname><given-names>B.P.</given-names></name><name><surname>da Veiga-J&#x000fa;nior</surname><given-names>V.F.</given-names></name><name><surname>de Souza Lima</surname><given-names>M.M.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name></person-group><article-title><italic>Leishmania amazonensis</italic>: Effects of oral treatment with copaiba oil in mice</article-title><source>Exp. Parasitol.</source><year>2011</year><volume>129</volume><fpage>145</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2011.06.016</pub-id><?supplied-pmid 21771592?><pub-id pub-id-type="pmid">21771592</pub-id></element-citation></ref><ref id="B98-ijms-19-01511"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>N.D.M.</given-names></name><name><surname>Rezende</surname><given-names>C.D.M.</given-names></name><name><surname>Fontes</surname><given-names>S.P.</given-names></name><name><surname>Hovell</surname><given-names>A.M.C.</given-names></name><name><surname>Landgraf</surname><given-names>R.G.</given-names></name><name><surname>Matheus</surname><given-names>M.E.</given-names></name><name><surname>Pinto</surname><given-names>A.D.C.</given-names></name><name><surname>Fernandes</surname><given-names>P.D.</given-names></name></person-group><article-title>Antineoplasic activity of <italic>Copaifera multijuga</italic> oil and fractions against ascitic and solid Ehrlich tumor</article-title><source>J. Ethnopharmacol.</source><year>2008</year><volume>119</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2008.06.033</pub-id><?supplied-pmid 18647645?><pub-id pub-id-type="pmid">18647645</pub-id></element-citation></ref><ref id="B99-ijms-19-01511"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>N.M.</given-names></name><name><surname>Rezende</surname><given-names>C.M.</given-names></name><name><surname>Fontes</surname><given-names>S.P.</given-names></name><name><surname>Matheus</surname><given-names>M.E.</given-names></name><name><surname>Fernandes</surname><given-names>P.D.</given-names></name></person-group><article-title>Antinociceptive activity of Amazonian copaiba oils</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>109</volume><fpage>486</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.08.018</pub-id><?supplied-pmid 17029841?><pub-id pub-id-type="pmid">17029841</pub-id></element-citation></ref><ref id="B100-ijms-19-01511"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>N.D.M.</given-names></name><name><surname>de Rezende</surname><given-names>C.M.</given-names></name><name><surname>Fontes</surname><given-names>S.P.</given-names></name><name><surname>Matheus</surname><given-names>M.E.</given-names></name><name><surname>Pinto</surname><given-names>A.D.C.</given-names></name><name><surname>Fernandes</surname><given-names>P.D.</given-names></name></person-group><article-title>Characterization of the antinociceptive and anti-inflammatory activities of fractions obtained from <italic>Copaifera multijuga</italic> Hayne</article-title><source>J. Ethnopharmacol.</source><year>2010</year><volume>128</volume><fpage>177</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.01.005</pub-id><?supplied-pmid 20064592?><pub-id pub-id-type="pmid">20064592</pub-id></element-citation></ref><ref id="B101-ijms-19-01511"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brito</surname><given-names>N.M.B.</given-names></name><name><surname>Brito</surname><given-names>M.V.H.</given-names></name><name><surname>Carvalho</surname><given-names>R.D.K.V.</given-names></name><name><surname>Matos</surname><given-names>L.T.D.M.B.</given-names></name><name><surname>Lobato</surname><given-names>R.C.</given-names></name><name><surname>Correa</surname><given-names>S.C.</given-names></name><name><surname>Brito</surname><given-names>R.B.</given-names></name></person-group><article-title>The effect of copaiba balsam on Walker 256 carcinoma inoculated into the vagina and uterine cervix of female rats</article-title><source>Acta Cir. Bras.</source><year>2010</year><volume>25</volume><fpage>176</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1590/S0102-86502010000200010</pub-id><?supplied-pmid 20305885?><pub-id pub-id-type="pmid">20305885</pub-id></element-citation></ref><ref id="B102-ijms-19-01511"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieri</surname><given-names>F.A.</given-names></name><name><surname>Mussi</surname><given-names>M.C.M.</given-names></name><name><surname>Fiorini</surname><given-names>J.E.</given-names></name><name><surname>Moreira</surname><given-names>M.A.S.</given-names></name><name><surname>Schneedorf</surname><given-names>J.M.</given-names></name></person-group><article-title>Bacteriostatic effect of copaiba oil (<italic>Copaifera officinalis</italic>) against <italic>Streptococcus mutans</italic></article-title><source>Braz. Dent. J.</source><year>2012</year><volume>23</volume><fpage>36</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1590/S0103-64402012000100006</pub-id><?supplied-pmid 22460312?><pub-id pub-id-type="pmid">22460312</pub-id></element-citation></ref><ref id="B103-ijms-19-01511"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>A.L.</given-names></name><name><surname>Cunha</surname><given-names>E.A.</given-names></name><name><surname>Matias</surname><given-names>F.O.</given-names></name><name><surname>Garcia</surname><given-names>P.G.</given-names></name><name><surname>Danopoulos</surname><given-names>P.</given-names></name><name><surname>Swikidisa</surname><given-names>R.</given-names></name><name><surname>Pinheiro</surname><given-names>V.A.</given-names></name><name><surname>Nogueira</surname><given-names>R.J.</given-names></name></person-group><article-title>Antimicrobial activity of copaiba (<italic>Copaifera officinalis</italic>) and pracaxi (<italic>Pentaclethra macroloba</italic>) oils against <italic>Staphylococcus aureus</italic>: Importance in compounding for wound care</article-title><source>Int. J. Pharm. Compd.</source><year>2016</year><volume>20</volume><fpage>58</fpage><lpage>62</lpage><?supplied-pmid 27125055?><pub-id pub-id-type="pmid">27125055</pub-id></element-citation></ref><ref id="B104-ijms-19-01511"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>A.O.</given-names></name><name><surname>Izumi</surname><given-names>E.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Dias-Filho</surname><given-names>B.P.</given-names></name><name><surname>da Veiga-J&#x000fa;nior</surname><given-names>V.F.</given-names></name><name><surname>Vataru Nakamura</surname><given-names>C.</given-names></name></person-group><article-title>Antileishmanial activity of diterpene acids in copaiba oil</article-title><source>Mem. Inst. Oswaldo Cruz</source><year>2013</year><volume>108</volume><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1590/S0074-02762013000100010</pub-id></element-citation></ref><ref id="B105-ijms-19-01511"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curio</surname><given-names>M.</given-names></name><name><surname>Jacone</surname><given-names>H.</given-names></name><name><surname>Perrut</surname><given-names>J.</given-names></name><name><surname>Pinto</surname><given-names>&#x000c2;.C.</given-names></name><name><surname>Veiga Filho</surname><given-names>V.F.</given-names></name><name><surname>Silva</surname><given-names>R.C.B.</given-names></name></person-group><article-title>Acute effect of <italic>Copaifera reticulata</italic> Ducke copaiba oil in rats tested in the elevated plus-maze: An ethological analysis</article-title><source>J. Pharm. Pharmacol.</source><year>2009</year><volume>61</volume><fpage>1105</fpage><lpage>1110</lpage><pub-id pub-id-type="doi">10.1211/jpp.61.08.0015</pub-id><?supplied-pmid 19703355?><pub-id pub-id-type="pmid">19703355</pub-id></element-citation></ref><ref id="B106-ijms-19-01511"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>I.G.</given-names></name><name><surname>Zanon</surname><given-names>V.O.M.</given-names></name><name><surname>Silva</surname><given-names>H.H.G.</given-names></name></person-group><article-title>Larvicidal activity of <italic>Copaifera reticulata</italic> Ducke oil-resin against <italic>Culex quinquefasciatus</italic> Say (Diptera: Culicidae)</article-title><source>Neotrop. Entomol.</source><year>2003</year><volume>32</volume><fpage>729</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1590/S1519-566X2003000400029</pub-id></element-citation></ref><ref id="B107-ijms-19-01511"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Da Silva</surname><given-names>H.H.G.</given-names></name><name><surname>Geris</surname><given-names>R.</given-names></name><name><surname>Rodrigues Filho</surname><given-names>E.</given-names></name><name><surname>Rocha</surname><given-names>C.</given-names></name><name><surname>da Silva</surname><given-names>I.G.</given-names></name></person-group><article-title>Larvicidal activity of oil-resin fractions from the Brazilian medicinal plant <italic>Copaifera reticulata</italic> Ducke (Leguminosae-Caesalpinoideae) against <italic>Aedes aegypti</italic> (Diptera, Culicidae)</article-title><source>Rev. Soc. Bras. Med. Trop.</source><year>2007</year><volume>40</volume><fpage>264</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1590/S0037-86822007000300002</pub-id><?supplied-pmid 17653457?><pub-id pub-id-type="pmid">17653457</pub-id></element-citation></ref><ref id="B108-ijms-19-01511"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes</surname><given-names>F.D.F.</given-names></name><name><surname>Freitas</surname><given-names>E.D.P.S.</given-names></name></person-group><article-title>Acaricidal activity of an oleoresinous extract from <italic>Copaifera reticulata</italic> (Leguminosae: Caesalpinioideae) against larvae of the southern cattle tick, <italic>Rhipicephalus</italic> (<italic>Boophilus</italic>) <italic>microplus</italic> (Acari: Ixodidae)</article-title><source>Vet. Parasitol.</source><year>2007</year><volume>147</volume><fpage>150</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2007.02.035</pub-id><?supplied-pmid 17478043?><pub-id pub-id-type="pmid">17478043</pub-id></element-citation></ref><ref id="B109-ijms-19-01511"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dos Santos</surname><given-names>A.O.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Dias Filho</surname><given-names>B.P.</given-names></name><name><surname>da Veiga Junior</surname><given-names>V.F.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name></person-group><article-title>Copaiba oil: An alternative to development of new drugs against leishmaniasis</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2012</year><volume>2012</volume><pub-id pub-id-type="doi">10.1155/2012/898419</pub-id><?supplied-pmid 21716677?><pub-id pub-id-type="pmid">21716677</pub-id></element-citation></ref><ref id="B110-ijms-19-01511"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>T.A.R.C.</given-names></name><name><surname>Barata</surname><given-names>L.E.S.</given-names></name><name><surname>Duarte</surname><given-names>M.C.T.</given-names></name></person-group><article-title>A ntimicrobial activity of copaiba (<italic>Copaifera</italic> spp.) balsams</article-title><source>Rev. Bras. Plantas Med.</source><year>2006</year><volume>8</volume><fpage>123</fpage><lpage>124</lpage></element-citation></ref><ref id="B111-ijms-19-01511"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izumi</surname><given-names>E.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Veiga</surname><given-names>V.F.</given-names></name><name><surname>Pinto</surname><given-names>A.C.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name></person-group><article-title>Terpenes from <italic>Copaifera</italic> demonstrated in vitro antiparasitic and synergic activity</article-title><source>J. Med. Chem.</source><year>2012</year><volume>55</volume><fpage>2994</fpage><lpage>3001</lpage><pub-id pub-id-type="doi">10.1021/jm201451h</pub-id><?supplied-pmid 22440015?><pub-id pub-id-type="pmid">22440015</pub-id></element-citation></ref><ref id="B112-ijms-19-01511"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soares</surname><given-names>D.C.</given-names></name><name><surname>Portella</surname><given-names>N.A.</given-names></name><name><surname>Ramos</surname><given-names>M.F.D.S.</given-names></name><name><surname>Siani</surname><given-names>A.C.</given-names></name><name><surname>Saraiva</surname><given-names>E.M.</given-names></name></person-group><article-title><italic>trans</italic>-&#x003b2;-Caryophyllene: An effective antileishmanial compound found in commercial copaiba oil (<italic>Copaifera</italic> spp.)</article-title><source>Evid.-Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><pub-id pub-id-type="doi">10.1155/2013/761323</pub-id><?supplied-pmid 23864897?><pub-id pub-id-type="pmid">23864897</pub-id></element-citation></ref><ref id="B113-ijms-19-01511"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases-Part III: In-silico molecular docking investigations</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>1389</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21101389</pub-id><?supplied-pmid 27775577?><pub-id pub-id-type="pmid">27775577</pub-id></element-citation></ref><ref id="B114-ijms-19-01511"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>In-silico <italic>Leishmania</italic> target selectivity of antiparasitic terpenoids</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>7761</fpage><lpage>7847</lpage><pub-id pub-id-type="doi">10.3390/molecules18077761</pub-id><?supplied-pmid 23823876?><pub-id pub-id-type="pmid">23823876</pub-id></element-citation></ref><ref id="B115-ijms-19-01511"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name><name><surname>Ng</surname><given-names>J.D.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Interactions of antiparasitic alkaloids with <italic>Leishmania</italic> protein targets: A molecular docking analysis</article-title><source>Future Med. Chem.</source><year>2013</year><volume>5</volume><fpage>1777</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.4155/fmc.13.114</pub-id><?supplied-pmid 24144413?><pub-id pub-id-type="pmid">24144413</pub-id></element-citation></ref><ref id="B116-ijms-19-01511"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name><name><surname>Erwin</surname><given-names>W.R.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Antileishmanial phytochemical phenolics: Molecular docking to potential protein targets</article-title><source>J. Mol. Graph. Model.</source><year>2014</year><volume>48</volume><fpage>105</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.jmgm.2013.12.010</pub-id><?supplied-pmid 24463105?><pub-id pub-id-type="pmid">24463105</pub-id></element-citation></ref><ref id="B117-ijms-19-01511"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mcculley</surname><given-names>S.F.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>An in-silico investigation of anti-Chagas phytochemicals</article-title><source>Curr. Clin. Pharmacol.</source><year>2014</year><volume>9</volume><fpage>205</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.2174/157488470903140806114147</pub-id><?supplied-pmid 23173969?><pub-id pub-id-type="pmid">23173969</pub-id></element-citation></ref><ref id="B118-ijms-19-01511"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warfield</surname><given-names>J.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name></person-group><article-title>Interactions of antiparasitic sterols with sterol 14&#x003b1;-demethylase (CYP51) of human pathogens</article-title><source>SpringerPlus</source><year>2014</year><volume>3</volume><fpage>679</fpage><pub-id pub-id-type="doi">10.1186/2193-1801-3-679</pub-id><?supplied-pmid 25932361?><pub-id pub-id-type="pmid">25932361</pub-id></element-citation></ref><ref id="B119-ijms-19-01511"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setzer</surname><given-names>M.S.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>The search for herbal antibiotics: An in-silico investigation of antibacterial phytochemicals</article-title><source>Antibiotics</source><year>2016</year><volume>5</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics5030030</pub-id><?supplied-pmid 27626453?><pub-id pub-id-type="pmid">27626453</pub-id></element-citation></ref><ref id="B120-ijms-19-01511"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veeck</surname><given-names>J.</given-names></name><name><surname>Esteller</surname><given-names>M.</given-names></name></person-group><article-title>Breast cancer epigenetics: From DNA methylation to microRNAs</article-title><source>J. Mammary Gland Biol. Neoplasia</source><year>2010</year><volume>15</volume><fpage>5</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1007/s10911-010-9165-1</pub-id><?supplied-pmid 20101446?><pub-id pub-id-type="pmid">20101446</pub-id></element-citation></ref><ref id="B121-ijms-19-01511"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.</given-names></name><name><surname>Hevi</surname><given-names>S.</given-names></name><name><surname>Gay</surname><given-names>F.</given-names></name><name><surname>Tsujimoto</surname><given-names>N.</given-names></name><name><surname>He</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name><name><surname>Ueda</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>E.</given-names></name></person-group><article-title>Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells</article-title><source>Nat. Genet.</source><year>2007</year><volume>39</volume><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1038/ng1982</pub-id><?supplied-pmid 17322882?><pub-id pub-id-type="pmid">17322882</pub-id></element-citation></ref><ref id="B122-ijms-19-01511"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>R.K.</given-names></name><name><surname>Wu</surname><given-names>C.Y.</given-names></name><name><surname>Chang</surname><given-names>J.W.</given-names></name><name><surname>Juan</surname><given-names>L.J.</given-names></name><name><surname>Hsu</surname><given-names>H.S.</given-names></name><name><surname>Chen</surname><given-names>C.Y.</given-names></name><name><surname>Lu</surname><given-names>Y.Y.</given-names></name><name><surname>Tang</surname><given-names>Y.A.</given-names></name><name><surname>Yang</surname><given-names>Y.C.</given-names></name><name><surname>Yang</surname><given-names>P.C.</given-names></name><etal/></person-group><article-title>Dysregulation of p53/Sp1 control leads to DNA methyltransferase-1 overexpression in lung cancer</article-title><source>Cancer Res.</source><year>2010</year><volume>70</volume><fpage>5807</fpage><lpage>5817</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-4161</pub-id><?supplied-pmid 20570896?><pub-id pub-id-type="pmid">20570896</pub-id></element-citation></ref><ref id="B123-ijms-19-01511"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina-Franco</surname><given-names>J.L.</given-names></name><name><surname>Caulfield</surname><given-names>T.</given-names></name></person-group><article-title>Advances in the computational development of DNA methyltransferase inhibitors</article-title><source>Drug Discov. Today</source><year>2011</year><volume>16</volume><fpage>418</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2011.02.003</pub-id><?supplied-pmid 21315180?><pub-id pub-id-type="pmid">21315180</pub-id></element-citation></ref><ref id="B124-ijms-19-01511"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maldonado-Rojas</surname><given-names>W.</given-names></name><name><surname>Olivero-Verbel</surname><given-names>J.</given-names></name><name><surname>Marrero-Ponce</surname><given-names>Y.</given-names></name></person-group><article-title>Computational fishing of new DNA methyltransferase inhibitors from natural products</article-title><source>J. Mol. Graph. Model.</source><year>2015</year><volume>60</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/j.jmgm.2015.04.010</pub-id><?supplied-pmid 26099696?><pub-id pub-id-type="pmid">26099696</pub-id></element-citation></ref><ref id="B125-ijms-19-01511"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isshiki</surname><given-names>Y.</given-names></name><name><surname>Kohchi</surname><given-names>Y.</given-names></name><name><surname>Iikura</surname><given-names>H.</given-names></name><name><surname>Matsubara</surname><given-names>Y.</given-names></name><name><surname>Asoh</surname><given-names>K.</given-names></name><name><surname>Murata</surname><given-names>T.</given-names></name><name><surname>Kohchi</surname><given-names>M.</given-names></name><name><surname>Mizuguchi</surname><given-names>E.</given-names></name><name><surname>Tsujii</surname><given-names>S.</given-names></name><name><surname>Hattori</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2011</year><volume>21</volume><fpage>1795</fpage><lpage>1801</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2011.01.062</pub-id><?supplied-pmid 21316218?><pub-id pub-id-type="pmid">21316218</pub-id></element-citation></ref><ref id="B126-ijms-19-01511"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weekes</surname><given-names>C.D.</given-names></name><name><surname>Von Hoff</surname><given-names>D.D.</given-names></name><name><surname>Adjei</surname><given-names>A.A.</given-names></name><name><surname>Leffingwell</surname><given-names>D.P.</given-names></name><name><surname>Eckhardt</surname><given-names>S.G.</given-names></name><name><surname>Gore</surname><given-names>L.</given-names></name><name><surname>Lewis</surname><given-names>K.D.</given-names></name><name><surname>Weiss</surname><given-names>G.J.</given-names></name><name><surname>Ramanathan</surname><given-names>R.K.</given-names></name><name><surname>Dy</surname><given-names>G.K.</given-names></name><etal/></person-group><article-title>Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer</article-title><source>Clin. Cancer Res.</source><year>2013</year><volume>19</volume><fpage>1232</fpage><lpage>1243</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-12-3529</pub-id><?supplied-pmid 23434733?><pub-id pub-id-type="pmid">23434733</pub-id></element-citation></ref><ref id="B127-ijms-19-01511"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>M.</given-names></name><name><surname>Gustafsson</surname><given-names>J.&#x000c5;.</given-names></name></person-group><article-title>The role of estrogen receptor &#x003b2; (ER&#x003b2;) in malignant diseases&#x02014;A new potential target for antiproliferative drugs in prevention and treatment of cancer</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2010</year><volume>396</volume><fpage>63</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.02.144</pub-id><?supplied-pmid 20494112?><pub-id pub-id-type="pmid">20494112</pub-id></element-citation></ref><ref id="B128-ijms-19-01511"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>B.</given-names></name><name><surname>Gustafsson</surname><given-names>J.A.</given-names></name></person-group><article-title>Estrogen receptor &#x003b2; as a pharmaceutical target</article-title><source>Trends Pharmacol. Sci.</source><year>2017</year><volume>38</volume><fpage>92</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2016.10.006</pub-id><?supplied-pmid 27979317?><pub-id pub-id-type="pmid">27979317</pub-id></element-citation></ref><ref id="B129-ijms-19-01511"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tibes</surname><given-names>U.</given-names></name></person-group><article-title>Phospholipase A2 inhibitors in development</article-title><source>Expert Opin. Investig. Drugs</source><year>1997</year><volume>6</volume><fpage>279</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1517/13543784.6.3.279</pub-id><?supplied-pmid 15989628?><pub-id pub-id-type="pmid">15989628</pub-id></element-citation></ref><ref id="B130-ijms-19-01511"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>K.M.</given-names></name><name><surname>McReynolds</surname><given-names>C.B.</given-names></name><name><surname>Schmidt</surname><given-names>W.K.</given-names></name><name><surname>Hammock</surname><given-names>B.D.</given-names></name></person-group><article-title>Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases</article-title><source>Pharmacol. Ther.</source><year>2017</year><volume>180</volume><fpage>62</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2017.06.006</pub-id><?supplied-pmid 28642117?><pub-id pub-id-type="pmid">28642117</pub-id></element-citation></ref><ref id="B131-ijms-19-01511"><label>131.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Setzer</surname><given-names>W.N.</given-names></name><name><surname>Byler</surname><given-names>K.G.</given-names></name></person-group><article-title>In-silico approaches to natural products drug discovery: A review of the recent literature</article-title><source>Natural Products and Drug Discovery: From Pharmacochemistry to Pharmacological Approaches</source><person-group person-group-type="editor"><name><surname>Diniz</surname><given-names>M.F.F.M.</given-names></name><name><surname>Scotti</surname><given-names>M.T.</given-names></name><name><surname>Scotti</surname><given-names>L.</given-names></name><name><surname>Alves</surname><given-names>M.F.E.</given-names></name></person-group><publisher-name>Editora UFPB</publisher-name><publisher-loc>Jo&#x000e3;o Pessoa, Brazil</publisher-loc><year>2018</year></element-citation></ref><ref id="B132-ijms-19-01511"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setzer</surname><given-names>M.S.</given-names></name><name><surname>Byler</surname><given-names>K.G.</given-names></name><name><surname>Ogungbe</surname><given-names>I.V.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name></person-group><article-title>Natural products as new treatment options for trichomoniasis: A molecular docking investigation</article-title><source>Sci. Pharm.</source><year>2017</year><volume>85</volume><elocation-id>5</elocation-id><pub-id pub-id-type="doi">10.3390/scipharm85010005</pub-id><?supplied-pmid 28134827?><pub-id pub-id-type="pmid">28134827</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-19-01511-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Clerodane diterpenoids found in <italic>Copaifera</italic> species.</p></caption><graphic xlink:href="ijms-19-01511-g001"/></fig><fig id="ijms-19-01511-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Kaurane diterpenoids found in <italic>Copaifera</italic> species.</p></caption><graphic xlink:href="ijms-19-01511-g002"/></fig><fig id="ijms-19-01511-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Labdane diterpenoids found in <italic>Copaifera</italic> species.</p></caption><graphic xlink:href="ijms-19-01511-g003"/></fig><table-wrap id="ijms-19-01511-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t001_Table 1</object-id><label>Table 1</label><caption><p>Major components of the essential oils of <italic>Copaifera</italic> species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EO Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Major Components (&#x0003e;5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. cearensis</italic> Huber ex Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (8.2%),<break/>&#x003b2;-caryophyllene (19.7%),<break/>&#x003b4;-cadinene (7.2%),<break/>&#x003b2;-bisabolol (8.2%),<break/>hardwickiic acid (6.2%),<break/>clorechinic acid (11.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. cearensis</italic> Huber ex Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (8.2%),<break/>&#x003b2;-caryophyllene (19.7%),<break/>hardwickiic acid (6.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (0.7&#x02013;6.2%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (3.4&#x02013;7.9%),<break/>&#x003b2;-selinene (5.5&#x02013;7.3%),<break/>&#x003b2;-bisabolene (8.9&#x02013;12.1%),<break/>kaur-16-en-19-oic acid (19.8&#x02013;24.5%),<break/>polyalthic acid (17.1&#x02013;27.7%),<break/>hardwickiic acid (0&#x02013;24.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B8-ijms-19-01511" ref-type="bibr">8</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-elemene (8.3&#x02013;9.4%),<break/>&#x003b2;-caryophyllene (13.0&#x02013;15.5%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (8.3&#x02013;10.6%),<break/>&#x003b2;-selinene (13.8&#x02013;15.4%),<break/>&#x003b1;-selinene (8.8&#x02013;9.9%),<break/>&#x003b2;-bisabolene (15.7&#x02013;17.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-ijms-19-01511" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (25.1&#x02013;50.2%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (6.4&#x02013;12.0%),<break/>(<italic>E</italic>)-&#x003b2;-farnesene (2.9&#x02013;5.8%),<break/>&#x003b2;-selinene (1.8&#x02013;6.7%),<break/>&#x003b2;-bisabolene (5.2&#x02013;33.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B49-ijms-19-01511" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. guianensis</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>trans</italic>-&#x003b1;-bergamotene (7.2%),<break/>caryophyllene oxide (19.1%),<break/>kaur-16-en-19-oic acid (17.5%),<break/>polyalthic acid (10.6%),<break/>hardwickiic acid (11.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B8-ijms-19-01511" ref-type="bibr">8</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (32.8%),<break/>kaurenoic acid (44.3%),<break/>copalic acid (5.6%),<break/>hardwickiic acid (8.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cyclosativene (5.0%),<break/>&#x003b2;-elemene (5.1%),<break/>&#x003b2;-caryophyllene (5.5%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (48.4%),<break/>&#x003b2;-selinene (5.0%),<break/>&#x003b1;-himachalene (11.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-ijms-19-01511" ref-type="bibr">50</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (5.8%),<break/>&#x003b3;-muurolene (22.7%),<break/>eremophilone (6.8%),<break/>kaurene (6.8%),<break/>methyl oleate (26.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-ijms-19-01511" ref-type="bibr">51</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-elemene (8.0%),<break/>&#x003b2;-caryophyllene (31.4%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (10.2%),<break/>&#x003b3;-muurolene (16.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-ijms-19-01511" ref-type="bibr">52</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (1.1&#x02013;9.0%),<break/>germacrene D (4.0&#x02013;18.0%),<break/>bicyclogermacrene (1.5&#x02013;5.7%),<break/>spathulenol (12.6&#x02013;35.7%),<break/>caryophyllene oxide (7.4&#x02013;16.6%),<break/>&#x003b1;-cadinol (3.2&#x02013;7.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B53-ijms-19-01511" ref-type="bibr">53</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pericarp</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (3.2&#x02013;14.4%),<break/>&#x003b2;-elemene (0&#x02013;11.1%),<break/>&#x003b2;-caryophyllene (2.7&#x02013;10.5%),<break/>germacrene D (1.9&#x02013;10.7%),<break/>bicyclogermacrene (0&#x02013;6.3%),<break/>spathulenol (2.2&#x02013;16.2%),<break/>caryophyllene oxide (4.0&#x02013;5.1%),<break/><italic>iso</italic>-spathulenol (5.6&#x02013;21.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-ijms-19-01511" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leaf</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (1.8&#x02013;6.9%),<break/>&#x003b2;-elemene (0&#x02013;8.4%),<break/>&#x003b2;-caryophyllene (5.7&#x02013;17.5%),<break/>germacrene D (0&#x02013;17.3%),<break/>bicyclogermacrene (0&#x02013;11.5%),<break/>&#x003b4;-cadinene (1.6&#x02013;6.1%),<break/>spathulenol (3.8&#x02013;12.4%),<break/>caryophyllene oxide (0&#x02013;15.6%),<break/>&#x003b1;-muurolol (4.8&#x02013;6.2%),<break/>&#x003b1;-cadinol (4.9&#x02013;6.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-ijms-19-01511" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leaf</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (10.1&#x02013;16.8%),<break/>germacrene D (9.1&#x02013;45.2%),<break/>bicyclogermacrene (4.8&#x02013;21.1%),<break/>spathulenol (4.9&#x02013;29.4%),<break/>caryophyllene oxide (3.8&#x02013;18.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B55-ijms-19-01511" ref-type="bibr">55</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">seed</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">coumarin (0&#x02013;12.6%),<break/>spathulenol (19.4&#x02013;38.9%),<break/>caryophyllene oxide (0&#x02013;21.8%),<break/>humulene epoxide II (0&#x02013;5.1%),<break/><italic>iso</italic>-spathulenol (6.9&#x02013;25.8%),<break/>&#x003c4;-muurolol (1.3&#x02013;5.0%),<break/>&#x003b1;-cadinol (2.0&#x02013;10.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-ijms-19-01511" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">stem</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (2.4&#x02013;13.9%),<break/>germacrene D (0&#x02013;19.1%),<break/>bicyclogermacrene (0&#x02013;8.0%),<break/>&#x003b4;-cadinene (0&#x02013;5.7%),<break/>spathulenol (3.6&#x02013;13.7%),<break/>caryophyllene oxide (4.9&#x02013;13.3%),<break/><italic>iso</italic>-spathulenol (0&#x02013;7.9%),<break/>&#x003c4;-muurolol (3.4&#x02013;7.9%),<break/>&#x003b1;-cadinol (4.9&#x02013;11.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B54-ijms-19-01511" ref-type="bibr">54</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. lucens</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">polyalthic acid (69.8%),<break/>copalic acid (11.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. martii</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (36.4&#x02013;51.2%),<break/>&#x003b2;-elemene (4.1&#x02013;6.2%),<break/><italic>allo</italic>-aromadendrene (4.2&#x02013;5.0%),<break/>&#x003b4;-cadinene (13.7&#x02013;17.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B56-ijms-19-01511" ref-type="bibr">56</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. martii</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-bisabolene (10.7%),<break/>zingiberene (7.2%),<break/>kaurenoic acid (7.9%),<break/>kovalenic acid (29.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (2.1&#x02013;5.2%),<break/>&#x003b2;-caryophyllene (42.9&#x02013;60.3%),<break/><italic>trans</italic>-&#x003b2;-bergamotene (2.0&#x02013;7.0%),<break/>caryophyllene oxide (tr&#x02013;8.8%),<break/>copalic acid (1.9&#x02013;11.0%),<break/>3-acetoxycopalic acid (0.8&#x02013;6.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B8-ijms-19-01511" ref-type="bibr">8</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (57.5%),<break/>&#x003b1;-humulene (8.3%),<break/>copalic acid (6.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-ijms-19-01511" ref-type="bibr">57</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (57.5%),<break/>&#x003b1;-humulene (8.3%),<break/>copalic acid (6.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (60.2%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (6.4%),<break/>&#x003b1;-humulene (8.6%),<break/>copalic acid (9.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-ijms-19-01511" ref-type="bibr">44</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (57.5%),<break/>copalic acid (6.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (18.8%),<break/>&#x003b2;-caryophyllene (36.0%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (7.0%),<break/>&#x003b2;-bisabolene (8.5%),<break/>&#x003b4;-cadinene (6.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-ijms-19-01511" ref-type="bibr">58</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (2.0&#x02013;15.0%),<break/>&#x003b2;-caryophyllene (5.1&#x02013;64.0%),<break/>&#x003b1;-humulene (0&#x02013;8.9%),<break/>germacrene D (0&#x02013;16.7%),<break/>&#x003b4;-cadinene (0&#x02013;5.4%),<break/>caryophyllene oxide (0.2&#x02013;31.5%),<break/>copalic acid (1.7&#x02013;7.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B17-ijms-19-01511" ref-type="bibr">17</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (57.1%),<break/>&#x003b1;-humulene (10.2%),<break/>&#x003b2;-sesquiphellandrene (9.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-ijms-19-01511" ref-type="bibr">59</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (2.5&#x02013;14.9%),<break/>&#x003b2;-caryophyllene (10.6&#x02013;62.7%),<break/>&#x003b1;-humulene (2.4&#x02013;8.7%),<break/>germacrene D (0&#x02013;18.9%),<break/>caryophyllene oxide (0.2&#x02013;32.5%),<break/>copalic acid (1.1&#x02013;5.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-ijms-19-01511" ref-type="bibr">60</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (5.0%),<break/>&#x003b2;-gurjunene (5.3%),<break/>&#x003b2;-caryophyllene (29.6%),<break/>&#x003b1;-humulene (5.7%),<break/>caryophyllene alcohol (5.8%),<break/>caryophyllene oxide (13.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-ijms-19-01511" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (58.4%),<break/>&#x003b1;-humulene (8.4%),<break/>copalic acid (6.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-ijms-19-01511" ref-type="bibr">61</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (8.5%),<break/>copalic acid (13.9%),<break/>hardwickiic acid (30.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (24.9%),<break/><italic>allo</italic>-aromadendrene (7.5%),<break/>germacrene B (5.1%),<break/>&#x003b2;-bisabolene (6.3%),<break/>&#x003b4;-cadinene (15.3%),<break/>&#x003b1;-cadinene (5.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-ijms-19-01511" ref-type="bibr">62</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (62.7%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (7.6%),<break/>&#x003b1;-humulene (8.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Setzer <sup>a</sup></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (87.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Setzer <sup>b</sup></td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-bisabolene (20.2%),<break/>zingiberene (19.4%),<break/>kaurenoic acid (13.3%),<break/>copalic acid (6.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-cubebene (5.5%),<break/>&#x003b1;-copaene (42.5%),<break/>&#x003b2;-caryophyllene (14.1%),<break/>&#x003b4;-cadinene (10.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-ijms-19-01511" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. piresii</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (45.5%),<break/>&#x003b2;-caryophyllene (10.3%),<break/>&#x003b4;-cadinene (13.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-ijms-19-01511" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. publflora</italic> Benth.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (65.9%),<break/>&#x003b1;-humulene (7.3%),<break/>&#x003b2;-selinene (10.2%),<break/>&#x003b1;-selinene (5.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B63-ijms-19-01511" ref-type="bibr">63</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (40.9%),<break/>&#x003b1;-humulene (6.0%),<break/>germacrene D (5.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin (Par&#x000e1;)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (40.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin (Acre)</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b1;-copaene (25.1%),<break/>&#x003b2;-caryophyllene (13.1%),<break/>copalic acid (7.7%),<break/>kaurenoic acid (7.5%),<break/>hardwickiic acid (6.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-elemene (0.5&#x02013;5.6%),<break/>&#x003b2;-caryophyllene (1.4&#x02013;68.0%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (2.4&#x02013;29.6%),<break/>&#x003b1;-humulene (1.1&#x02013;9.7%),<break/>&#x003b2;-selinene (0&#x02013;20.6%),<break/>&#x003b1;-selinene (0&#x02013;13.2%),<break/>&#x003b2;-bisabolene (3.7&#x02013;42.4%),<break/>caryophyllene oxide (0.1&#x02013;15.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B64-ijms-19-01511" ref-type="bibr">64</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-elemene (0&#x02013;6.0%),<break/>&#x003b2;-caryophyllene (0&#x02013;43.4%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (12.0&#x02013;32.8%),<break/>&#x003b1;-guaiene (0&#x02013;9.5%),<break/>&#x003b1;-humulene (0&#x02013;7.0%),<break/>&#x003b2;-selinene (0&#x02013;17.1%),<break/>&#x003b1;-selinene (0&#x02013;10.4%),<break/><italic>trans</italic>-&#x003b2;-guaiene (0&#x02013;5.8%),<break/>&#x003b2;-bisabolene (24.2&#x02013;50.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B65-ijms-19-01511" ref-type="bibr">65</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (25.1&#x02013;50.2%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (6.4&#x02013;12.0%),<break/>&#x003b1;-humulene (4.1&#x02013;5.8%),<break/>&#x003b2;-selinene (1.8&#x02013;6.7%),<break/>&#x003b2;-bisabolene (5.2&#x02013;17.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B66-ijms-19-01511" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (37.3%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (9.0%),<break/>&#x003b1;-humulene (5.4%),<break/>&#x003b2;-bisabolene (14.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-ijms-19-01511" ref-type="bibr">67</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (7.7%),<break/><italic>trans</italic>-&#x003b1;-bergamotene (22.0%),<break/>&#x003b2;-selinene (12.2%),<break/>&#x003b1;-selinene (11.4%),<break/>&#x003b2;-bisabolene (24.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-ijms-19-01511" ref-type="bibr">68</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. trapezifolia</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leaf</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene (33.5%),<break/>&#x003b1;-humulene (6.2%),<break/>germacrene D (11.0%),<break/>spathulenol (7.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B69-ijms-19-01511" ref-type="bibr">69</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Unpublished analysis of a commercial essential oil from New Directions Aromatics (Sydney, Australia). <sup>b</sup> Unpublished analysis of a commercial essential oil from Am&#x000e9;o Essential Oils/Zija International (Lehi, Utah).</p></fn></table-wrap-foot></table-wrap><table-wrap id="ijms-19-01511-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t002_Table 2</object-id><label>Table 2</label><caption><p>Nonvolatile components isolated and/or identified from <italic>Copaifera</italic> species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Part</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compounds Isolated and/or Identified</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. cearensis</italic> Huber ex Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">epuric acid, cativic acid, copalic acid, kolavenic acid, crolechinic acid, hardwickiic acid, haplociliatic acid, labdanolic acid, patagonic acid.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B76-ijms-19-01511" ref-type="bibr">76</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. guianensis</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">methyl copalate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid, kaurenoic acid, acetoxycopalic acid (=3&#x003b1;-alepterolic acid acetate), <italic>ent</italic>-agathic acid, hydroxycopalic acid (=3&#x003b1;-alepterolic acid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid, acetoxycopalic acid (=3&#x003b1;-alepterolic acid acetate), 3-hydroxy-14,15-dinorlabd-8(17)-en-13-one, <italic>ent</italic>-agathic acid, hydroxycopalic acid <break/>(=3&#x003b1;-alepterolic acid)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-ijms-19-01511" ref-type="bibr">70</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-ijms-19-01511" ref-type="bibr">72</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-ijms-19-01511" ref-type="bibr">73</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">sclareol, manool, copalic acid, acetoxycopalic acid (=3&#x003b1;-alepterolic acid acetate), hydroxycopalic acid (=3&#x003b1;-alepterolic acid), <italic>ent</italic>-agathic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-ijms-19-01511" ref-type="bibr">77</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid, quercitrin, afzelin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-ijms-19-01511" ref-type="bibr">78</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rutin, quercetin-3-<italic>O</italic>-&#x003b1;-<sc>l</sc>-rhamnopyranoside, kaempferol-3-<italic>O</italic>-&#x003b1;-<sc>l</sc>-rhamnopyranoside, quercetin, kaempferol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-ijms-19-01511" ref-type="bibr">79</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">fruit</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">gallic acid, epicatechin gallate, catechin, epicatechin, isoquercitrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-ijms-19-01511" ref-type="bibr">80</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">leaves</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid, quercitrin, afzelin, eupatorin, galloyl quinic acid, gallic acid 4-<italic>O</italic>-glucoside</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-ijms-19-01511" ref-type="bibr">81</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid, 3-hydroxycopalic acid <break/>(=3&#x003b1;-alepterolic acid), 3-acetoxycopalic acid <break/>(=3&#x003b1;-alepterolic acid acetate)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid, methyl copalate, agathic acid 15-methyl ester, agathic acid 15,19-dimethyl ester, <italic>ent</italic>-polyalthic acid, methyl <italic>ent</italic>-polyalthate, <italic>ent</italic>-pinifolic acid, methyl 3&#x003b2;-hydroxy-labda-8(17),13-dien-15-ate, methyl 18-hydroxy-copaiferolate, 14,15-bisnorlabd-8(17)-en-13-one, <italic>ent</italic>-kaurenic acid, 16&#x003b2;-kauran-19-oic acid, 3-methyl-5-(2,2,6-trimethyl-6-hydroxycyclohexyl)- pentanoic acid, pauperol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>]</td></tr><tr><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-alepterolic acid, 3&#x003b2;-alepterolic acid acetate, 3&#x003b2;-hydroxylabdan-8(17)-en-15-oic acid, <italic>ent</italic>-agathic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-ijms-19-01511" ref-type="bibr">82</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="ijms-19-01511-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t003_Table 3</object-id><label>Table 3</label><caption><p>Biological activities of <italic>Copaifera</italic> oleoresins, essential oils, and isolated components.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Material</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Biological Activity</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. cearensis</italic> Huber ex Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: At a concentration of 50 &#x003bc;g/mL, in vitro NO production in mouse peritoneal macrophages was significantly reduced by <italic>C. cearensis</italic> oil.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. cearensis</italic> Huber ex Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 18.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. cearensis</italic> Huber ex Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA, MIC = 125 &#x003bc;g/mL), <break/><italic>B. subtilis</italic> (MIC = 62.5 &#x003bc;g/mL), <italic>Enterococcus faecalis</italic> (MIC = 62.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: Carrageenin-induced paw edema test (rats, 18% edema inhibition with dose of 1802 mg/kg; granuloma test, 42% inhibition with dose of 1802 mg/kg); <break/>croton oil-induced dermatitis test (mice, IC<sub>50</sub> = 663 mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-ijms-19-01511" ref-type="bibr">84</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antinociceptive: Mouse model (acetic acid-induced writhing test, IC<sub>50</sub> = 704 mg/kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-ijms-19-01511" ref-type="bibr">84</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vivo hepatocellular proliferation, partial hepatectomy, rats. Hepatocellular proliferation and liver mitochondrial respiration were significantly lower in <italic>C. duckei</italic> treated rats compared to control (saline solution).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-ijms-19-01511" ref-type="bibr">85</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. duckei</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. evansi</italic>, in vivo mouse model, doses of 0.63 mL/kg/day over 5 days showed no curative effects. <italic>T. evansi</italic>, in vitro trypomastigotes, 0.5% solution of <italic>C. duckei</italic> oil showed 100% killing after 6 h.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-ijms-19-01511" ref-type="bibr">86</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: Preincubation of LPS-stimulated human THP-1 monocytes with diterpenoid-rich oleoresin reduced the release of proinflammatory cytokines <break/>(IL-1&#x003b2;, IL-6, TNF&#x003b1;).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-ijms-19-01511" ref-type="bibr">50</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antifungal: <italic>Tricophyton mentagrophytes</italic> (MIC = 170 &#x003bc;g/mL). Scanning electron microscopic (SEM) analysis revealed physical damage and morphological alterations of the fungi upon exposure to copaiba oleoresin.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B52-ijms-19-01511" ref-type="bibr">52</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antipsoriatic: Human clinical trial, topical application of copaiba resin exhibited a significant improvement of the typical signs of psoriasis.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B50-ijms-19-01511" ref-type="bibr">50</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Gastroprotective: Ethanol or indomethacin-induced ulcer in rats, oral administration of copaiba resin at doses of 400 mg/kg provided dose-dependent significant protection against gastric damage caused by ethanol or indomethacin.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-ijms-19-01511" ref-type="bibr">87</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Gastroprotective: Mesenteric ischemia/reperfusion (I/R) in rats: Copaiba resin treatment caused significant attenuations in I/R-associated increases of myeloperoxidase, malondialdehyde, and catalase, and effectively prevented the I/R-associated depletion of glutathione.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-ijms-19-01511" ref-type="bibr">88</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Wound-healing: Rat incision wounds, 4% oleoresin topically applied showed significant wound contraction and tensile strength compared to controls.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-ijms-19-01511" ref-type="bibr">89</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Wound healing: Rat dorsal skin flaps, oral administration of copaiba oleoresin <break/>(400 mg/kg), copaiba-treatment presented discrete anti-lipoperoxidation action, intense antioxidant action, and anti-inflammatory activity during the ischemia and reperfusion of randomized cutaneous flaps.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-ijms-19-01511" ref-type="bibr">90</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: Rat model of experimental endometriosis. Copaiba oil caused a marked reduction in endometrial growth.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-ijms-19-01511" ref-type="bibr">91</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 20.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>B. subtilis</italic> (MIC = 62.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10% copaiba oil ointment</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Wound-healing: Rat dorsal skin flaps, topical copaiba oil ointment favors angiogenesis and accelerates the viability of random skin flaps in rats.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B51-ijms-19-01511" ref-type="bibr">51</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10% oleoresin cream</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Open wounds on rats inoculated with <italic>Streptococcus pyogenes</italic> or <italic>Staphylococcus aureus</italic>. Treatment with 10% copaiba cream reduced bacterial populations to 0.02% (<italic>S. pyogenes</italic>) and 0.3% (<italic>S. aureus</italic>) after 14 days.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-ijms-19-01511" ref-type="bibr">92</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10% oleoresin cream</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Wound-healing: Rabbit ears, 10% oleoresin cream-treated wounds presented better clinical outcomes, confirmed by histology with evidence of fibroblastic activity by day 7 and organized collagen fibers observed from day 14.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-ijms-19-01511" ref-type="bibr">93</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10% oleoresin cream</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Wound-healing: Rat skin biopsy punch on dorsal surface, 10% oleoresin cream-treated wounds showed a faster wound-healing rate compared to saline or cream only controls, by regulating matrix metalloproteinase, (MMP)-2 and MMP-9 activities, stimulating collagen synthesis, and promoting tissue remodeling and re-epithelialization.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-ijms-19-01511" ref-type="bibr">94</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b1;-alepterolic acid acetate</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Cariogenic <italic>Streptococcus</italic> spp.; MIC range 12.0&#x02013;60.0 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-ijms-19-01511" ref-type="bibr">70</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">aqueous leaf extract</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: 5% Extract inhibited <italic>Bemisia tabaci</italic> infestation of tomato plants in the field.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-ijms-19-01511" ref-type="bibr">95</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Gram-positive bacteria (MIC range 0.5 &#x003bc;g/mL to 15.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Cariogenic <italic>Streptococcus</italic> spp.; MIC range 2.0&#x02013;6.0 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B70-ijms-19-01511" ref-type="bibr">70</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Periodontal anaerobic bacteria: <italic>Actinomyces naeslundii</italic> (MIC 6.2 &#x003bc;g/mL), <italic>Bacteroides fragilis</italic> (MIC 25.0 &#x003bc;g/mL), <italic>Peptostreptococcus anaerobius</italic> (MIC 3.1 &#x003bc;g/mL), <italic>Porphyromonas gingivalis</italic> (MIC 3.1 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B77-ijms-19-01511" ref-type="bibr">77</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity on MO59J (human glioblastoma cells, <break/>IC<sub>50</sub> = 68.3 &#x003bc;g/mL) and HeLa (human cervical adenocarcinoma cells, IC<sub>50</sub> = 44.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EtOH/H<sub>2</sub>O leaf extract</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Gastroprotective: Ethanol/HCl-induced ulcer in mice, the extract (500 mg/kg) showed a significant decrease in the total gastric juice acidity and an increase in mucus production; isolated compounds (30 mg/kg) &#x003b1;-humulene, &#x003b2;-caryophyllene and caryophyllene oxide showed greater gastroprotective activity in the ethanol/HCl induced ulcer model.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B78-ijms-19-01511" ref-type="bibr">78</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: Rat model of acetic acid-induced colitis. A marked reduction in gross damage score (52% and 42%) and wet weight of damaged colon tissue (39% and 32%) were observed in rats that received 100 mg/kg kaurenoic acid, respectively, <break/>by rectal and oral routes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B72-ijms-19-01511" ref-type="bibr">72</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Gram-positive bacteria (MIC range 5.0 &#x003bc;g/mL to 100.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B71-ijms-19-01511" ref-type="bibr">71</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, 78 &#x003bc;M concentration, on CEM (human leukemia, 95% growth inhibition), MCF-7 (human breast tumor, 45% growth inhibition), and HCT-8 (human colon tumor, 45% growth inhibition) cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-ijms-19-01511" ref-type="bibr">73</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, 20 &#x003bc;M concentration, on AGP01 <break/>(human gastric cancer, 28% growth inhibition) and SF-295 (human glioblastoma, 28% growth inhibition) cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. langsdorffii</italic> Desf.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Smooth muscle relaxant: Rat uterine muscle ex vivo: kaurenoic acid, exerts a uterine relaxant effect acting principally through calcium blockade and in part, by the opening of ATP-sensitive potassium channels.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-ijms-19-01511" ref-type="bibr">96</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. lucens</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 20.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. lucens</italic> Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>S. aureus</italic> (MIC = 125 &#x003bc;g/mL), <italic>B. subtilis</italic> (MIC = 125 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. martii</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 14.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. martii</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: In vivo mouse model, copaiba oil oral treatment (100 mg/kg/day) caused a significant reduction in the average lesion size (1.1 &#x000b1; 0.4 mm) against <italic>Leishmania amazonensis</italic> lesions compared with untreated mice (4.4 &#x000b1; 1.3 mm).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-ijms-19-01511" ref-type="bibr">97</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. martii</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>S. aureus</italic> (MIC = 62.5 &#x003bc;g/mL), MRSA (MIC = 62.5 &#x003bc;g/mL), <italic>B. subtilis</italic>
<break/>(MIC = 15.6 &#x003bc;g/mL), <italic>S. epidermidis</italic> (MIC = 62.5 &#x003bc;g/mL), <italic>Enterococcus faecalis</italic>
<break/>(MIC = 62.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, B16F10 (murine melanoma cells, IC<sub>50</sub> = 457 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-ijms-19-01511" ref-type="bibr">57</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vivo lung metastasis and tumor growth, mouse model: Oral administration of <italic>C. multijuga</italic> oleoresin (at 2 g/Kg in the days 3, 5, 7, 10, 12, and 14 after inoculation of tumoral cells) reduced tumor growth by 58% and tumor weight by 76% and reduced the number of lung nodules by 47.1%.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-ijms-19-01511" ref-type="bibr">57</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vivo Ehrlich ascitic and solid tumor, mouse model: <italic>C. multijuga</italic> oleoresin (doses varying between 100 and 200 mg/kg) showed antineoplastic properties against Ehrlich ascitic tumor (EAT) and solid tumor during 10 consecutive <break/>days of treatment.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-ijms-19-01511" ref-type="bibr">98</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: Mosquito larvicidal activity (<italic>Anopheles darlingi</italic>, LC<sub>50</sub> = 31 &#x003bc;g/mL; <italic>Aedes aegypti</italic>, LC<sub>50</sub> = 93 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-ijms-19-01511" ref-type="bibr">59</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: The &#x003b2;-caryophyllene-rich oleoresin oil of <italic>C. multijuga</italic>, at a dose of <break/>100 mg/kg, inhibited zymosan-induced pleurisy in a mouse model, reducing total leukocytes by 45% and neutrophil accumulation by 73%. <italic>C. multijuga</italic> oil also showed in vitro reduction of NO production in mouse peritoneal macrophages at a concentration of 5 &#x003bc;g/mL.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: Rat pleurisy model, doses of 100 mg/kg and 200 mg/kg presented in vivo anti-inflammatory effects.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-ijms-19-01511" ref-type="bibr">58</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 10.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: MRSA (MIC = 125 &#x003bc;g/mL), <italic>B. subtilis</italic> (MIC = 125 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antinociceptive: Mouse model (acetic acid-induced writhing, tail flick, hot plate), oral administration of <italic>C. multijuga</italic> oil with doses of 30&#x02013;150 mg/kg significantly showed antinociception, which was reversed with naloxone.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-ijms-19-01511" ref-type="bibr">99</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: Mosquito larvicidal activity (<italic>Anopheles darlingi</italic>, LC<sub>50</sub> = 128 &#x003bc;g/mL; <break/><italic>Aedes aegypti</italic>, LC<sub>50</sub> = 18 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B59-ijms-19-01511" ref-type="bibr">59</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin extracts</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: The CH<sub>2</sub>Cl<sub>2</sub> and MeOH fractions obtained from <italic>C. multijuga</italic> oleoresin, given by the intraperitoneal route, caused a significant inhibition of carrageenan-induced rat paw edema with inhibition of 49 &#x000b1; 13% and 64 &#x000b1; 9%, respectively.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B61-ijms-19-01511" ref-type="bibr">61</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin extracts</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: The hexane, chloroform and methanol fractions obtained from <break/><italic>C. multijuga</italic> oleoresin, given by the oral gavage, caused a significant inhibition of carrageenan-induced rat paw edema.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-ijms-19-01511" ref-type="bibr">100</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin extracts</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antinociceptive: The hexane, chloroform and methanol fractions obtained from <break/><italic>C. multijuga</italic> oleoresin, given by the oral gavage, caused a significant inhibition (in a concentration-dependent way) the number of contortions induced by acetic acid and the second phase of formalin-induced licking response. Similar results were observed in the tail flick model; administration of naloxone inhibited the antinociceptive effect of the fractions indicating that copaiba resin maybe acting on opioid receptors.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-ijms-19-01511" ref-type="bibr">100</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-alepterolic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, 20 &#x003bc;M concentration, on AGP01 (human gastric cancer, 8.5% growth inhibition) and SF-295 (human glioblastoma, 21% growth inhibition) cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. multijuga</italic> Hayne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-alepterolic acid acetate</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, 20 &#x003bc;M concentration, on AGP01 (human gastric cancer, 13% growth inhibition) and SF-295 (human glioblastoma, 18% growth inhibition) cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B74-ijms-19-01511" ref-type="bibr">74</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vivo Walker 256 carcinoma inoculated into the vagina and uterine cervix of female rats, <italic>C. officinalis</italic> oleoresin stimulated tumor growth by 70%.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-ijms-19-01511" ref-type="bibr">101</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin EO</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: Dias and coworkers investigated the immunomodulatory effects of <italic>C. officinalis</italic> oleoresin essential oil on inflammatory cytokines (NO, H<sub>2</sub>O<sub>2</sub>, TNF-&#x003b1;, IFN-&#x003b3;, and IL-17) in a murine model of experimental autoimmune encephalomyelitis. At a concentration of 100 &#x003bc;g/mL, <italic>C. officinalis</italic> oil inhibited the in vitro production of the inflammatory cytokines, modulating the immune response.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B62-ijms-19-01511" ref-type="bibr">62</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 20.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>S. aureus</italic> (MIC = 62.5 &#x003bc;g/mL), MRSA (MIC = 125 &#x003bc;g/mL), <italic>B. subtilis</italic>
<break/>(MIC = 31.3 &#x003bc;g/mL), <italic>S. epidermidis</italic> (MIC = 31.3 &#x003bc;g/mL), <italic>Enterococcus faecalis</italic>
<break/>(MIC = 31.3 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>Streptococcus mutans</italic> (MIC = 780 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-ijms-19-01511" ref-type="bibr">102</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>Staphylococcus aureus</italic> (MIC = 312.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-ijms-19-01511" ref-type="bibr">103</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">agathic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 28.0 &#x003bc;g/mL), amastigotes <break/>(IC<sub>50</sub> = 17.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alepterolic acid<break/> (=hydroxycopalic acid)</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 2.5 &#x003bc;g/mL), amastigotes <break/>(IC<sub>50</sub> = 18.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 28.0 &#x003bc;g/mL), amastigotes <break/>(IC<sub>50</sub> = 3.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">methyl copalate</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 6.0 &#x003bc;g/mL), amastigotes <break/>(IC<sub>50</sub> = 14.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pinifolic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 70.0 &#x003bc;g/mL), amastigotes <break/>(IC<sub>50</sub> = 4.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. officinalis</italic> (Jacq.) L.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>ent</italic>-polyalthic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 35.0 &#x003bc;g/mL), amastigotes <break/>(IC<sub>50</sub> = 15.0 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-ijms-19-01511" ref-type="bibr">104</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> promastigotes (IC<sub>50</sub> = 11.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>B. subtilis</italic> (MIC = 62.5 &#x003bc;g/mL), <italic>Enterococcus faecalis</italic> (MIC = 62.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>Bacillus subtilis</italic> (MIC = 3.1&#x02013;6.3 &#x003bc;g/mL), <italic>Staphylococcus aureus</italic>
<break/>(MIC = 8&#x02013;10 &#x003bc;g/mL), <italic>Staphylococcus epidermidis</italic> (MIC = 4&#x02013;5 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>ent</italic>-polyalthic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>Bacillus subtilis</italic> (MIC = 20&#x02013;30 &#x003bc;g/mL), <italic>Staphylococcus aureus</italic>
<break/>(MIC = 40&#x02013;50 &#x003bc;g/mL), <italic>Staphylococcus epidermidis</italic> (MIC = 40 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>Bacillus subtilis</italic> (MIC = 2.5&#x02013;5 &#x003bc;g/mL), <italic>Staphylococcus aureus</italic>
<break/>(MIC = 6&#x02013;8 &#x003bc;g/mL), <italic>Staphylococcus epidermidis</italic> (MIC = 4&#x02013;6 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. paupera</italic> (Herzog) Dwyer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">methyl copalate</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, P-388 (murine lymphoma, IC<sub>50</sub> = 2.5 &#x003bc;g/mL), A-549 (human lung carcinoma, IC<sub>50</sub> = 5 &#x003bc;g/mL), HT-29 (human colon carcinoma, IC<sub>50</sub> = 5 &#x003bc;g/mL), MEL-28 (human melanoma, IC<sub>50</sub> = 10 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B75-ijms-19-01511" ref-type="bibr">75</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>Porphyromonas gingivalis</italic> (MIC = 6.25 &#x003bc;g/mL), <italic>Streptococcus</italic> spp. <break/>(MIC 25&#x02013;50 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-ijms-19-01511" ref-type="bibr">68</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antiproliferative: In vitro cytotoxicity, GM07492-A (human lung fibroblast cells, <break/>IC<sub>50</sub> = 51.85 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B68-ijms-19-01511" ref-type="bibr">68</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anxiolytic: elevated plus-maze test with rats: Oral doses of 100, 400, and 800 mg/kg produced a dose-dependent anxiolytic-like effect over the dose range tested.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-ijms-19-01511" ref-type="bibr">105</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: Mosquito larvicidal activity (<italic>Culex quinquefasciatus</italic>, LC<sub>50</sub> = 0.4, 0.9, 39, and <break/>90 &#x003bc;g/mL against the 1st, 2nd, 3rd, and 4th larval instars, respectively)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-ijms-19-01511" ref-type="bibr">106</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: Mosquito larvicidal activity (<italic>Aedes aegypti</italic>, LC<sub>50</sub> = 8.9 &#x003bc;g/mL against the 3rd larval instar)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-ijms-19-01511" ref-type="bibr">107</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Neuroprotective: Rat model of motor cortex excitotoxic injury, <italic>C. reticulata</italic> resin treatment induces neuroprotection by modulating inflammatory response following an acute damage to the central nervous system.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B67-ijms-19-01511" ref-type="bibr">67</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Acaricidal: <italic>Rhipicephalus</italic> (<italic>Boophilus</italic>) <italic>microplus</italic> (LC<sub>50</sub> = 1579 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B108-ijms-19-01511" ref-type="bibr">108</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Anti-inflammatory: At a concentration of 500 &#x003bc;g/mL, <italic>C. reticulata</italic> oleoresin oil showed 85% inhibition of NO production in mouse peritoneal macrophages in vitro.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B13-ijms-19-01511" ref-type="bibr">13</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: A &#x003b2;-caryophyllene-rich <italic>C. reticulata</italic> (from Par&#x000e1; state) oleoresin oil showed remarkable activity against <italic>L. amazonensis</italic> promastigotes with IC<sub>50</sub> of 5.0 &#x003bc;g/mL. Another sample of <italic>C. reticulata</italic> oil (from Acre) with lower concentration of &#x003b2;-caryophyllene was less active (IC<sub>50</sub> = 22.0 &#x003bc;g/mL).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B48-ijms-19-01511" ref-type="bibr">48</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin EO</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>C. reticulata</italic> oleoresin essential oil showed significant antileishmanial activity against axenic amastigotes (IC<sub>50</sub> = 15.0 &#x003bc;g/mL) and intracellular amastigotes <break/>(IC<sub>50</sub> = 20 &#x003bc;g/mL) of <italic>L. amazonensis</italic>. Note that the major component of the oil, <break/>&#x003b2;-caryophyllene, was inactive against the amastigotes. Interference with the mitochondrial membrane was suggested as the mechanism for antileishmanial activity.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B109-ijms-19-01511" ref-type="bibr">109</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antinociceptive: Mouse model (acetic acid-induced writhing, tail flick, hot plate), oral administration of <italic>C. reticulata</italic> oil with doses of 30&#x02013;150 mg/kg significantly showed antinociception, which was reversed with naloxone.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-ijms-19-01511" ref-type="bibr">99</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. evansi</italic>, in vivo mouse model, doses of 0.63 mL/kg/day over 5 days showed no curative effects. <italic>T. evansi</italic>, in vitro trypomastigotes, 0.5% solution of <italic>C. reticulata</italic> oil showed 100% killing after 6 h.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B86-ijms-19-01511" ref-type="bibr">86</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin EO (Acre)</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: <italic>S. aureus</italic> (MIC = 62.5 &#x003bc;g/mL), MRSA (MIC = 125 &#x003bc;g/mL), <italic>B. subtilis</italic>
<break/>(MIC = 31.3 &#x003bc;g/mL), <italic>S. epidermidis</italic> (MIC = 62.5 &#x003bc;g/mL), <italic>Enterococcus faecalis</italic>
<break/>(MIC = 62.5 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B83-ijms-19-01511" ref-type="bibr">83</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-alepterolic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: Mosquito larvicidal activity (<italic>Aedes aegypti</italic>, LC<sub>50</sub> = 87.3 &#x003bc;g/mL against the 3rd larval instar)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-ijms-19-01511" ref-type="bibr">82</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>C. reticulata</italic> Ducke</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3&#x003b2;-alepterolic acid acetate</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Insecticidal: Mosquito larvicidal activity (<italic>Aedes aegypti</italic>, LC<sub>50</sub> = 0.8 &#x003bc;g/mL against the 3rd larval instar)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-ijms-19-01511" ref-type="bibr">82</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">oleoresin</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antibacterial: Oleoresin oils from unidentified species of <italic>Copaifera</italic> showed remarkable antibacterial activity against the Gram-positive <italic>Bacillus subtilis</italic> and <italic>Staphylococcus aureus</italic> (MIC = 5 &#x003bc;g/mL). The oils were inactive against Gram-negative organisms.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-ijms-19-01511" ref-type="bibr">110</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">agathic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 86.8 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 823 &#x003bc;M), amastigotes (IC<sub>50</sub> = 14.9 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">copalic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 47.2 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 444 &#x003bc;M), amastigotes (IC<sub>50</sub> = 1.3 &#x003bc;M). Note: &#x003b2;-caryophyllene + copalic acid showed a significant synergistic effect against <italic>T. cruzi</italic> trypomastigotes.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">alepterolic acid <break/>(=hydroxycopalic acid)</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 41.2 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 453 &#x003bc;M), amastigotes (IC<sub>50</sub> = 1.8 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">kaurenoic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 167 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 596 &#x003bc;M), amastigotes (IC<sub>50</sub> = 16.5 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">methyl copalate</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 83.3 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 377 &#x003bc;M), amastigotes (IC<sub>50</sub> = 2.5 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">pinifolic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 854 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 1630 &#x003bc;M), amastigotes (IC<sub>50</sub> = 18.6 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><italic>ent</italic>-polyalthic acid</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 168 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 965 &#x003bc;M), amastigotes (IC<sub>50</sub> = 28.4 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antileishmanial: <italic>L. amazonensis</italic> amastigotes (IC<sub>50</sub> = 1.3 &#x003bc;g/mL)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-ijms-19-01511" ref-type="bibr">112</xref>]</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Copaifera</italic> spp.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-caryophyllene</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Antitrypanosomal: <italic>T. cruzi</italic> epimastigotes (IC<sub>50</sub> = 78.4 &#x003bc;M), trypomastigotes <break/>(IC<sub>50</sub> = 1593 &#x003bc;M), amastigotes (IC<sub>50</sub> = 63.7 &#x003bc;M)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B111-ijms-19-01511" ref-type="bibr">111</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="ijms-19-01511-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t004_Table 4</object-id><label>Table 4</label><caption><p>MolDock docking energies (kJ/mol) of <italic>Copaifera</italic> diterpenoids with <italic>Leishmania</italic> protein targets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Leishmania</italic> Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDB<sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (ave)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Best-Docking Diterpenoid Ligand</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cathepsin B (LdonCatB)</td><td align="center" valign="middle" rowspan="1" colspan="1">homology</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;84.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.6</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cathepsin B (LmajCatB)</td><td align="center" valign="middle" rowspan="1" colspan="1">homology</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;80.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;93.7</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cyclophilin A (LdonCypA)</td><td align="center" valign="middle" rowspan="1" colspan="1">3EOV</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;102.6</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic>ent</italic>-Pinifolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Deoxyuridine triphosphate nucleotidohydrolase (LmajdUTPase)</td><td align="center" valign="middle" rowspan="1" colspan="1">2YAY</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;103.8</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dihydroorotate dehydrogenase (LdonDHODH)</td><td align="center" valign="middle" rowspan="1" colspan="1">3GYE</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;102.7</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dihydroorotate dehydrogenase (LmajDHODH)</td><td align="center" valign="middle" rowspan="1" colspan="1">3MHU</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;109.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;126.7</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glucose-6-phosphate isomerase (LmexGPI)</td><td align="center" valign="middle" rowspan="1" colspan="1">1Q50</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;73.0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.3</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glyceraldehyde-3-phosphate dehydrogenase (LmexGAPDH)</td><td align="center" valign="middle" rowspan="1" colspan="1">1A7K</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;74.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.0</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glycerol-3-phosphate dehydrogenase (LmexGPDH)</td><td align="center" valign="middle" rowspan="1" colspan="1">1N1E</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;114.3</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Methionyl-tRNA synthetase (LmajMetRS)</td><td align="center" valign="middle" rowspan="1" colspan="1">3KFL</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;123.0</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nicotinamidase (LinfPnC1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3R2J</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;61.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;75.9</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b2;-Alepterolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>N</italic>-Myristoyl transferase (LmajNMT)</td><td align="center" valign="middle" rowspan="1" colspan="1">4A30</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;104.0</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nucleoside diphosphate kinase b (LmajNDKb)</td><td align="center" valign="middle" rowspan="1" colspan="1">3NGS</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;105.8</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nucleoside hydrolase (LmajNH)</td><td align="center" valign="middle" rowspan="1" colspan="1">1EZR</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;80.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;90.5</td><td align="left" valign="middle" rowspan="1" colspan="1">7-Acetylbacchotricuneatin D</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Oligopeptidase B (LmajOPB)</td><td align="center" valign="middle" rowspan="1" colspan="1">2XE4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.1</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Phosphodiesterase B1 (LmajPDEB1)</td><td align="center" valign="middle" rowspan="1" colspan="1">2R8Q</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;105.8</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b2;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Phosphomannumutase (LmexPMM)</td><td align="center" valign="middle" rowspan="1" colspan="1">2I55</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;117.5</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pteridine reductase 1 (LmajPTR1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1E7W</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;93.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;110.7</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pyruvate kinase (LmexPYK)</td><td align="center" valign="middle" rowspan="1" colspan="1">1PKL</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;103.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;113.5</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sterol 14&#x003b1;-demethylase (LinfCYP51)</td><td align="center" valign="middle" rowspan="1" colspan="1">3L4D</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;90.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;111.3</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Thiol-dependent reductase I (LinfTDR1)</td><td align="center" valign="middle" rowspan="1" colspan="1">4AGS</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;78.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;88.8</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Triosephosphate isomerase (LmexTIM)</td><td align="center" valign="middle" rowspan="1" colspan="1">2VXN</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;90.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.5</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Trypanothione reductase (LinfTR)</td><td align="center" valign="middle" rowspan="1" colspan="1">4APN</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;109.0</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Tyrosyl-tRNA synthetase (LmajTyrRS)</td><td align="center" valign="middle" rowspan="1" colspan="1">3P0J</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;102.9</td><td align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Uridine diphosphate-glucose pyrophosphorylase (LmajUGPase)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2OEG</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;99.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;113.9</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> PDB = Protein Data Bank. </p></fn></table-wrap-foot></table-wrap><table-wrap id="ijms-19-01511-t005" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t005_Table 5</object-id><label>Table 5</label><caption><p>MolDock docking energies (kJ/mol) of <italic>Copaifera</italic> diterpenoids with <italic>Trypanosoma cruzi</italic> protein targets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>Trypanosoma cruzi</italic> Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDB</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (ave)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Best-Docking Diterpenoid Ligand</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cruzain</td><td align="center" valign="middle" rowspan="1" colspan="1">3IUT</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;80.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.6</td><td align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cyclophilin (TcCyp19)</td><td align="center" valign="middle" rowspan="1" colspan="1">1XQ7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;78.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.0</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b2;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Deoxyuridine triphosphatase (TcUTPase)</td><td align="center" valign="middle" rowspan="1" colspan="1">1OGK</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.0</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b2;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dihydrofolate reductase&#x02014;thymidylate synthase (TcDHFR-TS)</td><td align="center" valign="middle" rowspan="1" colspan="1">3IRN</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;93.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;110.7</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Dihydroorotate dehydrogenase (TcDHODH)</td><td align="center" valign="middle" rowspan="1" colspan="1">3W6Y</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;109.7</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Farnesyl diphosphate synthase (TcFPPS)</td><td align="center" valign="middle" rowspan="1" colspan="1">3ICZ</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;96.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;109.8</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Glyceraldehyde-3-phosphate dehydrogenase (TcGAPDH)</td><td align="center" valign="middle" rowspan="1" colspan="1">1QXS</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;70.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.3</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Hypoxanthine phosphoribosyltransferase (TcHPRT)</td><td align="center" valign="middle" rowspan="1" colspan="1">1P19</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;82.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.4</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Hydroxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Nucleoside diphosphate kinase B (TcNDKb)</td><td align="center" valign="middle" rowspan="1" colspan="1">3PRV</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;71.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;88.4</td><td align="left" valign="middle" rowspan="1" colspan="1">Crolechinic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Old yellow enzyme (=Prostaglandin F2&#x003b1; synthase) (TcPGFS)</td><td align="center" valign="middle" rowspan="1" colspan="1">3ATY</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.3</td><td align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pteridine reductase 2 (TcPTR2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1MXH</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;96.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;118.4</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Pyruvate kinase (TcPYK)</td><td align="center" valign="middle" rowspan="1" colspan="1">3QV9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;80.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;87.4</td><td align="left" valign="middle" rowspan="1" colspan="1">(&#x02212;)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Spermidine synthase (TcSpdSyn)</td><td align="center" valign="middle" rowspan="1" colspan="1">3BWC</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;96.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.8</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Sterol 14&#x003b1;-demethylase (TcCYP51)</td><td align="center" valign="middle" rowspan="1" colspan="1">3KLO</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.8</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Triosephosphate isomerase (TcTIM)</td><td align="center" valign="middle" rowspan="1" colspan="1">1SUX</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;88.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.7</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic>ent</italic>-Polyalthic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Trypanothione reductase (TcTR)</td><td align="center" valign="middle" rowspan="1" colspan="1">1BZL</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;81.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;95.8</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">UDP-galactose mutase (TcUGM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4DSH</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;104.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;115.7</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr></tbody></table></table-wrap><table-wrap id="ijms-19-01511-t006" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t006_Table 6</object-id><label>Table 6</label><caption><p>MolDock docking energies (kJ/mol) of <italic>Copaifera</italic> diterpenoids with bacterial protein targets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Bacterial Protein Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDB</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (ave)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Best Docking Diterpenoid Ligand</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Pseudomonas aeruginosa</italic> peptide deformylase (PaPDF)</td><td align="center" valign="middle" rowspan="1" colspan="1">1LRY</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;96.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;113.5</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Streptococcus pneumoniae</italic> peptide deformylase (SpPDF)</td><td align="center" valign="middle" rowspan="1" colspan="1">2AIE</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;115.4</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> peptide deformylase (MtPDF)</td><td align="center" valign="middle" rowspan="1" colspan="1">3E3U</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;95.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;107.3</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Escherichia coli</italic> topoisomerase IV (EcTopoIV)</td><td align="center" valign="middle" rowspan="1" colspan="1">1S16</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;118.8</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> DNA gyrase B (MtDNAGyrB)</td><td align="center" valign="middle" rowspan="1" colspan="1">3ZKD</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;118.3</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> protein tyrosine phosphatase (MtPTPB)</td><td align="center" valign="middle" rowspan="1" colspan="1">2OZ5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;107.2</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic>ent</italic>-Polyalthic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> UDP-galactopyranose mutase (MtUGM)</td><td align="center" valign="middle" rowspan="1" colspan="1">4RPL</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;104.4</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> mycocyclosin synthase (MtCYP121)</td><td align="center" valign="middle" rowspan="1" colspan="1">5IBE</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;87.0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;108.2</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Escherichia coli</italic> DNA ligase (EcLigA)</td><td align="center" valign="middle" rowspan="1" colspan="1">2OWO</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;108.5</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> DNA ligase (MtLigA)</td><td align="center" valign="middle" rowspan="1" colspan="1">1ZAU</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;107.2</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Staphylococcus aureus</italic> DNA ligase (SaLigA)</td><td align="center" valign="middle" rowspan="1" colspan="1">4CC6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.8</td><td align="left" valign="middle" rowspan="1" colspan="1">Methyl copalate</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1"><italic>Streptococcus pneumoniae</italic> DNA ligase (SpLigA)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4GLW</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;88.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;109.5</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Cativic acid</td></tr></tbody></table></table-wrap><table-wrap id="ijms-19-01511-t007" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t007_Table 7</object-id><label>Table 7</label><caption><p>MolDock docking energies (kJ/mol) of <italic>Copaifera</italic> diterpenoids with cancer-relevant protein targets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer-Relevant Protein Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDB</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (ave)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Best Docking Ligand</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human androgen receptor (HsAR)</td><td align="center" valign="middle" rowspan="1" colspan="1">5VO4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;67.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;103.2</td><td align="left" valign="middle" rowspan="1" colspan="1">Cativic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human aromatase (HsCYP19A1)</td><td align="center" valign="middle" rowspan="1" colspan="1">5JKW</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;112.7</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic>ent</italic>-Pinifolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human casein kinase II (HsCK2)</td><td align="center" valign="middle" rowspan="1" colspan="1">5N9K</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.0</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human cyclin-dependent kinase 2 (HsCDK2)</td><td align="center" valign="middle" rowspan="1" colspan="1">5JQ8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;91.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;104.1</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human cyclin-dependent kinase 4 (HsCDK4)</td><td align="center" valign="middle" rowspan="1" colspan="1">2W96</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;95.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;117.6</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human cyclin-dependent kinase 6 (HsCDK6)</td><td align="center" valign="middle" rowspan="1" colspan="1">5L2S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;87.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;99.0</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine cyclooxygenase 2 (MmCOX-2)</td><td align="center" valign="middle" rowspan="1" colspan="1">6COX</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;93.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.9</td><td align="left" valign="middle" rowspan="1" colspan="1">Kolavenic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human DNA (cytosine-5)-methyltransferase 1 (HsDNMT1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3SWR</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;102.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;121.8</td><td align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human DNA (cytosine-5)-methyltransferase 3A (HsDNMT3A)</td><td align="center" valign="middle" rowspan="1" colspan="1">2QRV</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;113.4</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Hydroxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human epidermal growth factor receptor (HsEGFR)</td><td align="center" valign="middle" rowspan="1" colspan="1">1XKK</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;81.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;98.8</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human estrogen receptor &#x003b1; (HsER&#x003b1;)</td><td align="center" valign="middle" rowspan="1" colspan="1">1X7E</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;96.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;107.5</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human estrogen receptor &#x003b2; (HsER&#x003b2;)</td><td align="center" valign="middle" rowspan="1" colspan="1">1U3S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;99.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;120.1</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human heat shock protein HSP 90-&#x003b1;</td><td align="center" valign="middle" rowspan="1" colspan="1">5J2X</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.8</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.6</td><td align="left" valign="middle" rowspan="1" colspan="1">Cativic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human insulin-like growth factor 1 receptor (HsIGF1R)</td><td align="center" valign="middle" rowspan="1" colspan="1">3LW0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;86.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.2</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human 5-lipoxygenase (Hs5-LOX)</td><td align="center" valign="middle" rowspan="1" colspan="1">3V99</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.2</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human mitogen-activated protein kinase kinase 1 (HsMEK1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3OS3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;113.5</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b2;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine nuclear factor &#x003ba;-light-chain-enhancer of activated B cells (MmNF-&#x003ba;B)</td><td align="center" valign="middle" rowspan="1" colspan="1">1VKX</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;74.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;87.7</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human p90 ribosomal protein S6 kinase (HsRSK2) <italic>C</italic>-terminal domain</td><td align="center" valign="middle" rowspan="1" colspan="1">4D9U</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;75.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;90.7</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b2;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human p90 ribosomal protein S6 kinase (HsRSK2) <italic>N</italic>-terminal domain</td><td align="center" valign="middle" rowspan="1" colspan="1">4NW6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;86.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;99.7</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine P-glycoprotein</td><td align="center" valign="middle" rowspan="1" colspan="1">3G60</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;116.1</td><td align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human phosphatidylinositol-4,5-bisphosphate 3-kinase (HsPI3K)</td><td align="center" valign="middle" rowspan="1" colspan="1">2A5U</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;84.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.6</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human topoisomerase I (HsTOPO-I)</td><td align="center" valign="middle" rowspan="1" colspan="1">1NH3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;99.6</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human topoisomerase II&#x003b1; (HsTOPO-II&#x003b1;)</td><td align="center" valign="middle" rowspan="1" colspan="1">4FM9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;105.2</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human topoisomerase II&#x003b2; (HsTOPO-II&#x003b2;)</td><td align="center" valign="middle" rowspan="1" colspan="1">4J3N</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;98.9</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bovine tubulin (colchicine binding site)</td><td align="center" valign="middle" rowspan="1" colspan="1">1SA1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;103.8</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bovine tubulin (paclitaxel binding site)</td><td align="center" valign="middle" rowspan="1" colspan="1">1JFF</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;79.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;88.6</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Bovine tubulin (vinblastine binding site)</td><td align="center" valign="middle" rowspan="1" colspan="1">1Z2B</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;101.0</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Human vascular endothelial growth factor receptor (HsVEGFR)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4ASE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;92.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;105.5</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">7-acetylbacchotricuneatin D</td></tr></tbody></table></table-wrap><table-wrap id="ijms-19-01511-t008" orientation="portrait" position="float"><object-id pub-id-type="pii">ijms-19-01511-t008_Table 8</object-id><label>Table 8</label><caption><p>MolDock docking energies (kJ/mol) of <italic>Copaifera</italic> diterpenoids with cancer-relevant protein targets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Inflammation-Relevant Protein Targets</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">PDB</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (ave)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>E</italic><sub>dock</sub> (min)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Best Docking Ligand</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine soluble epoxide hydrolase (MmEPHX2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1CR6</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;108.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;125.6</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human soluble epoxide hydrolase (HsEPHX2)</td><td align="center" valign="middle" rowspan="1" colspan="1">4HAI</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;95.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;104.5</td><td align="left" valign="middle" rowspan="1" colspan="1"><italic>ent</italic>-Agathic_acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human fibroblast collagenase (HsMMP-1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1CGL</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;96.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;109.0</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Porcine phospholipase A2 (SsPLA2)</td><td align="center" valign="middle" rowspan="1" colspan="1">2B03</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.0</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;112.4</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human phospholipase A2 (HsPLA2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1J1A</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;95.4</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;109.5</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human 5-lipoxygenase (Hs5-LOX)</td><td align="center" valign="middle" rowspan="1" colspan="1">3V99</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;89.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.2</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine inducible nitric oxide synthase (MmiNOS)</td><td align="center" valign="middle" rowspan="1" colspan="1">1M8D</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;87.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;110.4</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human phosphatidylinositol-4,5-bisphosphate 3-kinase &#x003b3; (HsPI3K&#x003b3;)</td><td align="center" valign="middle" rowspan="1" colspan="1">2A5U</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;84.5</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.6</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human interleukin-1 receptor-associated kinase 4 (HsIRAK4)</td><td align="center" valign="middle" rowspan="1" colspan="1">5T1S</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;90.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.6</td><td align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human glutathione <italic>S</italic>-transferase &#x003c9;-1 (HsGSTO1)</td><td align="center" valign="middle" rowspan="1" colspan="1">5V3Q</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;82.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;94.2</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ovine cyclooxygenase-1 (OaCOX-1)</td><td align="center" valign="middle" rowspan="1" colspan="1">3N8Z</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;62.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;92.0</td><td align="left" valign="middle" rowspan="1" colspan="1">Crolechinic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine cyclooxygenase-2 (MmCOX-2)</td><td align="center" valign="middle" rowspan="1" colspan="1">6COX</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;93.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;106.9</td><td align="left" valign="middle" rowspan="1" colspan="1">Kolavenic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human c-Jun <italic>N</italic>-terminal kinase (HsJNK)</td><td align="center" valign="middle" rowspan="1" colspan="1">4Y46</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;83.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;97.7</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><italic>Xenopus laevis</italic> inhibitor of &#x003ba;B kinase &#x003b2; (XlIKKB)</td><td align="center" valign="middle" rowspan="1" colspan="1">3RZF</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;88.1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;100.9</td><td align="left" valign="middle" rowspan="1" colspan="1">Patagonic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human NF-&#x003ba;B essential modulator (HsNEMO)</td><td align="center" valign="middle" rowspan="1" colspan="1">3BRT</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;105.3</td><td align="left" valign="middle" rowspan="1" colspan="1">3&#x003b1;-Alepterolic acid acetate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human lipid binding protein MD-2 (HsMD-2)</td><td align="center" valign="middle" rowspan="1" colspan="1">2E59</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;71.2</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;84.3</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human myeloperoxidase (HsMPO)</td><td align="center" valign="middle" rowspan="1" colspan="1">4C1M</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;84.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;98.8</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Murine nuclear factor &#x003ba;-light-chain-enhancer of activated B cells (MmNF-&#x003ba;B)</td><td align="center" valign="middle" rowspan="1" colspan="1">3DO7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;72.7</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;85.9</td><td align="left" valign="middle" rowspan="1" colspan="1">(+)-Hardwickiic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human p38 mitogen-activated protein kinase (Hsp38MAPK)</td><td align="center" valign="middle" rowspan="1" colspan="1">1OZ1</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;91.3</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;116.4</td><td align="left" valign="middle" rowspan="1" colspan="1">19-<italic>O</italic>-Acetyl-1,2-dehydrokautriwaic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Human peroxisome proliferator-activated receptor &#x003b3; (HsPPAR&#x003b3;)</td><td align="center" valign="middle" rowspan="1" colspan="1">3ADV</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;91.9</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;107.6</td><td align="left" valign="middle" rowspan="1" colspan="1">Copaiferolic acid</td></tr><tr><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">Human cAMP-specific 3&#x02032;,5&#x02032;-cyclic phosphodiesterase 4D (HsPDE4D)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5K32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;90.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02212;107.3</td><td style="border-bottom:solid thin" align="left" valign="middle" rowspan="1" colspan="1">7&#x003b1;-Acetoxyhardwickiic acid</td></tr></tbody></table></table-wrap></floats-group></article>